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ABSTRACT 
FACTOR INHIBITING HIF’S (FIH) STRUCTURE CONTROLS O2 ACTIVATION 
AND REACTIVITY 
 
SEPTEMBER 2014 
 
JOHN A. HANGASKY III  
 
B.S., B.S., UNIVERSITY OF NEW HAVEN 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Michael J. Knapp 
 
 
Factor Inhibiting HIF (FIH) is a Fe(II)-αKG dependent oxygenase that acts as a 
cellular oxygen sensor in humans.  FIH regulates the transcriptional activity of the 
hypoxia-inducible factor-1 (HIF-1α or HIF), a transcription factor responsible cellular O2 
homeostasis.  Hydroxylation of the target residue HIF-Asn803, found in the C-terminal 
transactivation domain (CTAD), inactivates HIF-dependent gene expression. Central to 
FIH’s function is the activation of O2 after CTAD binding.  The mechanistic and 
structural features of FIH leading to tight coupling between CTAD binding and 
subsequent O2-activation and reactivity are key for efficient O2 sensing.  
Our mechanistic studies of WT FIH have revealed inverse solvent isotope effects 
(SIE) in the steady-state rate constants at limiting concentrations of CTAD or αKG 
providing direct evidence for aquo release during steady-state turnover.  Moreover, the 
inverse SIEs arise due to a rate-limiting O2 activation step.  Characterization of FIH’s O2 
activation mechanism using a suite of kinetic probes indicates FIH limits its overall 
activity through αKG decarboxylation.   
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A key aspect of FIH’s catalytic cycle is that binding and positioning of CTAD 
precedes O2-activation, yet the means by which CTAD binding stimulates O2 activation 
is not well understood.  The steady-state characterization of five FIH-Gln239 variants 
tested the role of hydrogen bonding and sterics near the target residue.  Coupling ratios 
indicated a disconnect between O2 activation and CTAD hydroxylation in these variants, 
whereas WT was tightly coupled. This characterization showed that the proper 
positioning of HIF-Asn803 by FIH-Gln239 is necessary to suppress uncoupled turnover and 
to support substrate hydroxylation. 
The facial triad carboxylate of FIH (Asp201) makes a hydrogen bond to the axial 
aquo ligand that must be displaced O2 activation to occur.  Kinetic pKa’s observed for 
Asp201→Gly indicate the H-bond gives stability to the Fe-H2O. Increased 
autohydroxylation rates were observed for Asp201→Glu compared to WT. New O2 
dependent chromophores are observed for Asp201→Gly and Asp201→Ala suggesting this 
H-bond is crucial to controlling O2 reactivity. 
Overall, the data suggests FIH’s structure controls O2 activation.  Gln239 ensures 
proper positioning of HIF-Asn803  and Asp201 provides stability to the Fe-H2O suppressing 
autohydroxylation.  These structural features allow for FIH to efficiently sense O2 to 
properly regulate HIF mediated gene transcription. 
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PREFACE 
 This dissertation focuses on mechanistic studies aimed to probe O2 activation in 
the nonheme Fe(II)/αKG hydroxylase Factor Inhibiting HIF (FIH). Chapter 1 presents 
background information on the molecular mechanisms of O2 sensing in bacteria and 
mammalians.  Portions of Chapter 1 have been published in Metallomics (2013) and the 
Journal of Inorganic Biochemistry (2014). 
 Chapter 2 focuses on the general methodologies used for sample preparation, 
experimental design and data collection.  The exact experimental conditions used for 
experiments can be found in the subsequent chapters. 
 Chapter 3 presents a study based on solvent isotope effects of FIH, which indicate 
an O2 activation step as rate-limiting. Dr. Evren Saban, while a graduate student in the 
Knapp lab, performed the initial solvent isotope effect assays.  I completed the solvent 
isotope effect assays, as well as the pH, viscosity and ionic strength profile experiments.  
This work was published in Biochemistry (2013). 
 Chapter 4 complements the solvent isotope effect study, identifying the overall 
rate-limiting step as αKG decarboxylation.  This work was done in collaboration with 
Professor Nathaniel E. Ostrom and Dr. Hasand Gandhi at Michigan State University, who 
performed the 18O KIE analysis.  Meaghan Valliere, an undergraduate from UMass-
Amherst (B.S., 2014), was instrumental in this work, collecting the steady-state kinetic 
data varying O2. I prepared the samples for 18O KIE analysis and performed control 
experiments, as well as the complete analysis of the data.   
 Chapter 5 presents a study examining the role of substrate positioning in O2 
reactivity.  Geoffrey Ivison, an undergraduate from Hampshire College (B.A., 2012), 
  
 
ix 
helped prepare and purify all protein samples, performed initial steady-state assays 
varying CTAD and performed the DSC analysis. I completed the steady-state assays 
varying CTAD and αKG, performed the solvent isotope effect experiments, fluorescence 
titrations and collected the coupling data.  This chapter was published in Biochemistry 
(2014). 
 Chapters 6 and 7 present studies aimed to probe the contributions of the facial 
triad carboxylate to controlled O2 activation and reactivity. Cornelius Taabazuing, a 
fellow graduate student in the Knapp Lab, performed the initial screen of exogenous 
ligands with WT FIH and dose-response curves involving NO with WT FIH and 
Asp201→Gly in Chapter 7. Although these studies are not complete, correlations between 
the facial triad carboxylate and O2 reactivity are becoming apparent. 
 Chapter 8 reflects on the overall work presented in this dissertation and identifies 
potential new directions for future work. 
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CHAPTER 1 
BIOCHEMICAL APPROACHES TO CELLULAR O2 SENSING  
Portions of this chapter have been published as: Taabazuing, C.Y.; Hangasky, J.A.; 
Knapp, M.J. J. Inorganic. Biochem. 133, 2014 63-72. and Hangasky, J.A.; 
Taabazuing,C.Y.; Valliere, M.A.; Knapp, M.J. Metallomics 5, 2013 287-301. 
 
 
1.1 Introduction 
O2 is essential for aerobic life.  Cellular respiration involves a complex series of 
biochemical reactions beginning with glycolysis and ending with the reduction of O2 to 
water.  Glycolysis breaks down glucose into two pyruvate molecules. Pyruvate oxidation 
forms acetyl CoA and in the presence of O2 enters the citric acid cycle.  The citric acid 
cycle is an eight-step reaction cycle producing the electron carrier molecules NADH and 
FADH2. These molecules serve as electron carriers for the electron transport chain 
(ETC), ultimately leading to the reduction of O2 to H2O (Figure 1.1). These pathways are 
composed of numerous proteins and enzymatic reactions, but can be expressed, in its 
simplest form, with a net chemical equation. 
 C!H!"O! + 6O! → 6CO! + 6H!O + Energy (ATP) 
 
The energy from these chemical reactions is in the form of adenosine-5’-triphosphate 
(ATP), with ~30 molecules formed per reaction cycle1.  In the absence of O2, anaerobic 
glycolysis produces only 2 molecules of ATP and leads to the accumulation of lactic 
acid. 
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Figure 1.1. Cellular Respiration. ETC, Electron Transport Chain. 
 
Approximately 95% of the O2 we breathe is consumed for cellular respiration and 
the production of ATP.  The remaining 5% having key roles in biochemical processes 
including amino acid metabolism, signal transduction, drug detoxification, fatty acid 
metabolism and nucleic acid synthesis2.  Cells have developed numerous strategies to 
regulate O2 homeostasis allowing for these processes to occur, ensuring enough ATP is 
produced, as well as prevent oxidative stress resulting from reactive oxygen species 
(ROS). Strategies to minimize and regulate cellular ROS include enzymatic reactions 
with peroxidases and superoxide dismutase. One of the cellular strategies used in humans 
to maintain cellular O2 homeostasis is to sense changes in pO2 resulting in changes in 
gene expression.  This document will focus on the human hypoxia sensor, Factor 
Inhibiting HIF (FIH) and the molecular mechanisms used to regulate the transcriptional 
activity of the Hypoxia Inducible Factor-1α (HIF).  
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1.2 O2 sensing strategies 
Maintaining cellular O2 homeostasis is key to cellular development and function 
in both mammalian and bacterial cells.  Many O2 sensing strategies involve 
metalloproteins that either reversibly or irreversibly bind O2, ultimately leading to O2 
dependent regulation of gene expression. Reversible binding of O2 generally induces 
conformational changes of the sensing protein initiating signal transduction. Irreversible 
O2 binding results in the catalysis of oxidation reactions to elicit a transcriptional 
response. The evolution of O2 sensing strategies found in mammals and bacteria appear 
to have diverged from one another.  Mammalian strategies primarily rely on nonheme 
iron proteins, where as bacterial strategies rely on heme and iron-sulfur centered proteins. 
 
1.2.1 Bacterial O2 sensing Strategies 
Bacterial responses to changes in pO2 are crucial for balancing central metabolism 
as well as inducing cellular machinery needed for specialized metabolic pathways. These 
pathways include nitrogen fixation, hydrogen production and sulfate reduction, which 
utilize enzymes with metal cofactors that are highly sensitive to O2. Bacteria rely largely 
on sensory proteins containing [Fe–S] clusters or hemes to regulate gene expression in 
response to changes in pO2.  
Bacterial sensor proteins bind O2 to the iron cofactor leading to altered 
downstream effects. Reversible binding of O2 to the heme protein sensors induces 
structural changes that affect binding to DNA or other proteins, allowing for reversible 
and dynamic gene regulation based on the O2-binding equilibrium. Heme-based sensors 
have been classified by their heme-binding-domains into four families3. Well studied 
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heme-sensors include FixL4, EcDos5, AxPDEA16, HemAT7, and the CO-binding sensor 
CooA8. In contrast, O2 binding to [Fe–S] clusters leads to cluster degradation and 
diminished DNA binding affinity of the sensory proteins, making O2 sensing responsive 
to multiple steps, such as sensor protein production, cluster degradation, and 
metallocluster formation. [Fe–S] proteins such as FNR9, NreB10, ArnR11, and WhiB12 all 
sense O2; other reactive species such as CO, NO, and reactive oxygen species are sensed 
in a similar way. 
Two modes of bacterial O2 sensing are direct transcriptional control and two-
component signaling cascades. The well studied O2-sensor FNR exemplifies direct 
transcriptional control, as the [Fe4S4]2 + cofactor is degraded by O2, leading to attenuated 
DNA binding affinity9. The classic example of a two component signal transduction 
pathway for O2 sensing is the FixL/FixJ system, in which the O2 sensing protein (FixL) 
relays its response to varying pO2 through a histidine kinase (HK) domain to the response 
regulator protein (FixJ). The sensing proteins in these latter systems are typically heme-
based sensing proteins, with exceptions to this including the [Fe–S] two component 
systems NreBC10,13,14 and AirSR15. 
1.2.1.1 Sensing of O2 by transcriptional regulators 
Direct O2 sensing at the transcriptional level occurs when the sensor serves the 
dual roles of O2 binding and DNA binding. FNR is one of the most extensively studied 
O2-sensing DNA binding proteins. Escherichia coli FNR is a 53 kDa homodimeric 
protein16 under anaerobic conditions, with each monomer containing a [Fe4S4]2 + cluster 
coordinated by four cysteine residues9,16,17. Dimeric FNR binds to DNA to promote the 
expression of genes for proteins involved in anaerobic metabolism and to repress those 
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involved in aerobic metabolism18. 
The cofactor of FNR is highly sensitive to O2 in vitro, with ~ 95% activity at 
0.3 µM O2 but only ~ 50% activity at 6 µM O219, which mirrors in vivo measurements20. 
Upon exposure to O2, the [Fe4S4]2 + cluster of FNR rapidly degrades to [Fe2S2]2 + (Figure 
1.2)18,21,22.  The rapid [Fe4S4]2 + to [Fe2S2]2 + cluster conversion leads to the dissociation 
of homodimeric FNR into its subunits, ultimately weakening the DNA-binding18,23. There 
are two proposed mechanisms for oxidative decomposition of the [Fe4S4]2 + clusters: 
metal oxidation24–27 and sulfur-based oxidation17,28,29. Regardless of the mechanism for 
cluster conversion, when exposed to superoxide, [Fe2S2]2 + FNR converts to apo-FNR 
(Figure 1.2)22.  In vivo, the reactivation of apo-FNR to [Fe4S4]2 + FNR is possible under 
anaerobic conditions30, most likely utilizing the Isc pathway proteins31. 
 
 
Figure 1.2. O2 sensing by FNR. A) FNR protein domain arrangement. B) FNR [Fe4S4]2 + 
cluster degradation. In the presence of O2, the FNR [Fe4S4]2 + cofactor is rapidly oxidized 
to [Fe2S2]2 +, leading to dissociation of dimeric FNR. Reconstitution of the [Fe4S4]2 + 
cluster in FNR occurs through the Isc pathway in vivo, but can also be reconstituted in 
vitro by exogenous Fe2 + and DTT.29 
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1.2.1.2 Two-component signal transduction 
Two component signal transduction is a fundamental signaling pathway primarily 
found in prokaryotes, with limited examples in eukaryotic systems32–34.  The two 
components referred to in these systems are: 1) a sensory protein; and 2) a response-
regulator protein. The sensing protein is a multidomain protein with a sensing domain 
and a histidine kinase (HK) domain. Ligand binding to the sensing domain induces an 
ATP dependent autophosphorylation on the HK domain. Subsequent phosphoryl group 
transfer from the HK domain to the response-regulator protein transduces the signal. As 
phosphorylation of the response-regulator protein can stimulate or repress gene 
expression of downstream targets depending on the specific system, two-component 
signal transduction can lead to a wide variety of sensory responses. 
Representative bacterial O2-sensing two-component signal transduction systems 
include Aer235, DosS-R, DosT-R36, and FixL/FixJ37. The FixL/FixJ two component 
signal transduction sensor pathway exemplifies many of the key features needed for O2 
sensing. FixL/FixJ was first identified in Sinorhizobium meliloti (SmFixL)38 but has been 
characterized in other bacterial systems including Bradyrhizobium japonicum (BjFixL) 
and Rhizobium etli (ReFixL), with a homologous FixL in the algae Chlamydomonas 
reinhardtii 39. These two-component regulatory systems are found widely, even in 
Mycobacterium tuberculosis, a pathogen responsible for causing tuberculosis40. 
FixL proteins contain a HK domain and at least one PAS (Per–ARNT–Sim) 
domain, which contains the heme that binds O2 (Figure 1.3)37. FixL has a relatively low 
O2 affinity (KD ~ 100 µM)41–43, allowing for physiological changes in pO2 to alter the 
transcriptional activity of FixJ. Under hypoxic conditions, the unligated five coordinate 
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high spin Fe(II) of FixL induces gene expression44–47 as this state of FixL 
autophosphorylates a conserved His residue within its HK domain. Phosphoryl transfer to 
a conserved Asp residue in the response regulator FixJ4 induces a conformational change 
that leads to dimerization, thereby increasing the affinity for the fixK promoter and 
inducing gene expression48,49.  Upon binding of O2, the Fe(II) converts to low spin six 
coordinate geometry, flattening the heme ring and disrupting hydrogen bonding 
interactions to the heme propionate groups. Most notable is the distal arginine residue 
breaking a salt bridge with a heme propionate group to help stabilize O2, initiating the 
conformational change of FixL's FG loop needed to inhibit phosphorylation50–52. 
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Figure 1.3. A) Protein crystal structure of the heme binding PAS domain of FixL from B. 
japonicum in the unliganded Fe3 + oxidation state (PDB 1LSW)51, with the 
conformationally mobile FG loop labeled in black. B) The heme active site of BjFixL. 
Hydrogen bond interactions to the heme propionate groups have a significant role in 
shifting the FG loop conformation for oxy-FixL, slowing autophosphorylation42,50–55 C) 
Protein constructs of BjFixL, ReFixL and SmFixL. The empty N-terminal PAS domain 
likely tunes O2 affinity and influences signal transduction.56–59 
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1.2.1.3 Hemerythrin-domain proteins 
Recent research shows that hemerythrin-like diiron proteins are emerging as O2 
sensors in both bacteria and humans. While hemerythrin (Hr) is a classic O2 binding 
protein from invertebrates, proteins containing an Hr-like domain have been found in 
bacteria and mammalian cells60–62 where they are proposed to sense O2 and/or Fe levels.  
Bacterial hemerythrin DcrH-Hr is thought to function as an O2-sensor, using the 
[Fe(II) Fe(II)] cofactor found within its Hr-like domain. Invertebrate Hrs reversibly bind 
O2 to the reduced form of the cofactor to form oxy-Hr: [Fe(II) Fe(II)] + O2 ⇋ [Fe(III) 
Fe(II) O2−] [139]. As invertebrate oxy-Hr is relatively stable, O2 can be delivered before 
oxy-Hr undergoes the much slower auto-oxidation process which forms met-Hr: [Fe(II) 
Fe(III) O2−] ⟶ [Fe(III) Fe(III)] + H2O2. In contrast, oxy DcrH-Hr rapidly auto-oxidizes 
to form an extremely stable met-DcrH-Hr, suggesting a role in O2-sensing rather than 
reversible O2 delivery63–65 (Figure1.4). Structural features identified in DcrH-Hr that are 
proposed to promote rapid auto-oxidation and lead to its function as a sensor include a 
large solvent channel that would facilitate O2 and water access65. 
 
Scheme 1.1. Proposed Hemerythrin O2 Reaction Mechanism. Adapted from Ref. 63. 
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The signal transduction mechanism for O2-sensing in proteins containing a 
bacterial Hr domain likely relies on an oxidation-state dependent conformational change 
in the Hr domain. Recently, O2-sensing was demonstrated for the protein known as Bhr-
DGC, a bacterial hemerythrin from Vibrio cholerae66. The rate for producing cyclic di-
GMP, a secondary messenger in bacteria, by Bhr-DGC decreased by 10-fold when the 
protein was oxidized to the [Fe(III) Fe(III)] oxidation state, indicating that oxidation by 
O2 to form met Bhr-DGC led to a detectable change in an important signaling molecule66. 
 
1.2.2 Mammalian O2 sensing strategies 
Mammals use numerous mechanisms to adapt to changes in pO2. Maintaining 
oxygen homeostasis is imperative to prevent disease states such as cancer, ischemia and 
stroke. Proposed O2 sensing proteins in mammals include three isoforms of heme 
oxygenase (HO-1/2/3), F-box and leucine-rich repeat protein 5 (FBXL5) and the hypoxia 
inducible factor (HIF) hydroxylases.   The HO isoforms have high affinity for O2 
(P50(O2)=13-36 nM)67,68 and are not capable of responding to subtle changes in pO2 for 
efficient O2 sensing. HO-2 was identified in knockout mouse models as a potential 
hypoxia sensor69, but the mechanisms connecting HO-2 and hypoxia have yet to be fully 
resolved70. 
1.2.2.1 F-box and leucine-rich repeat protein 5 (FBXL5) 
FBXL5 is a human protein containing a HR-like domain that imparts O2-
dependent stabilization to the protein. Although it is not clear as to whether or not 
FBXL5 serves to sense physiological relevant changes in [O2], this protein does connect 
Fe homeostasis to O2 levels. FBXL5 is an adaptor protein that binds to IRP2 and an SCF 
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E3 ubiquitin ligase, imparting O2 and Fe sensitivity to the IRP2 protein in human cells. 
This leads to the proteasomal degradation of IRP2 in the presence of Fe and O2 60,71 as a 
cellular signal that [Fe] levels are sufficiently high. 
The N-terminal HR domain of FBXL5 reversibly binds a [Fe(II) Fe(II)] cofactor 
which closely resembles the structure of the canonical Hr72,73. As the reduced form of 
FBXL5 is in equilibrium with unfolded FBXL5, it is degraded by the cell, allowing IRP2 
to accumulate. Upon exposure to O2, the cofactor oxidizes to the [Fe(III) Fe(III)] 
oxidation state which locks in the structure of FBXL5, thereby stabilizing this protein. 
Oxidized FBXL5 binds IRP2 and an SCF E3 ubiquitin ligase, leading to IRP2 
ubiquitinylation and degradation. Consequently, FBXL5 responds to both [Fe] and [O2], 
with IRP2 degradation as the signal for sufficient levels of these essential compounds.  
FBXL5 does not form an observable O2-adduct, suggesting that cofactor 
oxidation may involve an alternate chemical mechanism.  Crystal structures of FBXL5 
(PDBID: 3V5Z, 3V5Y, 3V5X)73 show that the binding pocket of FBXL5 is not large 
enough for O2 binding, suggesting an outer sphere electron transfer between O2 and the 
[Fe(II) Fe(II)] center73. Unlike DcrH-Hr, which has been demonstrated to directly bind 
O2, there is strong experimental evidence that FBXL5 does not bind O2 at the dinuclear 
center72,73, including NMR studies ruling out significant conformational changes  
1.2.2.2 Hypoxia Inducible Factor 
The most prominent model for controlling O2 homeostasis is the regulation of the 
transcription factor hypoxia inducible factor (HIF), as it is the master regulator of O2 
homeostasis and controls the O2 dependent transcription of over 100 genes74.  These 
genes are crucial for angiogenesis, energy and glucose metabolism, cell proliferation and 
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migration, erythropoiesis and apoptosis75–77.  HIF contains a basic-Helix-Loop-Helix 
(bHLH) domain involved in DNA binding, a Per-Arnt-Sim(PAS) domain involved in 
protein-protein interaction, an oxygen dependent degradation domain (ODDD) and a C-
terminal transactivation domain (CTAD).78  In normoxic cells, HIF is found in the 
cytoplasm79.  Under hypoxic conditions, HIF translocates to the nucleus of the cell80 and 
dimerizes with the constitutively expressed HIF-1β.  This heterodimer binds to hypoxia 
response elements (HREs) of target gene promoters and the binding of transcription co-
activator p300 initiates gene expression.   
Many of the genes HIF activates are important for normal cellular processes such 
as pH regulation, energy metabolism, cell proliferation and angiogenesis and 
vascularization.75 Likewise, many disease states have been attributed in part to 
overexpression of HIF. For example cancers including brain, breast, colon, liver, stomach 
and leukemia have been reported to be hypoxic and to have elevated HIF levels.81  The 
mechanisms by which cellular levels of HIF and HIF-mediate gene expression  are 
controlled are key for not only understanding fundamental aspects of cellular growth and 
development, but also for the treatment of numerous disease states.82,83 
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Figure 1.4. O2 dependent regulation of HIF. 
 
1.2.2.3 HIF Hydroxylases 
HIF relies on post-translational modification by a small number of enzymes, 
known as the HIF hydroxylases, to regulate both its cellular concentrations and 
transcriptional activity based on pO2 (Figure 1.4).84–86 The HIF hydroxylases include 
three isoforms of prolyl hydroxylase domain (PHD1, PHD2, PHD3) and factor inhibiting 
HIF (FIH). These enzymes are mononuclear nonheme Fe(II)/ αKG dependent oxygenases 
that activate O2 and hydroxylate HIF. The PHD isoforms hydroxylate two proline 
residues, HIF-Pro402 and HIF-Pro564 found in the ODDD87.  This post-translational 
modification leads to recognition by the E3-ubitiquitin ligase known as Von Hipple-
Lindau (pVHL) ultimately resulting proteasomal degradation87,88.  FIH hydroxylates the 
β-carbon of HIF-Asn803 found in the CTAD89.  This hydroxylation does not affect the 
dimerization of the HIFαβ complex or binding of the HRE, but prevents the recruitment 
of the transcription coactivator p300.90 HIFα interacts with p300 CH-1 
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(Cysteine/Histidine rich) domain91 and the hydroxylation of Asn803 proposed to disrupt 
this interaction, leading to inactivation of the target gene.92 
There are two predominant reasons to study the molecular mechanism of the HIF 
hydroxylases.  First, the HIF hydroxylases are of therapeutic interest to treat diseases 
such as myocardial ischemia, anemia and gastrointestinal disease, as well as improve 
stem cell proliferation.120-122 However, due to the conserved active site structure of the 
PHD isoforms, FIH and related Fe(II)/αKG oxygenases (see Section 1.4), developing 
selective inhibitors is challenging.123  Inhibitor selectivity typically focuses on unique 
interactions and pockets within the active site.  Identifying enzyme forms that naturally 
accumulate may open new avenues for designing potent inhibitors.  Second, O2 activation 
in nonheme iron enzymes is not well understood.  As O2 sensors, we hypothesize the HIF 
hydroxylases are ideal enzymes to study O2 activation in nonheme iron enzymes. 
 
1.3 Linking FIH’s Structure to O2 Sensing 
Numerous crystal structures of FIH and FIH variants in complexes with various 
substrates and inhibitors are readily available (Table 1.1).  These structures have helped 
identify residues key to turnover and have guided biochemical studies elucidating unique 
mechanistic and structural features of FIH.  Previous studies have shown FIH is only 
active in a dimeric state and the kinetic parameters for FIH are slow (kcat = 30 min-1, 
kcat/KM(CTAD) = 0.40 µM min-1).115,116 Also, FIH’s two half reactions are tightly coupled 
and ROS are not formed.117 Mutation of first and second coordination sphere residues of 
FIH identified residues important for αKG decarboxylation and CTAD 
hydroxylation.109,115 Although FIH and other Fe(II)/αKG oxygenases have been 
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intensively studied over the past decade, the key structural features leading to efficient O2 
sensing by FIH remain largely unknown.  Based on the function of FIH as an O2 sensor, 
we hypothesized FIH could be a model enzyme to study O2 activation and the structural 
aspects controlling O2 reactivity in Fe(II)/ αKG oxygenases. 
One of the challenges of studying O2 activation in nonheme Fe enzymes is that 
the transient intermediates are spectroscopically silent.  Many O2 activation studies are 
performed using FeNO adducts,118 computationally114 or using small molecule 
complexes.119 We took an alternative approach to understand O2 activation in FIH and 
used a combination of kinetic probes including steady-state kinetics, solvent kinetic 
isotope effects and 18O kinetic isotope effects.  These probes, coupled with site-directed 
mutagenesis allows for the elucidation of molecular details surrounding the contributions 
of FIH’s structure to O2 reactivity. 
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Table 1.1. Structures of FIH deposited in the PDBa. 
a.  All structures of the homo sapien FIH. 
 
 
 
 
     
PDB 
 ID 
Resolution 
(Å) 
Enzyme  
Form 
Water 
Ligand 
Present 
H-bond 
Length 
(Å) 
1MZE16 2.20 (Fe+Tartrate)FIH No 
 1MZF16 2.40 (Fe+αKG)FIH Unresolved 
 1H2K126 2.15 (Fe+NOG+CTAD(41-mer))FIH No 
 1H2M126 2.50 (Zn+NOG+CTAD(52-mer))FIH No 
 1H2N126 2.84 (Fe+αKG)FIH No 
 1H2L126 2.25 (Fe+αKG+CTAD(41-mer))FIH No 
 1IZ3124 2.80 ApoFIH No 
 1YCI125 2.70 (Fe+N-(carboxycarbonyl)-D-phenylalanine)FIH Yes 2.62 
2CGN132 2.40 (Fe+Succinate)FIH No 
 2CGO132 2.30 (Fe+Fumarate)FIH Yes 2.73 
2ILM109 2.30 (Fe+αKG+CTAD(35-mer))D201A FIH No 
 3D8C109 2.10 (Zn+αKG+CTAD(19-mer))D201G FIH No 
 2WOX133 2.12 (Fe+Pyridine 2,4 Dicarboxylic Acid)FIH No 
 2WA3133 2.50 (Fe+2-(3-Hydroxyphenyl)-2-oxoacetic acid)FIH No 
 2WA4133 2.50 (Fe+N,3-Dihydroxybenzamide)FIH No 
 3KCX129 2.60 (Fe+Clioquinol)FIH No 
 3KCY129 2.59 (Fe+8-hydroxyquinoline)FIH No 
 3P3N130 2.40 (Fe+αKG+Notch-1)FIH Yes 2.65 
3P3P130 2.60 (Fe+αKG+Notch-1)FIH Yes 2.85 
2XUM127 2.20 (Zn+NOG+Asp-Substrate(20-mer))Q239H FIH Yes 2.59 
2Y0I134 2.28 (Fe+αKG+TNKS2(21-mer))FIH Yes 2.85 
2YCO128 2.15 (Fe+R-2-Hydroxyglutarate)FIH No 
 2YDE128 2.28 (Fe+S-2-Hydroxyglutarate)FIH No 
 3OD4137 2.20 (Zn+8-hydroxyquinoline-5-carboxylic acid)FIH No 
 4AI8131 2.40 (Fe+Daminozide)FIH Yes 2.52 
4B7E135 2.5 (Fe+NOG+Ankyrin-Leu(20-mer))FIH No 
 4B7K135 2.39 (Fe+NOG+Ankyrin-Ser(20-mer))FIH No 
 4BIO136 2.45 (Fe+8-hydroxyquinoline-5-carboxylic acid)FIH Yes 2.96 
4JAA138 2.39 (Zn+NOG+Ankyrin-Leu)FIH No 
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1.4 Fe(II)/αKG dependent oxygenases  
The Fe(II)/αKG dependent oxygenase superfamily require molecular oxygen to 
catalyze a diverse range of oxidation reactions ranging from hydroxylations and  
demethylations to desaturations and ring closure reactions93.  This family of enzymes 
shares a common chemical mechanism leading to the oxidation of an unactivated C-H 
bond.  These enzymes sequentially bind Fe(II), αKG, the primary substrate and O2.  Due 
to the sterics of the primary substrate binding above the Fe(II) active site, the axial aquo 
ligand is subsequently released opening a coordination site for O2.94  The binding and 
activation of O2 leads to the oxidative decarboxylation of αKG forming a highly reactive 
ferryl intermediate.  The ferryl intermediate is the oxidant catalyzing the insertion of an O 
atom into an unactivated C-H bond by abstracting the hydrogen atom (HAT) and 
subsequent  •OH rebound hydroxylates the primary substrate (Scheme 1.2). 93,95 
 
Scheme 1.2. General mechanism for Fe(II)/αKG dependent oxygenases. 
 
The overall chemical reaction is divided into two half reactions. The oxidative half 
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reaction includes the steps of O2 activation forming succinate and the ferryl intermediate.  
The reductive half reaction involves the steps of the ferryl intermediate reacting with the 
primary substrate.  When the reaction stoichiometry is one to one, the overall reaction is 
coupled.  A disconnect between O2 activation and substrate oxidation uncouples the 
overall reaction, producing more succinate than hydroxylated product.  Uncoupling can 
potentially lead to protein inactivation or formation of ROS.  Although WT FIH half 
reactions are tightly coupled, variants of FIH could alter the coupling ratio.  In Chapter 5, 
coupling ratios are determined for Gln239 variants and suggest the mis-positioning of 
substrate leads to uncoupled turnover. 
1.4.1 Autohydroxylation 
Many of the αKG oxygenases undergo autohydroxylation in the absence of the 
primary substrate.96–102 These enzymes in their resting form will slowly activate O2 to 
oxidative decarboxylation of αKG and form the ferryl intermediate. The ferryl 
intermediate attacks a nearby amino acid group, with appropriate electron density, and 
with subsequent rebound forms a hydroxylated residue. Autohydroxylation chemistry 
indicates that the oxidative and reductive half reactions are separable, as proposed by the 
steps of HAT followed by rebound in the consensus mechanism. 
Autohydroxylation of FIH can be monitored through the formation of a 
chromophore center at 583 nm.98 FIH slowly autohydroxylates as the Fe active site is six 
coordinate until the primary substrate, CTAD, binds and displaces an aquo ligand.139  The 
facial triad carboxylate of FIH, Asp201, hydrogen bonds to the Fe-H2O and may contribute 
to minimizing the rate of autohydroxylation.  Autohydroxylation rates of FIH-Asp201 
variants are determined in Chapter 6. 
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1.5 Oxidative halogenases SyrB2 and CytC3 
The αKG-dependent halogenases contain an active site Fe2+ that resembles those 
found in the αKG oxygenases, with the replacement of the facial triad carboxylate 
(Asp/Glu) residue by an Ala residue and a chloride ligand coordinated to the Fe.103,104 
The chemical mechanism of these halogenases is thought to be very similar to that of the 
αKG hydroxylases, in which oxidative decarboxylation of αKG leads to the ferryl 
intermediate reacting via HAT with the substrate. However, the reductive half reaction 
takes the unique direction of chlorination due to rebound between Cl˙105 and the substrate 
radical; such chlorination chemistry has precedent from small molecule models.106 The 
structural factors that make oxidative decarboxylation lead to chlorination rather than 
hydroxylation are not clear, but analysis of the first and second coordination sphere 
suggests the halogenases use a combination of the sterics and the positioning of primary 
substrate favor halogenation over hydroxylation chemistry. 
A number of studies using alternative substrates or point mutants to identify the 
structural features distinguishing halogenation and hydroxylation chemistry, establishing 
that the difference between an αKG hydroxylase and an αKG halogenase is more 
involved than the presence or absence of the Asp/Glu ligand from the facial triad. It was 
shown that SyrB2 will hydroxylate alternate substrates, suggesting that the partitioning 
between chlorination and hydroxylation is due to the proximity of substrate to the ferryl 
oxo ligand, which affects the relative efficiency of rebound from the ˙OH and ˙Cl 
groups.107 Hausinger et al., prepared the Asp101 → Ala mutant of TauD, however that 
enzyme was inactive for both hydroxylation and halogenation;108 similar attempts by 
Schofield et al., to convert FIH into a halogenase by preparing the Asp201 → Ala mutant 
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were also unsuccessful.109 Preparation of the Ala → Asp and Ala → Glu mutants of 
SyrB2 by Drennan et al., led to enzymes that were similarly inactive for hydroxylation 
and halogenation.104   
Recently, SyrB2 was shown to catalyze the azidation and nitration of 
unactivatived C-H bonds.140 A point mutation of the noncoordinating Ala created less 
steric hindrance in the in the anion binding pocket, significantly increasing the azidation 
and nitration yields. However, as with halogenation chemistry, substrate positioning was 
the dominating factor leading to azidation and nitration.   
Although attempts to convert FIH to a halogenase have been unsuccessful,109 
Chapter 7 explores halide-dependent activity of FIH-Asp201 Variants.  This halide 
dependence suggests Asp201 provides a steric environment necessary for hydroxylation 
chemistry to occur. 
1.6 Stereochemistry of αKG oxygenase active sites 
All of nonheme Fe(II)/αKG dependent oxygenases coordinate the Fe(II) through 
a 2His-1 Carboxylate facial triad.  This motif, in addition to cosubstrate αKG and an 
aquo ligand coordinate the Fe in the resting form.  The coordination of these ligands give 
rise to two stereoisomers of the Fe found in nature, OC-6-35-Anti and OC-6-35-Clock. 
Although the ligand-set found within the active sites of αKG hydroxylases can 
lead to a large number of possible of isomers in the absence of protein linkage, the only 
isomers found in nature are the chiral pair noted above. This means that the Fe of every 
αKG oxygenase adopts the same geometrical arrangement of ligands. In order to 
understand the reasons for this restriction on Fe geometry, we considered each potential 
isomer using an idealized ligand set with Bailar's method110 and then considered the 
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merits of each isomer in the face of protein structure and chemical imperatives. 
All of the isomers considered were octahedral Fe complexes coordinated by six 
ligands; two equivalent histidines, a protein derived carboxylate, one aquo ligand, and a 
bidentate αKG. Each ligand was treated as a single point, and protein connectivity was 
ignored. A convenient frame of reference is the keto O-atom of αKG, as this allows us to 
consider the isomers according to which ligand is trans to this O-atom, and the keto O is 
the highest priority ligand. There are seven possible geometrical isomers, five of which 
are chiral (Figure 1.5). 
 
 
Figure 1.5. Possible isomers for an iron center coordinated by a bidentate αKG, an aquo 
ligand two equivalent histidines (H), and a carboxylate ligand (D). 
 
Each isomer was named using the IUPAC naming convention for metal 
complexes.111 This notation indicates the idealized site symmetry of the metal (O = 
octahedral), the number of ligands (6) and then two numbers indicating the priority of the 
ligands located trans to the highest priority ligands. The ligands were ranked according to 
the following priority: αKG keto > αKG carboxylate > Asp/Glu > H2O > His. When the 
crystal structure contained a monodentate ligand other than water, this ligand was given 
the same priority as H2O, for consistent identification of the exchangeable ligand site. 
The geometrical constraint on O2 reacting with the keto group excludes certain 
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isomers, as the three protein derived ligands can be arranged in a facial (fac) or 
meridional (mer) orientation. As O2 must bind at one of the positions occupied by non-
protein derived ligands, only the fac isomers enable O2 to bind in a fashion permitting 
nucleophilic attack on the keto position. The mer isomers cannot support O2 activation, 
and therefore cannot be found in a functional oxygenase. This is sufficient to explain why 
a facial triad is a defining feature of the αKG oxygenases. As the three fac isomers are 
chiral, there are six total isomers that could support O2 activation. 
Of the three fac isomers, only one has the keto group of αKG trans to the facial 
triad carboxylate. This is the best arrangement for O2 activation from an electronics 
perspective, as it supports good electron flow between the Fe–O2 π-bonding orbitals and 
keto group of αKG. The trans arrangement also ensures that the keto group remains 
bound in the resting enzyme, as the potential for Fe–keto – back-bonding is enhanced 
when the keto group is located trans to the anionic ligand of the facial triad – typically 
Asp. Consequently, the only Fe isomer that is viable for oxygenation is the naturally 
observed OC-6-35(A/C) isomer (Figure 1.5). 
 
1.7 Nonheme Fe(II) O2 Activation  
O2 is kinetically unreactive as it is found in its triplet ground state. Incorporation 
of O2 into substrates relies on the activation of O2.  Nonheme iron enzymes have evolved 
two distinct O2 activation mechanisms for the incorporation of O atoms into substrate: 1) 
substrate based and 2) metal based O2 activation. 
Substrate based activation is utilized by nonheme iron enzymes such as 
lipoxygenase and intradiol dioxygenases.  These enzymes rely on a high spin Fe(III) 
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active site to abstract a substrate based proton to create a substrate-based radical.112 This 
substrate-based radical directly reacts with molecular O2.  Metal based O2 activation 
relies on a high spin Fe(II) active site to directly coordinate O2.  Electron transfer from a 
co-substrate, such as αKG, pterin or an FeS cluster forms an activated Fe-oxo species. 
Among mononuclear nonheme iron enzymes there are numerous proposed (and 
observed) intermediates for metal-based O2 activation. The intermediates proposed for 
αKG oxygenases include Fe(III)-superoxo, Fe(III)-persuccinate and  
Fe(IV)=peroxohemiketal (Figure 1.6).113,114  The cleavage of the O-O bond forms a high 
valent Fe(IV)=O.  As the structural features of the αKG oxygenase are remarkable 
similar, identifying mechanistically unique features of these enzymes O2 activation 
mechanism may be the key to controlling these enzymes activity. 
 
 
Figure 1.6. Proposed O2 Intermediates for Fe(II)/	  αKG oxygenases. 
 
In Chapter 3, solvent isotope effects to identify an O2 activation step as rate-limiting step 
in FIH, focusing subsequent studies on the kinetic parameter kcat/KM(O2).  In Chapter 4, 
oxygen-18 kinetic isotope effects identify the rate-limiting formation of a 
peroxohemiketal or persuccinate transition state structure on kcat/KM(O2) (Figure 1.6). 
 
 
 
  
 
24 
1.8 References 
(1)  Rich, P. R. (2003) The molecular machinery of Keilin’s respiratory chain. 
Biochem. Soc. Trans. 31, 1095–1105. 
(2)  Bertini, I., Gray, H., Stiefel, E., and Valentine, J. (Eds.). (2007) Biological 
Inorganic Chemistry: Structure and Reactivity. University Science Books. 
(3) Gilles-Gonzalez, M. A., and Gonzalez, G. (2005) Heme-based sensors: defining 
characteristics, recent developments, and regulatory hypotheses. J. Inorg. 
Biochem. 99, 1–22. 
(4)  Gilles-Gonzalez, M. A., and Gonzalez, G. (1993) Regulation of the kinase-activity 
of heme protein FixL from the 2-component system FixL/FixJ of Rhizobium-
Meliloti. J. Biol. Chem. 268, 16293–16297. 
(5)  Delgado-Nixon, V. M., Gonzalez, G., and Gilles-Gonzalez, M.A. (2000) Dos, a 
Heme-Binding PAS Protein from Escherichia coli, Is a Direct Oxygen Sensor. 
Biochemistry 39, 2685–2691. 
(6)  Chang, A. L., Tuckerman, J. R., Gonzalez, G., Mayer, R., Weinhouse, H., Volman, 
G., Amikam, D., Benziman, M., and Gilles-Gonzalez, M.A. (2001) 
Phosphodiesterase A1, a Regulator of Cellulose Synthesis in Acetobacter xylinum, 
Is a Heme-Based Sensor. Biochemistry 40, 3420–3426. 
(7)  Hou, S., Larsen, R. W., Boudko, D., Riley, C. W., Karatan, E., Zimmer, M., Ordal, 
G. W., and Alam, M. (2000) Myoglobin-like aerotaxis transducers in Archaea and 
Bacteria. Nature 403, 540–544. 
(8)  Shelver, D., Kerby, R. L., He, Y., and Roberts, G. P. (1997) CooA, a CO-sensing 
transcription factor from Rhodospirillum rubrum, is a CO-binding heme  protein. 
Proc. Natl. Acad. Sci. 94, 11216–11220. 
(9)  Kiley, P. J., and Beinert, H. (1998) Oxygen sensing by the global regulator, FNR: 
the role of the iron-sulfur cluster. FEMS Microbiol. Rev. 22, 341–352. 
(10)  Muellner, M., Hammel, O., Mienert, B., Schlag, S., Bill, E., and Unden, G. (2008) 
A     PAS Domain with an Oxygen Labile [4Fe-4S](2+) Cluster in the Oxygen 
Sensor Kinase NreB of Staphylococcus carnosus. Biochemistry 47, 13921–13932. 
(11)  Nishimura, T., Teramoto, H., Vertès, A. A., Inui, M., and Yukawa, H. (2008) 
ArnR, a Novel Transcriptional Regulator, Represses Expression of the narKGHJI 
Operon in Corynebacterium glutamicum. J. Bacteriol. 190, 3264–3273. 
  
 
25 
(12)  Bhat, S. A., Singh, N., Trivedi, A., Kansal, P., Gupta, P., and Kumar, A. (2012) 
The mechanism of redox sensing in Mycobacterium tuberculosis. Free Radic. Biol. 
Med. 53, 1625–1641. 
(13)  Fedtke, I., Kamps, A., Krismer, B., and Gotz, F. (2002) The nitrate reductase and 
nitrite reductase operons and the narT gene of Staphylococcus carnosus are 
positively controlled by the novel two-component system NreBC. J. Bacteriol. 
184, 6624–6634. 
(14)  Kamps, A., Achebach, S., Fedtke, I., Unden, G., and Gotz, F. (2004) 
Staphylococcal NreB: an O-2-sensing histidine protein kinase with an O-2-labile 
iron-sulphur cluster of the FNR type. Mol. Microbiol. 52, 713–723. 
(15)  Sun, F., Ji, Q., Jones, M. B., Deng, X., Liang, H., Frank, B., Telser, J., Peterson, S. 
N., Bae, T., and He, C. (2012) AirSR, a [2Fe-2S] Cluster-Containing Two-
Component System, Mediates Global Oxygen Sensing and Redox Signaling in 
Staphylococcus aureus. J. Am. Chem. Soc. 134, 305–314. 
(16)  Green, J., Sharrocks, A. D., Green, B., Geisow, M., and Guest, J. R. (1993) 
Properties of FNR proteins substituted at each of the five cysteine residues. Mol. 
Microbiol. 8, 61–68. 
(17)  Khoroshilova, N., Popescu, C., Munck, E., Beinert, H., and Kiley, P. J. (1997) 
Iron-sulfur cluster disassembly in the FNR protein of Escherichia coli by O-2: 
[4Fe-4S] to [2Fe-2S] conversion with loss of biological activity. Proc. Natl. Acad. 
Sci. U. S. A. 94, 6087–6092. 
(18)  Lazazzera, B. A., Beinert, H., Khoroshilova, N., Kennedy, M. C., and Kiley, P. J. 
(1996) DNA binding and dimerization of the Fe-S-containing FNR protein from 
Escherichia coli are regulated by oxygen. J. Biol. Chem. 271, 2762–2768. 
(19)  Jervis, A. J., Crack, J. C., White, G., Artymiuk, P. J., Cheesman, M. R., Thomson, 
A. J., Le Brun, N. E., and Green, J. (2009) The O-2 sensitivity of the transcription 
factor FNR is controlled by Ser24 modulating the kinetics of [4Fe-4S] to [2Fe-2S] 
conversion. Proc. Natl. Acad. Sci. U. S. A. 106, 4659–4664. 
(20)  Becker, S., Holighaus, G., Gabrielczyk, T., and Unden, G. (1996) O-2 as the 
regulatory signal for FNR-dependent gene regulation in Escherichia coli. J. 
Bacteriol. 178, 4515–4521. 
(21)  Jordan, P. A., Thomson, A. J., Ralph, E. T., Guest, J. R., and Green, J. (1997) FNR 
is a direct oxygen sensor having a biphasic response curve. FEBS Lett. 416, 349–
352. 
  
 
26 
(22) Sutton, V. R., Stubna, A., Patschkowski, T., Munck, E., Beinert, H., and Kiley, P. 
J. (2003) Superoxide Destroys the [2Fe-2S]2+ Cluster of FNR from Escherichia 
coli. Biochemistry 43, 791–798. 
(23) Lazazzera, B. A., Bates, D. M., and Kiley, P. J. (1993) The Activity of the 
Escherichia-Coli Transcription Factor FNR is Regulated by a Change is 
Oligomeric State. Genes Dev. 7, 1993–2005. 
(24)  Crack, J., Green, J., and Thomson, A. J. (2004) Mechanism of oxygen sensing by 
the bacterial transcription factor fumarate-nitrate reduction (FNR). J. Biol. Chem. 
279, 9278–9286. 
(25)  Crack, J. C., Gaskell, A. A., Green, J., Cheesman, M. R., Le Brun, N. E., and 
Thomson, A. J. (2008) Influence of the Environment on the [4Fe−4S]2+ to 
[2Fe−2S]2+ Cluster Switch in the Transcriptional Regulator FNR. J. Am. Chem. 
Soc. 130, 1749–1758. 
(26)  Crack, J. C., Green, J., Cheesman, M. R., Le Brun, N. E., and Thomson, A. J. 
(2007) Superoxide-mediated amplification of the oxygen-induced switch from 
[4Fe-4S] to [2Fe-2S] clusters in the transcriptional regulator FNR. Proc. Natl. 
Acad. Sci. 104 , 2092–2097. 
(27)  Crack, J. C., Green, J., Le Brun, N. E., and Thomson, A. J. (2006) Detection of 
Sulfide Release from the Oxygen-sensing [4Fe-4S] Cluster of FNR. J. Biol. Chem. 
281 , 18909–18913. 
(28)  Sutton, V. R., Mettert, E. L., Beinert, H., and Kiley, P. J. (2004) Kinetic analysis of 
the oxidative conversion of the [4Fe-4S](2+) cluster of FNR to a [2Fe-2S](2+) 
cluster. J. Bacteriol. 186, 8018–8025. 
(29)  Zhang, B., Crack, J. C., Subramanian, S., Green, J., Thomson, A. J., Le Brun, N. 
E., and Johnson, M. K. (2012) Reversible cycling between cysteine persulfide-
ligated [2Fe-2S] and cysteine-ligated [4Fe-4S] clusters in the FNR regulatory 
protein. Proc. Natl. Acad. Sci. 109, 15734–15739. 
(30) Mettert, E. L., and Kiley, P. J. (2005) ClpXP-dependent proteolysis of FNR upon 
loss of its O-2-sensing [4Fe-4S] cluster. J. Mol. Biol. 354, 220–232. 
(31)  Mettert, E. L., Outten, F. W., Wanta, B., and Kiley, P. J. (2008) The Impact of O-2 
on the Fe-S Cluster Biogenesis Requirements of Escherichia coli FNR. J. Mol. 
Biol. 384, 798–811. 
(32)  Gao, R., and Stock, A. M. (2009) Biological Insights from Structures of Two-
Component Proteins. Annu. Rev. Microbiol. 63, 133–154. 
  
 
27 
(33) Stock, A. M., Robinson, V. L., and Goudreau, P. N. (2000) Two-component signal 
transduction. Annu. Rev. Biochem. 69, 183–215. 
(34)  West, A. H., and Stock, A. M. (2001) Histidine kinases and response regulator 
proteins in two-component signaling systems. Trends Biochem. Sci. 26, 369–376. 
(35)  Airola, M. V, Huh, D., Sukomon, N., Widom, J., Sircar, R., Borbat, P. P., Freed, J. 
H., Watts, K. J., and Crane, B. R. (2013) Architecture of the Soluble Receptor 
Aer2 Indicates an In-Line Mechanism for PAS and HAMP Domain Signaling. J. 
Mol. Biol. 425, 886–901. 
(36) Green, J., Crack, J. C., Thomson, A. J., and LeBrun, N. E. (2009) Bacterial sensors 
of oxygen. Curr. Opin. Microbiol. 12, 145–151. 
(37) Monson, E. K., Weinstein, M., Ditta, G. S., and Helinski, D. R. (1992) The FixL 
protein of Rhizobium-Meliloti can be separated into a heme-binding oxygen-
sensing doamin and a functional C-terminal kinase domain. Proc. Natl. Acad. Sci. 
U. S. A. 89, 4280–4284. 
(38)  De Philip, P., Batut, J., and Boistard, P. (1990) Rhizobium meliloti Fix L is an 
oxygen sensor and regulates R. meliloti nifA and fixK genes differently in 
Escherichia coli. J. Bacteriol. 172 , 4255–4262. 
(39) Murthy, U. M. N., Wecker, M. S. A., Posewitz, M. C., Gilles-Gonzalez, M.-A., 
and Ghirardi, M. L. (2012) Novel FixL homologues in Chlamydomonas reinhardtii 
bind heme and O-2. FEBS Lett. 586, 4282–4288. 
(40)  Cho, H. Y., Cho, H. J., Kim, Y. M., Oh, J. Il, and Kang, B. S. (2009) Structural 
Insight into the Heme-based Redox Sensing by DosS from Mycobacterium 
tuberculosis. J. Biol. Chem. 284 , 13057–13067. 
(41)  Gilles-Gonzalez, M. A., Gonzalez, G., Perutz, M. F., Kiger, L., Marden, M. C., and 
Poyart, C. (1994) Heme-based sensors, exemplified by the kinase FixL, are a new 
class of heme protein with distinctive ligand-binding and autoxidation. 
Biochemistry 33, 8067–8073. 
(42)  Dunham, C. M., Dioum, E. M., Tuckerman, J. R., Gonzalez, G., Scott, W. G., and 
Gilles-Gonzalez, M. A. (2003) A distal arginine in oxygen-sensing Heme-PAS 
domains is essential to ligand binding, signal transduction, and structure. 
Biochemistry 42, 7701–7708. 
(43) Tanaka, A., Nakamura, H., Shiro, Y., and Fujii, H. (2006) Roles of the herne distal 
residues of FixL in O-2 sensing: A single convergent structure of the heme moiety 
is relevant to the downregulation of kinase activity. Biochemistry 45, 2515–2523. 
  
 
28 
(44)  Anthamatten, D., and Hennecke, H. (1991) The Regulatory Status of the FixL-like 
and FixJ-like Genes in Bradyrhizobium-Japonicum May Be Different From That 
in Rhizobium-Meliloti. Mol. Gen. Genet. 225, 38–48. 
(45)  David, M., Daveran, M. L., Batut, J., Dedieu, A., Domergue, O., GHAI, J., Hertig, 
C., Boistard, P., and Kahn, D. (1988) Cascade Regulation of Nif Gene-Expression 
in Rhizobium-Meliloti. Cell 54, 671–683. 
(46)  Fischer, H. M. (1994) Genetic-regulation of nitrogen-fixation in Rhizobia. 
Microbiol. Rev. 58, 352–386. 
(47)  Virts, E. L., Stanfield, S. W., Helinski, D. R., and Ditta, G. S. (1988) Common 
Regulatory Elements Control Symbiotic and Microaerobic Induction of NifA in 
Rhizobium-Meliloti. Proc. Natl. Acad. Sci. U. S. A. 85, 3062–3065. 
(48) Galinier, A., Garnerone, A. M., Reyrat, J. M., Kahn, D., Batut, J., and Boistard, P. 
(1994) Phosphorylation of the Rhizobium-Meliloti FixJ protein induces its binding 
to a compound regulatory region at the FixK promoter. J. Biol. Chem. 269, 23784–
23789. 
(49) Gouet, P., Fabry, B., Guillet, V., Birck, C., Mourey, L., Kahn, D., and Samama, J. 
P. (1999) Structural transitions in the FixJ receiver domain. Struct. with Fold. Des. 
7, 1517–1526. 
(50)  Gong, W. M., Hao, B., and Chan, M. K. (2000) New mechanistic insights from 
structural studies of the oxygen-sensing domain of Bradyrhizobium japonicum 
FixL. Biochemistry 39, 3955–3962. 
(51)  Hao, B., Isaza, C., Arndt, J., Soltis, M., and Chan, M. K. (2002) Structure-based 
mechanism of O-2 sensing and ligand discrimination by the FixL heme domain of 
Bradyrhizobium japonicum. Biochemistry 41, 12952–12958. 
(52) Hiruma, Y., Kikuchi, A., Tanaka, A., Shiro, Y., and Mizutani, Y. (2007) 
Resonance raman observation of the structural dynamics of FixL on signal 
transduction and ligand discrimination. Biochemistry 46, 6086–6096. 
(53)  Gong, W. M., Hao, B., Mansy, S. S., Gonzalez, G., Gilles-Gonzalez, M. A., and 
Chan, M. K. (1998) Structure of a biological oxygen sensor: A new mechanism for 
heme-driven signal transduction. Proc. Natl. Acad. Sci. U. S. A. 95, 15177–15182. 
(54) Balland, V., Bouzhir-Sima, L., Kiger, L., Marden, M. C., Vos, M. H., Liebl, U., 
and Mattioli, T. A. (2005) Role of arginine 220 in the oxygen sensor FixL from 
Bradyrhizobium japonicum. J. Biol. Chem. 280, 15279–15288. 
 
  
 
29 
(55)  Reynolds, M. F., Ackley, L., Blizman, A., Lutz, Z., Manoff, D., Miles, M., Pace, 
M., Patterson, J., Pozzessere, N., Saia, K., Sato, R., Smith, D., Tarves, P., Weaver, 
M., Sieg, K., Lukat-Rodgers, G. S., and Rodgers, K. R. (2009) Role of conserved 
F(alpha)-helix residues in the native fold and stability of the kinase-inhibited oxy 
state of the oxygen-sensing FixL protein from Sinorhizobium meliloti. Arch. 
Biochem. Biophys. 485, 150–159. 
(56)  Ayers, R. A., and Moffat, K. (2008) Changes in Quaternary Structure in the 
Signaling Mechanisms of PAS Domains. Biochemistry 47, 12078–12086. 
(57)  Key, J., and Moffat, K. (2005) Crystal structures of deoxy and CO-bound bjFixLH 
reveal details of ligand recognition and signaling. Biochemistry 44, 4627–4635. 
(58)  Moeglich, A., Ayers, R. A., and Moffat, K. (2009) Structure and Signaling 
Mechanism of Per-ARNT-Sim Domains. Structure 17, 1282–1294. 
(59)  Sousa, E. H., Tuckerman, J. R., Gondim, A. C., Gonzalez, G., and Gilles-
Gonzalez, M.-A. (2013) Signal Transduction and Phosphoryl Transfer by a FixL 
Hybrid Kinase with Low Oxygen Affinity: Importance of the Vicinal PAS Domain 
and Receiver Aspartate. Biochemistry 52, 456–465. 
(60)  Salahudeen, A. A., Thompson, J. W., Ruiz, J. C., Ma, H.W., Kinch, L. N., Li, Q., 
Grishin, N. V, and Bruick, R. K. (2009) An E3 Ligase Possessing an Iron-
Responsive Hemerythrin Domain Is a Regulator of Iron Homeostasis. Sci. 326, 
722–726. 
(61)  French, C. E., Bell, J. M. L., and Ward, F. B. (2008) Diversity and distribution of 
hemerythrin-like proteins in prokaryotes. FEMS Microbiol. Lett. 279, 131–145. 
(62)  Bailly, X., Vanin, S., Chabasse, C., Mizuguchi, K., and Vinogradov, S. (2008) A 
phylogenomic profile of hemerythrins, the nonheme diiron binding respiratory 
proteins. BMC Evol. Biol. 8, 244. 
(63)  Onoda, A., Okamoto, Y., Sugimoto, H., Shiro, Y., and Hayashi, T. (2011) Crystal 
Structure and Spectroscopic Studies of a Stable Mixed-Valent State of the 
Hemerythrin-like Domain of a Bacterial Chemotaxis Protein. Inorg. Chem. 50, 
4892–4899. 
(64)  Xiong, J., Kurtz, D. M., Ai, J., and Sanders-Loehr, J. (2000) A Hemerythrin-like 
Domain in a Bacterial Chemotaxis Protein. Biochemistry 39, 5117–5125. 
(65)  Isaza, C. E., Silaghi-Dumitrescu, R., Iyer, R. B., Kurtz, D. M., and Chan, M. K. 
(2006) Structural Basis for O2 Sensing by the Hemerythrin-like Domain of a 
Bacterial Chemotaxis Protein: Substrate Tunnel and Fluxional N Terminus. 
Biochemistry 45, 9023–9031. 
  
 
30 
(66)  Schaller, R. A., Ali, S. K., Klose, K. E., and Kurtz, D. M. (2012) A Bacterial 
Hemerythrin Domain Regulates the Activity of a Vibrio cholerae Diguanylate 
Cyclase. Biochemistry 51, 8563–8570. 
(67)  Ward, J. P. T. (2008) Oxygen sensors in context. Biochim. Biophys. Acta - 
Bioenerg. 1777, 1–14. 
(68)  Migita, C. T., Matera, K. M., Ikeda-Saito, M., Olson, J. S., Fujii, H., Yoshimura, 
T., Zhou, H., and Yoshida, T. (1998) The Oxygen and Carbon Monoxide 
Reactions of Heme Oxygenase. J. Biol. Chem. 273 , 945–949. 
(69)  Adachi, T., Ishikawa, K., Hida, W., Matsumoto, H., Masuda, T., Date, F., Ogawa, 
K., Takeda, K., Furuyama, K., Zhang, Y., Kitamuro, T., Ogawa, H., Maruyama, 
Y., and Shibahara, S. (2004) Hypoxemia and blunted hypoxic ventilatory 
responses in mice lacking heme oxygenase-2. Biochem. Biophys. Res. Commun. 
320, 514–522. 
(70)  Taabazuing, C. Y., Hangasky, J. A., and Knapp, M. J. (2014) Oxygen sensing 
strategies in mammals and bacteria. J. Inorg. Biochem. 133, 63–72. 
(71)  Vashisht, A. A., Zumbrennen, K. B., Huang, X., Powers, D. N., Durazo, A., Sun, 
D., Bhaskaran, N., Persson, A., Uhlen, M., Sangfelt, O., Spruck, C., Leibold, E. A., 
and Wohlschlegel, J. A. (2009) Control of Iron Homeostasis by an Iron-Regulated 
Ubiquitin Ligase. Sci. 326 , 718–721. 
(72)  Shu, C., Sung, M. W., Stewart, M. D., Igumenova, T. I., Tan, X., and Li, P. (2012) 
The Structural Basis of Iron Sensing by the Human F-box Protein FBXL5. 
ChemBioChem 13, 788–791. 
(73)  Thompson, J. W., Salahudeen, A. A., Chollangi, S., Ruiz, J. C., Brautigam, C. A., 
Makris, T. M., Lipscomb, J. D., Tomchick, D. R., and Bruick, R. K. (2012) 
Structural and Molecular Characterization of Iron-sensing Hemerythrin-like 
Domain within F-box and Leucine-rich Repeat Protein 5 (FBXL5). J. Biol. Chem. 
287 , 7357–7365. 
(74)  Semenza, G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 
721–32. 
(75)  Semenza, G. L. (2004) Hydroxylation of HIF-1: Oxygen sensing at the molecular 
level. Physiology 19, 176–182. 
(76)  chofield, C. J., and Ratcliffe, P. J. (2004) Oxygen sensing by HIF hydroxylases. 
Nat. Rev. Mol. Cell Biol. 5, 343–354. 
  
 
31 
(77) Wenger, R. H. (2002) Cellular adaptation to hypoxia: O2 sensing protein 
hydroxylases, hypoxia inducible transcription factors, O2 regulated gene 
expression. FASEB J. 16, 1151–1162. 
(78)  Wang, G. L., Jiang, B. H., Rue, E. a, and Semenza, G. L. (1995) Hypoxia-
inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by 
cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A. 92, 5510–5514. 
(79)  Kallio, P. J., Pongratz, I., Gradin, K., McGuire, J., and Poellinger, L. (1997) 
Activation of hypoxia-inducible factor 1α: Posttranscriptional regulation and 
conformational change by recruitment of the Arnt transcription  factor. Proc. Natl. 
Acad. Sci. 94 , 5667–5672. 
(80)  Kallio, P. J., Okamoto, K., Brien, S., Carrero, P., Makino, Y., Tanaka, H., and 
Poellinger, L. (1998) Signal transduction in hypoxic cells: inducible nuclear 
translocation and recruitment of theCBP/p300 coactivator by the hypoxia‐
induciblefactor‐1α. EMBO J. 17, 6573–6586. 
(81)  Semenza, G. L. (2013) HIF-1 mediates metabolic responses to intratumoral 
hypoxia and oncogenic mutations. J. Clin. Invest. 123, 3664–3671. 
(82) Nagel, S., Talbot, N. P., Mecinović, J., Smith, T. G., Buchan, A. M., and 
Schofield, C. J. (2010) Therapeutic manipulation of the HIF hydroxylases. 
Antioxid. Redox Signal. 12, 481-501 
(83)  Hewitson, K. S., and Schofield, C. J. (2004) The HIF pathway as a therapeutic 
target. Drug Discov. Today 9, 704–711. 
(84)  Webb, J. D., Coleman, M. L., and Pugh, C. W. (2009) Hypoxia, hypoxia-inducible 
factors (HIF), HIF hydroxylases and oxygen sensing. Cell. Mol. Life Sci. 66, 3539–
3554. 
(85)  Semenza, G. L. (2009) Regulation of Oxygen Homeostasis by Hypoxia-Inducible 
Factor 1. Physiology 24, 97–106. 
(86) Fandrey, J., and Gassmann, M. (2009) Oxygen Sensing and the Activation of the 
Hypoxia Inducible Factor 1 (HIF-1) (Gonzalez, C., Nurse, C. A., and Peers, C., 
Eds.), pp 197–206. Springer-Verlag Berlin, Berlin. 
(87)  Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. 
M., Lane, W. S., and Kaelin Jr, W. G. (2001) HIFa Targeted for VHL-Mediated 
Destruction by Proline Hydroxylation: Implications for O2 Sensing. Science 292, 
464–468. 
 
  
 
32 
(88)  Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell, S. J., 
Kriegsheim Av, Hebestreit, H. F., Mukherji, M., Schofield, C. J., Maxwell, P. H., 
Pugh, C. W., and Ratcliffe, P. J. (2001) Targeting of HIF-alpha to the von Hippel-
Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 
468–472. 
(89) McNeill, L. A., Hewitson, K. S., Claridge, T. D., Seibel, Jã¼. F., Horsfall, L. E., 
and Schofield, C. J. (2002) Hypoxia-inducible factor asparaginyl hydroxylase 
(FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochem. J. 
367, 571–575. 
(90)  Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., and Bruick, 
R. K. (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the 
transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466–1471. 
(91)  Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, 
G., and Eck, M. J. (2002) Structural basis for recruitment of CBP/p300 by 
hypoxia-inducible factor-1α. Proc. Natl. Acad. Sci. 99 , 5367–5372. 
(92)  Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., and Whitelaw, M. L. (2002) 
Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. 
Science 295, 858–861. 
(93)  Hausinger, R. P. (2004) Fe(II)/alpha-Ketoglutarate-dependent hydroxylases and 
related enzymes. Crit. Rev. Biochem. Mol. Biol. 39, 21–68. 
(94)  Solomon, E. I., Light, K. M., Liu, L. V, Srnec, M., and Wong, S. D. (2013) 
Geometric and Electronic Structure Contributions to Function in Non-heme Iron 
Enzymes. Acc. Chem. Res. 46, 2725–2739. 
(95)  Costas, M., Mehn, M. P., Jensen, M. P., and Que, L. (2004) Dioxygen Activation 
at Mononuclear Nonheme Iron Active Sites: Enzymes, Models, and Intermediates. 
Chem. Rev. 104, 939–986. 
(96)  Mantri, M., Zhang, Z., McDonough, M. A., and Schofield, C. J. (2012) 
Autocatalysed oxidative modifications to 2-oxoglutarate dependent oxygenases. 
FEBS J. 279, 1563–1575. 
(97)  Mantri, M., Webby, C. J., Loik, N. D., Hamed, R. B., Nielsen, M. L., McDonough, 
M. A., McCullagh, J. S. O., Bottger, A., Schofield, C. J., and Wolf, A. (2012) Self-
hydroxylation of the splicing factor lysyl hydroxylase, JMJD6. Med. Chem. 
Commun. 3, 80–85. 
 
  
 
33 
(98)  Chen, Y. H., Comeaux, L. M., Herbst, R. W., Saban, E., Kennedy, D. C., Maroney, 
M. J., and Knapp, M. J. (2008) Coordination changes and auto-hydroxylation of 
FIH-1: Uncoupled O-2-activation in a human hypoxia sensor. J. Inorg. Biochem. 
102, 2120–2129. 
(99)   Liu, A., Ho, R. Y. N., Que, L., Ryle, M. J., Phinney, B. S., and Hausinger, R. P. 
(2001) Alternative Reactivity of an alpha-Ketoglutarate-Dependent Iron(II) 
Oxygenase: Enzyme Self-Hydroxylation. J. Am. Chem. Soc. 123, 5126–5127. 
(100)  Ge, Y., Lawhorn, B. G., ElNaggar, M., Sze, S. K., Begley, T. P., and McLafferty, 
F. W. (2003) Detection of four oxidation sites in viral prolyl-4-hydroxylase by top-
down mass spectrometry. Protein Sci. 12, 2320–2326. 
(101) Koehntop, K., Marimanikkuppam, S., Ryle, M., Hausinger, R., and Que  Jr, L. 
(2006) Self-hydroxylation of taurine/α-ketoglutarate dioxygenase: evidence for 
more than one oxygen activation mechanism. JBIC J. Biol. Inorg. Chem. 11, 63–
72. 
(102) Sundheim, O., Vågbø, C. B., Bjørås, M., Sousa, M. M. L., Talstad, V., Aas, P. A., 
Drabløs, F., Krokan, H. E., Tainer, J. A., and Slupphaug, G. (2006) Human ABH3 
structure and key residues for oxidative demethylation to reverse DNA/RNA 
damage. EMBO J. 25, 3389–3397. 
(103)  Kulik, H. J., Blasiak, L. C., and Marzari, N. (2009) First-Principles Study of Non-
heme Fe ( II ) Halogenase SyrB2 Reactivity 14426–14433. 
(104) Blasiak, L. C., Vaillancourt, F. H., Walsh, C. T., and Drennan, C. L. (2006) Crystal 
structure of the non-haem iron halogenase SyrB2 in syringomycin biosynthesis. 
Nature 440, 368–371. 
(105) Vaillancourt, F. H., Yin, J., and Walsh, C. T. (2005) SyrB2 in syringomycin E 
biosynthesis is a nonheme FeII α-ketoglutarate- and O2-dependent halogenase. 
Proc. Natl. Acad. Sci. United States Am. 102 , 10111–10116. 
(106)  Kojima, T., Leising, R. A., Yan, S., and Que, L. (1993) Alkane functionalization at 
nonheme iron centers. Stoichiometric transfer of metal-bound ligands to alkane. J. 
Am. Chem. Soc. 115, 11328–11335. 
(107) Matthews, M. L., Neumann, C. S., Miles, L. a, Grove, T. L., Booker, S. J., Krebs, 
C., Walsh, C. T., and Bollinger, J. M. (2009) Substrate positioning controls the 
partition between halogenation and hydroxylation in the aliphatic halogenase, 
SyrB2. Proc. Natl. Acad. Sci. U. S. A. 106, 17723–17728. 
(108) Grzyska, P. K., Müller, T. a, Campbell, M. G., and Hausinger, R. P. (2007) Metal 
ligand substitution and evidence for quinone formation in taurine/alpha-
ketoglutarate dioxygenase. J. Inorg. Biochem. 101, 797–808. 
  
 
34 
(109) Hewitson, K. S., Holmes, S. L., Ehrismann, D., Hardy, A. P., Chowdhury, R., 
Schofield, C. J., and McDonough, M. A. (2008) Evidence that two enzyme-derived 
histidine ligands are sufficient for iron binding and catalysis by factor inhibiting 
HIF (FIH). J. Biol. Chem. 283, 25971–25978. 
(110) Bailar, J. C. (1957) The numbers and structures of isomers of hexacovalent 
complexes. J. Chem. Educ. 34, 334. 
(111) Block, B. P., Powell, W. H., and Fernelius, W. C. (1990) Inorganic chemical 
nomenclature: principles and practice. Washington, DC. 
(112)  Pau, M. Y. M., Lipscomb, J. D., and Solomon, E. I. (2007) Substrate activation for 
O2 reactions by oxidized metal centers in biology. Proc. Natl. Acad. Sci. 104, 
18355–18362. 
(113) Kovaleva, E. G., and Lipscomb, J. D. (2008) Versatility of biological non-heme 
Fe(II) centers in oxygen activation reactions. Nat Chem Biol 4, 186–193. 
(114)  Blomberg, M. R. A., Borowski, T., Himo, F., Liao, R.-Z., and Siegbahn, P. E. M. 
(2014) Quantum Chemical Studies of Mechanisms for Metalloenzymes. Chem. 
Rev. 114, 3601–3658. 
(115)  Saban, E., Chen, Y.-H., Hangasky, J., Taabazuing, C., Holmes, B., and Knapp, M. 
(2011) The second coordination sphere of FIH controls hydroxylation. 
Biochemistry. 50, 4733-4740 
(116)  Ehrismann, D., Flashman, E., Genn, D. N., Mathioudakis, N., Hewitson, K. S., 
Ratcliffe, P. J., and Schofield, C. J. (2007) Studies on the activity of the hypoxia-
inducible-factor hydroxylases using an oxygen consumption assay 401, 227–234. 
(117)  Saban, E., Flagg, S., and Knapp, M. (2011) Uncoupled O2-activation in the human 
HIF-asparaginyl hydroxylase, FIH, does not produce reactive oxygen species. J. 
Biol. Inorg. Chem. 105, 630-636. 
(118)  Diebold, A. R., Brown-Marshall, C. D., Neidig, M. L., Brownlee, J. M., Moran, G. 
R., and Solomon, E. I. (2011) Activation of alpha-Keto Acid-Dependent 
Dioxygenases: Application of an {FeNO}(7)/{FeO2}(8) Methodology for 
Characterizing the Initial Steps of O-2 Activation. J. Am. Chem. Soc. 133, 18148–
18160. 
(119)  Mehn, M. P., Fujisawa, K., Hegg, E. L., and Que, L. (2003) Oxygen activation by 
nonheme iron(II) complexes: alpha-keto carboxylate versus carboxylate. J. Am. 
Chem. Soc. 125, 7828–78242.  
 
  
 
35 
(120) S. Nagel, N.P. Talbot, J. Mecinovic, T.G. Smith, A.M. Buchan, C.J. Schofield 
(2010)  Therapeutic manipulation of the HIF hydroxylates Antioxid. Redox Signal. 
12, 481–501. 
(121)  Zhang, C.P., Zhu, L.L., Zhao, T., Zhao, H., Huang, X., Ma, X., Wang, H., and Fan, 
M. (2006) Characteristics of neural stem cells expanded in lowered oxygen and the 
potential role of hypoxia-inducible factor-1Alpha. Neurosignals 15, 259–265.  
(122)  N.A. Smirnova, I. Rakhman, N. Moroz, M. Basso, J. Payappilly, S. Kazakov, F. 
Hernandez-Guzman, I.N. Gaisina, A.P. Kozikowski, R.R. Ratan, I.G. Gazaryan 
(2010) Utilization of an in vivo reporter for igh throughput identification of 
branched small molecule regulators of hypoxic adaption. Chem. Biol. 17, 380–391 
 
(123) Flagg, S.C.; Martin, C.B.; Taabazuing, C.Y.; Holmes, B.E.; Knapp, M.J. (2012) 
Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and 
factor inhibiting HIF (FIH). J. Inorg. Biochem. 133, 25-30. 
 
(124) Lee, C., Kim, S. J., Jeong, D. G., Lee, S. M., and Ryu, S. E. (2003) Structure of 
Human FIH-1 Reveals a Unique Active Site Pocket and Interaction Sites for HIF-1 
and von Hippel-Lindau. J. Biol. Chem. 278, 7558–7563. 
 
(125) McDonough, M. A, McNeill, L. A, Tilliet, M., Papamicaël, C. A, Chen, Q.-Y., 
Banerji, B., Hewitson, K. S., and Schelofid, C. J. (2005) Selective inhibition of 
factor inhibiting hypoxia-inducible factor. J. Am. Chem. Soc. 127, 7680–7681. 
 
(126) Elkins, J. M., Hewitson, K. S., McNeill, L. A., Seibel, J. F., Schlemminger, I., 
Pugh, C. W., Ratcliffe, P. J., and Schofield, C. J. (2003) Structure of factor-
inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative 
modification of HIF-1 alpha, J. Biol. Chem. 278, 1802-1806. 
(127) Yang, M., Ge, W., Chowdhury, R., Claridge, T. D. W., Kramer, H. B., Schmierer, 
B., McDonough, M. a, Gong, L., Kessler, B. M., Ratcliffe, P. J., Coleman, M. L., 
and Schofield, C. J. (2011) Asparaginyl and aspartyl hydroxylation of the 
cytoskeletal ankyrin family is catalysed by factor inhibiting hypoxia-inducible 
factor (FIH). J. Biol. Chem. 286, 7648-7660. 
(128) Chowdhury, R.; Yeoh, K.; Tian, Y.; Hillringhaus, L.; Bagg, E.A.; Rose, N.R.; 
Leung, I.; Li, X.S.; Woon, E.; Yang, M.; McDonough, M. A.; King, O.N.; Clifton, 
I.J.; Klose, R.J.; Claridge, T.D.; Ratcliffe, P.; Schofield, C.J.; Kawamura, A. 
(2011) The oncometabolite	   2-­‐hydroxyglutarate	   inhibits	   histone	   lysine	  demethylases.	  EMBO	  Rep.	  12,	  463–469.	  	  
(129)  Moon, H., Han, S., Park, H., and Choe, J. (2007) Crystal structures of human FIH-
1 in complex with quinol family inhibitors. Mol. Cells 29, 471–474.  
  
 
36 
(130)  Coleman, M. L., McDonough, M. A., Hewitson, K. S., Coles, C., Mecinovic, J., 
Edelmann, M., Cook, K. M., Cockman, M. E., Lancaster, D. E., Kessler, B. M., 
Oldham, N. J., Ratcliffe, P. J., and Schofield, C. J. (2007) Asparaginyl 
hydroxylation of the notch ankyrin repeat domain by factor inhibiting hypoxia-
inducible factor, J. Biol. Chem. 282, 24027-24038. 
(131)  Rose, N. R., Woon, E. C. Y., Tumber, A., Walport, L. J., Chowdhury, R., Li, X. S., 
King, O. N. F., Lejeune, C., Ng, S. S., Krojer, T., Chan, M. C., Rydzik, A. M., 
Hopkinson, R. J., Che, K. H., Daniel, M., Strain-Damerell, C., Gileadi, C., 
Kochan, G., Leung, I. K. H., Dunford, J., Yeoh, K. K., Ratcliffe, P. J., Burgess-
Brown, N., von Delft, F., Muller, S., Marsden, B., Brennan, P. E., McDonough, M. 
A., Oppermann, U., Klose, R. J., Schofield, C. J., and Kawamura, A. (2012) Plant 
Growth Regulator Daminozide Is a Selective Inhibitor of Human KDM2/7 Histone 
Demethylases. J. Med. Chem. 55, 6639–6643. (132)	  Hewitson,	   K.	   S.,	   Liénard,	   B.	  M.	   R.,	   McDonough,	  M.	   A.,	   Clifton,	   I.	   J.,	   Butler,	   D.,	  Soares,	  A.	  S.,	  Oldham,	  N.	  J.,	  McNeill,	  L.	  A.,	  and	  Schofield,	  C.	  J.	  (2007)	  Structural	  and	   Mechanistic	   Studies	   on	   the	   Inhibition	   of	   the	   Hypoxia-­‐inducible	  Transcription	  Factor	  Hydroxylases	  by	  Tricarboxylic	  Acid	  Cycle	  Intermediates.	  	  
J.	  Biol. Chem. 282 , 3293–3301. 
(133)  Conejo-Garcia, A., McDonough, M. A., Loenarz, C., McNeill, L. A., Hewitson, K. 
S., Ge, W., Liénard, B. M., Schofield, C. J., and Clifton, I. J. (2010) Structural 
basis for binding of cyclic 2-oxoglutarate analogues to factor-inhibiting hypoxia-
inducible factor. Bioorg. Med. Chem. Lett. 20, 6125–6128.  
(134)  Yang, M., Chowdhury, R., Ge, W., Hamed, R. B., McDonough, M. A., Claridge, 
T. D. W., Kessler, B. M., Cockman, M. E., Ratcliffe, P. J., and Schofield, C. J. 
(2011) Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-
translational hydroxylation of histidinyl residues within ankyrin repeat domains, 
FEBS J. 278, 1086-1097. 
(135) Yang, M., Hardy, A. P., Chowdhury, R., Loik, N. D., Scotti, J. S., McCullagh, J. S. 
O., Claridge, T. D. W., McDonough, M. A., Ge, W., and Schofield, C. J. (2013) 
Substrate Selectivity Analyses of Factor Inhibiting Hypoxia-Inducible Factor. 
Angew. Chemie Int. Ed. 52, 1700–1704. 
(136)  Hopkinson, R. J., Tumber, A., Yapp, C., Chowdhury, R., Aik, W., Che, K. H., Li, 
X. S., Kristensen, J. B. L., King, O. N. F., Chan, M. C., Yeoh, K. K., Choi, H., 
Walport, L. J., Thinnes, C. C., Bush, J. T., Lejeune, C., Rydzik, A. M., Rose, N. 
R., Bagg, E. A., McDonough, M. A., Krojer, T. J., Yue, W. W., Ng, S. S., Olsen, 
L., Brennan, P. E., Oppermann, U., Mueller, S., Klose, R. J., Ratcliffe, P. J., 
Schofield, C. J., and Kawamura, A. (2013) 5-Carboxy-8-hydroxyquinoline is a 
broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron 
translocation. Chem. Sci. 4, 3110–3117.  
  
 
37 
(137)  PDB ID: 3OD4. King, O.N.F; Bashford-Roger, R.; Maloney, D.J.; Jadhay, A.; 
Heightman, T.D.; Simeonov, A.; Clifton, I.J.; McDonough, M.A.; Schofield, C.J. 
Crystal Structure of Factor Inhibiting HIF-1 Alpha Complexed with Inhibitor. 
(138) PDB ID: 4JAA. Scotti, J.S.; Ge, W.; McDonough, M.A.; Schofield, C.J. Factor 
inhibiting HIF-1 alpha in complex with consensus ankyrin repeat domain-(d)LEU 
peptide. 
(139) Light, K. M., Hangasky, J. A., Knapp, M. J., and Solomon, E. I. (2013) 
Spectroscopic Studies of the Mononuclear Non-Heme Fe-II Enzyme FIH: Second-
Sphere Contributions to Reactivity. J. Am. Chem. Soc. 135, 9665–9674. 
(140)  Matthews, M. L., Chang, W., Layne, A. P., Miles, L. A., Krebs, C., and Bollinger 
Jr., J. M. (2014) Direct nitration and azidation of aliphatic carbons by an iron-
dependent halogenase. Nat. Chem. Biol. 10, 209-215. 	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
38 
CHAPTER 2 
METHODS AND DATA ANALYSIS 
2.1 FIH Constructs 
The FIH gene was previously inserted into pET28a plasmid using NdeI and 
BamHI restriction sites with a N-terminal His6 tag.1  Frozen stock cultures of XL1 Blue 
and BL21 (DE3) cells containing the pET28a-FIH construct were also readily available. 
The pET28a-FIH plasmid was isolated from XL1 Blue cells using QIAprep miniprep 
kit (Qiagen).  Site-direct mutagenesis was used to insert point mutations in the pET28A-
FIH construct.   
The oligonucleotides for each mutation were initially designed using Stragene’s 
Primer Design tool.  Primer sequences were checked for G/C content and secondary 
structure motifs using Integrated DNA Technologies’ OligoAnalyzer v3.1. HPLC 
purified primers were purchased  (Integrated DNA Technologies, Coralville, Iowa), 
dissolved in ultra pure water to make a 100 mM stock and stored at -80°C.  Working 
stocks (125 nm/µL) were prepared and stored at -80°C until needed. 
Previously developed polymerase chain reaction (PCR) methods adapted from 
QuickChange were used to insert each point mutation into the pET28a-FIH construct.2   
Briefly, PCR reactions were performed in 1x ThermoPol reaction buffer (20mM Tris-HCl 
pH 8.8 at 25°C, 10 mM (NH4)2SO4, 10mM KCl, 2 mM MgSO4, 0.1% Triton X-100) 
and consisted of pET28a-FIH plasmid (100 ng), sense primer (125 ng), antisense primer 
(125 ng), dNTPs (1mM/dNTP), MgSO4 (0-1mM), DMSO (0-5%) and VENT polymerase 
(2 units).  The general thermal cycling conditions used are found in table 2.1. 
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Table 2.1.  General thermal cycling conditions 
Step Temperature  (°C) 
Time  
(min) 
Number  
of Cycles 
Initial Denaturation 95 0.83 1 
Denaturation 95 0.83 
16 Annealing TM-5 0.83 
Extension 72 7 
Final Extension 72 7 1 
Storage 4 600 1 
    
 
 
After PCR, all reaction mixtures were run on a 1% w/w agarose gel to ensure DNA 
amplification occurred.  Amplified samples were digested with DpnI and transformed 
into XL1-Blue competent cells.  Transformed cells were plated on LB Agar plates 
containing kanamycin (30 µg/mL) and incubated for 16 hours.  Colonies were cultured 
again in LB media (5 mL) containing kanamycin (30 µg/mL) for 16 hours.  These mini 
cell cultures were used to isolate the plasmid using a Qiagen MiniPrep kit.  Samples were 
sequenced (Genewiz) ensuring only the desired point mutation was present.   The 
sequenced plasmid was transformed into both XL1-Blue and BL21 (DE3) competent 
cells.  Aliquots (0.8 mL) of an overnight culture were mixed with an equivalent volume 
of sterile 50% glycerol and stored at -80°C. 
A total of nine point mutations were constructed and purified as described below 
(Table 2.2). The oligonucleotides used to insert each point mutation into the FIH plasmid 
can be found in the supplementary information. 
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Table 2.2. Purified FIH variants 
Facial 
 Triad 
Substrate  
Positioning 
Solvent Accessible  
Channel 
Asp201→Ala Gln239→Ala  Tyr93→Ala 
Asp201→Gly Gln239→Glu   Glu105→Ala 
Asp201→Glu Gln239→Leu   Gln147→Ala 
 
 
2.2 FIH Purification Optimization 
The purification of FIH is time consuming primarily due to the cleavage of the N-
terminal His6 tag and prolonged incubation with EDTA to remove exogenous metals.  
Previous methods developed in our laboratory required up to ten days to obtain FIH with 
>95% purity.  The method outline below retained the same techniques as previously used, 
but the optimization of the protocol allows for the purification process to be completed 
within four days, with high a yield (25-30 mg FIH/ L cell culture) and protein purity > 
95%. 
The cell pellet was thawed and suspended in lysis buffer (5mL/g pellet) and then 
incubated on ice for one hour.  Sonication of the solution ensured all cells were lysed.  
Centrifugation of the solution at 14,000 G for 30 minutes pelleted the cellular debris.  
The supernatant was buffer exchanged into 10 mM Tris pH 8.00 to remove the EDTA 
from the lysis buffer.   Centrifugation again at 14,000 G for 30 minutes removed any 
remaining cellular debris before being loaded onto a Ni-NTA affinity column.  The eluted 
His6-FIH was buffer exchanged into thrombin cleavage buffer and incubated with 
thrombin (~0.5 units/mg) for 36 hours at 4°C to ensure >80% cleavage. 
The His6-tag and uncleaved His6-FIH were separated using Ni-NTA affinity 
chromatography.  The flow through containing cleaved FIH was concentrated before 
adding EDTA (50 mM) and incubating overnight to remove all exogenous metals.  Size 
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exclusion chromatography used 50 mM Tris pH 8.00 and 50 mM NaCl as the mobile 
phase and yielded pure dimeric FIH.  Dimeric FIH was concentrated and buffer 
exchanged into 50 mM HEPES pH 7.00 at 37°C, removing the SEC mobile phase.  
Before storage at -20°C, the concentration of the final sample was determined using UV-
Vis spectroscopy (ε=48780 M-1cm-1).  SDS-PAGE was used to determine the purity of 
FIH.  ESI-MS was used to confirm the correct molecular weight ensuring proper cleavage 
of the His6 tag. 
 
2.3 Mass Spectrometry 
Two ionization methods were used for the mass spectrometry based work 
described throughout this document; Electrospray ionization (ESI) -time of flight (TOF)-
mass spectrometry (MS) and matrix assisted laser desorption ionization (MALDI)-time of 
flight-mass spectrometry.  ESI-TOF-MS was used to determine the molecular weight of 
FIH and all variants, ensuring proper cleavage of the His6 tag.  MALDI-TOF-MS was 
used to monitor the rate of peptide hydroxylation through the ratio of the unhydroxylated 
and hydroxylated peptide peak intensities in activity assays, as described below. 
2.3.1 ESI-TOF-MS 
The molecular weight of FIH and variants were determined using a Bruker 
MicroTOF-II. As samples were typically prepared in 50 mM HEPES pH 7.00, a HPLC 
with a C8 column was attached to the MS allowing for the desalting of samples before 
MS analysis. A column switching method was used to divert solvent and all salts away 
from the mass spectrometer until the salt free sample eluted from the column.  Once the 
sample eluted from the column the ports switched, allowing the sample to reach the mass 
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spectrometer for analysis.  An aliquot (20µL) of 5-10µM FIH in 0.1% formic acid (FA) 
was injected into the HPLC attached to the ESI-TOF-MS.  A 10 minute gradient from 5% 
acetonitrile/0.1% FA to 95% acetonitrile/0.1% FA was used to elute FIH from the HPLC 
column before MS analysis.   
If samples were prepared in buffers that were readily ionizable and contained low 
salt concentrations, a direct inject method could be used.  Typically, these samples (5-
10µM FIH) were buffer exchanged into either ammonium acetate or ammonium 
bicarbonate buffer (10 mM).  Samples were directly injected into the mass spectrometer 
for analysis using a 250 µL Hamilton syringe with an inner diameter of 2.3 mm, with a 
flow rate of 2 µL/min.   
2.3.2 MALDI-TOF-MS 
A Bruker OmniFlex MALDI-TOF-MS and a Bruker microFlex MALDI-TOF-
MS, (Referred throughout as MALDI for brevity) were two mass spectrometers used to 
monitor the formation of hydroxylated CTAD (CTADOH).  Samples with the 39-mer 
CTAD peptide were prepared for analysis by a 5x dilution into 75% acetonitrile, 0.2% 
trifluoroacetic acid saturated with 3,5-dimethoxy-4-hydroxycinnamic acid.  Samples that 
contained the 19-mer CTAD peptide were prepared for analysis by a 5x dilution into 75% 
acetonitrile, 0.2% trifluoroacetic acid saturated with a-cyano-4-hydroxycinnamic acid.  A 
small aliquot (<1 µL) of the quenched reaction aliquot was spotted onto a MALDI target 
and allowed to dry before inserting the target into the instrument for analysis. 
Both positive reflective and linear modes were used to calculate initial rates based 
off of the ratio of the CTAD and CTADOH peaks.  Initial rates from identical assays using 
reflective or linear mode varied <2%.  The reflective method was used obtain better 
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resolution, primarily when assays contained D2O. It is important to note, when solvent 
isotope effects were measured, the reflective method was used for both assays containing 
H2O and D2O. 
  The parameters for each mode can be found in table 2.3.  As MALDI 
predominately forms the +1 m/z charge state, the peaks for the 39mer CTAD and 
CTADOH were observed at 4256 m/z and 4272 m/z respectively.   The mole fraction of 
product χCTAD-OH, was determined from the relative intensitites of CTAD and CTADOH .  
The initial rates were determined from 5-7 time points with a fractional conversion up to 
~15%.  
 
	  Table 2.3. MALDI parameters for the positive linear and positive reflective methods 
 Ion  Source 1 
Ion  
Source 2 Lens Reflector 
Detector  
Gain 
Pulsed Ion 
Extraction 
Linear  20.00 kV 18.50 kV 9.00 kV ⎯ 2500 V 200 ns 
Reflective  19.00 kV 15.75 kV 9.85 kV 20.00 kV 1650 V 150-210 ns 
 
 
2.4  Succinate Quantification and Coupling 
There are three methods that can be used to monitor turnover by αKG 
consumption: 14CO2 capture assays, UV-Vis coupled assays and succinate quantification 
through HPLC-UV-Vis. 14CO2 capture assay are widely used to monitor decarboxylation 
reaction through the measurement of radioactive 14CO2 by scintillation counting.  A 
coupled assay utilizing succinyl-CoA synthetase, pyruvate kinase and lactate 
dehydrogenase allows for UV-Vis to monitor the coupling succinate production to 
NADH oxidation.3 HPLC-UV-Vis based succinate quantification methods have also been 
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reported.4  We adapted the HPLC-UV-Vis assay to quantitated succinate and CTADOH 
from the same quenched reaction aliquot.   
Our HPLC method involved an isocratic method using a mobile phase consisting 
of 500nM H2SO4 and 2% acetonitrile.  A Hamilton PRP-X300 column was used to 
separate succinate from the reaction mixtures and which could be monitored at 210 nm.  
Under these conditions, the succinate peak (Rt=2.2 minutes) was well resolved allowing 
for integration of the succinate peak.     To quantitate the succinate in a given reaction, a 
standard curve was determined from the peak area of 5-7 known succinate concentrations 
ranging from 60 µM to 500 µM in 50mM Tris pH 7.00. (Figure 2.1)  A small shift in the 
retention time (~0.1 min) was noted at increased succinate concentrations.  The least 
squares fit of the data yielded the standard curve used to quantify the succinate 
concentration in reaction aliquots. 
 
 
 
Figure 2.1. (Left) HPLC-UV-Vis trace at 210 nm. Inset: Elution of succinate.  
(Right) Standard curve generated from the succinate peak area. 
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Reactions (125 µL) were performed in 50mM Tris pH 7.00 containing αKG (500 
µM), FeSO4 (25 µM) and CTAD (350 µM) were initiated with the addition of enzyme 
(0.5-5 µL).  Reactions were performed in Tris, as the elution of HEPES interfered with 
the succinate analysis.  Reaction aliquots (20 µL) were quenched in 500 µM H2SO4 
(10µL) containing 500 µM succinate.  
Each quenched reaction aliquot (25 µL) was injected into the HPLC and the 
absorbance was monitored at 210 nm.  An isocratic method using a mobile phase 
consisting of 500 µM H2SO4, 2% acetonitrile, with a flow rate of 2 mL/min was used.  
The method was run for 10 minutes allowing the baseline to stabilize before injecting the 
next sample.  The integration of the eluted succinate peak (Rt = 2.2 min) resulted in the 
peak area of succinate for a given sample.  The concentration of succinate in each sample 
was determined based on a succinate standard curve.  A sample calculation can be found 
below. 
To determine the coupling of a reaction, the succinate and CTADOH 
concentrations of the same sample were compared as a function of time.  Before injecting 
the quenched reaction aliquot into the HPLC, a small aliquot (1µL) was mixed with 75% 
acetonitrile, 0.2% trifluoroacetic acid saturated with 33,5-dimethoxy-4-hydroxycinnamic 
acid.  The quantification of CTADOH was performed using MALDI, as described above. 
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Succinate Quantification Calculation 
 
Quench Solution 
 500𝜇𝑀  𝑆𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒  ×  10  𝜇𝐿 = 5.0  𝑛𝑚𝑜𝑙𝑠  𝑠𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒 
 
Total Succinate 
 𝑆𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒 !"!#$ = 𝑃𝑒𝑎𝑘  𝐴𝑟𝑒𝑎 𝑆𝑙𝑜𝑝𝑒  𝑜𝑓  𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑  𝐶𝑢𝑟𝑣𝑒 
 5.0  𝑛𝑚𝑜𝑙  + 𝑥  𝑛𝑚𝑜𝑙30  𝜇𝐿 = 𝑆𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒 !"!#$ 
 
Succinate Produced from the Reaction 
 𝑥  𝑛𝑚𝑜𝑙   =    𝑆𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒 !"!#$×  30𝜇𝐿 −   5.0  𝑛𝑚𝑜𝑙 
 
Succinate Concentration 
 𝑥  𝑛𝑚𝑜𝑙  𝑠𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒20  𝜇𝐿  𝑟𝑥𝑛  𝑎𝑙𝑖𝑞𝑢𝑜𝑡 =    𝑆𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒 !"#$%&'$ 
 
2.5 Oxygen-18 Kinetic Isotope Effect Sample Preparation and Analysis 
Assays used to determine the oxygen-18 kinetic isotope effect (18O KIE) 
contained αKG (1.0 mM), CTAD788-806 (250 µM), FeSO4 (50 µM), O2 (280 µM) in 50 
mM HEPES pH 7.00.  Buffer was equilibrated to ambient O2 concentration (280 µM) by 
gently stirring for two days 21°C.  All reagents, except enzyme, mixed in equilibrated 
buffer and injected in to a sealed 10 mL crimp vial, evacuating all air.  After incubation 
of the vial at 37°C, each reaction was initiated with an injection of a high concentration 
enzyme stock.  Reactions were quenched using 6 M HCl, 3.5 M ZnCl (40 µL) over an 
extended time course to obtain O2 fractional conversion up to 35%.  An aliquot (5 µL) 
was taken to determine the fractional conversion of CTAD using a Bruker MALDI-TOF-
MS.  The O2 fractional conversion was determined from the quantification of CTADOH 
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turnover and then corrected for O2 turnover.  The sealed crimp vials containing the 
quenched reaction were stored inverted and submerged in water until isotope ratio-mass 
spectrometry analysis. 
Professor Nathaniel Ostrom’s lab at Michigan State University performed the IR-
MS analysis.  Briefly, samples were carefully transferred into small volume Emerson 
bottles that had been thoroughly pre-evacuated with carbon dioxide.  The Emerson bottle 
was equilibrated with gentle shaking in a 25°C water bath overnight.  Before analysis, the 
water was taken out using a vacuum pump, leaving ~1mL in the bottle.  The Emerson 
bottles were then connected to an isotope-ratio mass spectrometer (IRMS) to determine 
the δ18O.  All δ18O isotopic values were reported using standard delta notation relative to 
the Vienna Standard Mean Ocean Water (VSMOW)5. The Rstd value for O2 in air 
(0.0020531)6 was used to convert the experimental δ18O to an R value, using equation 2.1 
 
𝑅!"# = ! !!"!""" + 1 ∗ 𝑅!"#  Equation 2.1 
 
The 18O KIE was determined by fitting Rf/Ro vs fractional conversion to equation 2.2, 
where Rf is the isotope ratio of the sample at time f, Ro is the isotope ratio of the blank, 
and f is the fractional conversion of O2. 
 !!!! = (1− 𝑓) !!  !!" !"  !!     Equation 2.2 
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2.6 Intrinsic Tryptophan Fluorescence 
The FIH/CTAD binding constants were measured through quenching of the 
intrinsic tryptophan fluorescence of (Co + αKG)FIH upon CTAD binding at room 
temperature using a PTI QM-4 2005SE spectrofluorometer.  The entrance slits (0.1 mm) 
and exit slits (2.4 mm) were adjusted to minimize photo-bleaching and maximize signal 
intensity. The lamp (40 Watts) was turned on for a minimum of 15 minutes before spectra 
were record. 
The fluorescence cuvette contained FIH (1.5µM), CoSO4 (25 µM), αKG (500 
µM) and 50 mM HEPES pH 7.00.  This solution was titrated with 50 mM HEPES pH 
7.00 containing CTAD (1mM), FIH (1.5µM), CoSO4 (25 µM) and αKG (500 µM).   After 
each addition of titrant, samples were gently mixed and allowed to equilibrate for five 
minutes before being excited at 295 nm.  The fluorescence intensity was measured 
between 310 nm and 400 nm.  The λMax (330 nm) was plot versus the total CTAD 
concentration, and fit using equation 2.3, where I is the fluorescence intensity, [E] is the 
protein concentration, [S] is the CTAD concentration, and KD is the binding affinity. 
 
!!!!!!!!! = ( ! ! ! !!!)! ! ! ! !!! !! ! ! !! !  Equation 2.3  
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2.7 Supplemental Information 
Mutagenesis Primers 
D201A,  
forward, 5’-GACACCTGCTCACTATGCTGAGCAGCAGAACTTTT-3’; 
reverse, 5’-AAAAGTTCTGCTGCTCAGCATAGTGAGCAGGTGTC-3’.  
D201G,  
forward, 5’-GTGACACCTGCTCACTATGGCGAGCAGCAGAAC-3’;  
reverse, 5’-GTTCTGCTGCTCGCCATAGTGAGCAGGTGTCAC-3’.  
D201E,  
forward, 5’-GACACCTGCTCACTATGAGGAGCAGCAGAACTTTTTT-3’;  
reverse, 5’-AAAAAAGTTCTGCTGCTCCTCATAGTGAGCAGGTGTC-3’. 
Q239A,  
forward, 5’-ATCACCCATGTGACAGAGCGAGCCAGGTGGACTTTG-3’;  
reverse 5’-CAAAGTCCACCTGGCTCGCTCTGTCACATGGGTGAT-3’. 
Q239E,  
forward, 5’-GTTCATCACCCATGTGACAGAGAGAGCCAGGTG-3’;  
reverse 5’-CACCTGGCTCTCTCTGTCACATGGGTGATGAAC-3’. 
Q239L,  
forward, 5’-CCCATGTGACAGACTGAGCCAGGTGGACT-3’;  
reverse 5’-AGTCCACCTGGCTCAGTCTGTCACATGGG-3’. 
Y93A,  
forward, 5’-TGGAGACTTCTCTGTGGCCAGTGCCAGCACCCAC-3’; 
reverse 5’-GTGGGTGCTGGCACTGGCCACAGAGAAGTCTCCA-3’. 
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E105A,  
forward, 5’-CAAGTTCTTGTACTATGATGCGAAGAAGATGGCCAATTTCC-3’;  
reverse 5’-GGAAATTGGCCATCTTCTTCGCATCATAGTACAAGAACTTG-3’. 
Q147A,  
forward, 5’-GGAAGAGAGGTTGTATCTGGCGCAAACGCTCAATGACACT-3’;  
reverse 5’-AGTGTCATTGAGCGTTTGCGCCAGATACAACCTCTCTTCC-3’. 
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 CHAPTER 3 
INVERSE SOLVENT ISOTOPE EFFECTS ARISING FROM SUBSTRATE 
TRIGGERING IN THE FACTOR INHIBITING HIF (FIH-1) 
 
This chapter has been published as: 
 
Hangasky, J.A.; Saban, E; and Knapp, M.J. (2013) Inverse solvent isotope effects arising 
from substrate triggering in the factor inhibiting HIF (FIH-1).  Biochemistry 52, 1594-
1602. 
 
3.1 Introduction 
Oxygen homeostasis is essential for proper cellular function in humans and is 
tightly controlled by a small group of non-heme Fe(II), alpha-ketoglutarate (αKG)-
dependent dioxygenases.  Oxygen-dependent regulation of the transcriptional coactivator 
hypoxia inducible factor-1α (HIF-1α) maintains O2 homeostasis as HIF-1α controls more 
than 100 genes, directing processes such as angiogenesis, glycolysis and erythropoeisis.1-
3 The Fe(II)/αKG-dependent dioxygenase ‘factor inhibiting HIF-1α’ (FIH-1 or FIH) 
inhibits HIF-1α in the presence of sufficient [O2] by hydroxylating the C-terminal 
activation domain (CTAD) of HIF-1α at HIF-Asn803.4-7 This hydroxylation prevents 
recruitment of the CREB binding protein, effectively down regulating HIF-1α dependent 
gene expression in response to normal or elevated [O2]. 
The consensus mechanism for Fe(II)/αKG-dependent dioxygenases proposes that 
binding of the primary substrate triggers the Fe(II) to bind O2, due to aquo release 
opening a coordination site for O2 (Scheme 3.1).  Substrate triggering is a central tenet of 
the consensus mechanism, as it can explain the relative O2-reactivity of αKG 
oxygenases.11,49 Subsequent O2 activation allows for oxidative decarboxylation of αKG 
and the formation of a highly reactive ferryl intermediate.  H-atom abstraction and 
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ensuing •OH rebound effectively hydroxylates the primary substrate. As sensing [O2] 
requires that O2-activation only occur when HIF-1α is bound, substrate triggering is the 
key to O2-sensing by FIH.  
Scheme 3.1. Consensus chemical mechanism for FIH. 
Various experimental techniques have been used to test the consensus mechanism 
of the Fe(II)/αKG-dependent dioxygenases. Extensive spectroscopic studies on the 
Fe(II)/αKG-dependent dioxygenase clavaminate synthase (CAS) have provided insight to 
the coordination change due to aquo release induced by primary substrate.  MCD and CD 
studies of (Fe + αKG)CAS indicate the Fe(II) is predominantly 6 coordinate.  Upon 
addition of primary substrate (S) the active site iron of (Fe + αKG + S)CAS adopts a 5 
coordinate square-pyramidal geometry8-10  due to release of the aquo ligand.  Stopped-
flow and freeze-quench techniques have been used to study the Fe(II)/αKG-dependent 
dioxygenase, taurine dioxygenase (TauD).  Loss of the aquo ligand was observed under 
single-turnover conditions, and these studies identified a Fe(IV)=O intermediate as the 
active oxidant in TauD.11-13 However these studies did not address aquo release under 
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multiple turnover conditions leaving open the possibility that aquo release is not a 
recurring step in the steady-state.   
To date, neither in depth spectroscopic studies of the coordination changes 
proposed upon substrate binding, nor mechanistic probes for substrate triggering have 
been reported for FIH, making substrate triggering in this enzyme largely speculative.  
The X-ray crystallographic data for FIH bound to various substrates is ambiguous with 
respect to the coordination geometry of Fe(II), making it difficult to draw conclusions 
about the link between substrate binding and aquo release.  Structures of (Fe + αKG)FIH 
are reported as containing either 5-coordinate15 or 6-coordinate16 Fe(II), however the 
crystal structure of (Fe + αKG + CTAD)FIH  shows a 5-coordinate Fe(II),15 suggesting 
that aquo release may partially occur prior to CTAD binding.  EPR spectroscopy of 
Co(II)-substituted (Co + αKG)FIH revealed a mixture of 5-coordinate and 6-coordinate 
Co(II), further suggesting that aquo release may occur prior to CTAD binding.17,18 
Crystal structures of both (Fe + αKG + Notch)FIH and (Fe + αKG + TNKS2)FIH were 
refined with an axial aquo ligand present, suggesting that aquo release occurs after these 
substrates bind.19,20 Direct mechanistic probes of aquo release during turnover would 
provide a crucial view into the mechanism of this enzyme, as well as providing insight 
into substrate triggering by this broad class of enzymes.   
We propose that the extensive H-bonding network surrounding the active site of 
FIH constitutes a second coordination sphere, which transduces CTAD binding into aquo 
release.  Steady-state kinetics of FIH point mutants indicate that removal of hydrogen-
bonds from several residues surrounding the Fe(II) impairs catalytic efficiency14, 
suggesting that substrate binding causes alterations to those hydrogen bonds.  FIH has 
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been shown to have a tightly coupled oxidative and reductive half reaction, avoiding the 
formation of reactive oxygen species during turnover.21 Point mutations that perturb this 
H-bonding network significantly decrease FIH activity and lead to uncoupled αKG 
consumption.14 Based on FIH crystal structures and mechanistic data for point mutants, 
we hypothesized that aquo release occurs on every turnover during the steady state. 
To test this hypothesis, we applied mechanistic probes that are sensitive to those 
steps preceding O2-activation. Specifically, we focused on the steps involving αKG and 
CTAD binding, as these steps lead to substrate triggering: the aquo release and priming 
of the Fe(II) for O2 binding/activation.  Steady-state kinetic assays were performed to 
identify the preferred binding order for CTAD and αKG.  Solvent isotope effects (SIEs) 
on steady-state rate constants were measured to test for the release of aquo ligands from 
the Fe(II) cofactor.  When the rate constants are larger in D2O-containing buffers than for 
H2O-containing buffer, the kinetics SIEs are ‘inverse’ and are diagnostic for pre-
equilibrium release of aquo ligands from metal cofactors.  We observed inverse SIEs on 
steady-state rate constants, providing direct evidence for the pre-equilibrium release of 1, 
2 and 3 aquo ligands from the Fe(II) under different conditions.  Our results establish two 
very important points.  First, CTAD-binding to (Fe + αKG)FIH leads to release of 1 aquo 
ligand, suggesting that the overall strategy to control hydroxylation in FIH relies on 
substrate triggered changes in hydrogen-bonding to release the aquo ligand.  Second, the 
rate-limiting step in the steady-state precedes or coincides with the first irreversible step – 
this is likely to be decarboxylation (Scheme 3.1), meaning that FIH does not accumulate 
oxidized intermediates.  Both observations point to an overall strategy for O2-activation 
that relies on careful control over substrate triggering in FIH. 
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3.2 Experimental Procedures 
3.2.1 Materials 
All buffers and reagents were purchased from commercial vendors and were not 
further purified, with the exception of the CTAD peptide.  The CTAD peptide 
corresponding to the C-terminal activation domain of human HIF-1α, (HIF-1α788–826) 
contained a Cys800 → Ala point mutation21:  
DESGLPQLTSYDAEVNAPIQGSRNLLQGEELLRALDQVN.  The CTAD peptide was 
purchased as a desalted peptide from EZBiolab (Carmel, IN, USA) with free N and C-
termini.  RP-HPLC utilizing a gradient from 30% acetonitrile/0.1% trifluoroacetic acid 
(TFA) to 95% acetonitrile/0.1% TFA was used to obtain CTAD of >95% purity. 
3.2.2 Protein Expression and Purification 
FIH was overexpressed in E. coli with an N-terminal His6 tag and purified as 
previously described.18 Briefly, His6-FIH was separated from cell lysate via Ni-NTA 
column chromatography and the affinity tag was then cleaved with thrombin.  Three 
additional residues, from the fusion protein (NH2-GlySerHis-) remained on the N-
terminus following thrombin cleavage.  Cleaved FIH was collected as flow through from 
a Ni-NTA column and then incubated with EDTA to removed metal.  Dimeric FIH was 
obtained with size-exclusion chromatography using Sephadex G-75 resin and 50 mM 
NaCl 50 mM Tris pH 8.00 as the running buffer.  Purified FIH was buffer exchanged into 
50 mM HEPES pH 7.00.  The molecular weight was confirmed by QSTAR TOF-MS 
(expected, 40.566 kDa; observed, 40.574 kDa), while the purity (>95%) was assessed by 
SDS-PAGE. 
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3.2.3 Steady-state kinetics assays 
All assays were performed at 37.0°C with saturating concentrations of FeSO4 (50 
µM) and ascorbate (2 mM), and ambient O2 concentration.  Assays in which CTAD was 
the varied substrate (15 µM - 250 µM) utilized saturating αKG (500 µM) unless specified 
otherwise.   Assays with αKG as the varied substrate (5 µM - 200 µM) utilized a fixed 
CTAD concentration of either 39 µM (~1/2KM(CTAD)) or 306 µM (~4xKM(CTAD)). Assay 
reagents were mixed and incubated for two minutes at 37.0°C in microcentrigue tubes.  
Then the reaction was initiated with the addition of enzyme ([E]T = 0.5 µM).  Reaction 
aliquots (5 µL) were quenched with 75% acetonitrile/0.2% TFA (20 µL) saturated with 
3,5-dimethoxy-4-hydroxycinnamic acid and analyzed for peptide hydroxylation using a 
Bruker Daltonics Omniflex MALDI-TOF-MS. The mole fraction of product, χCTAD-OH, 
was determined by the relative intensities of hydroxylated CTAD (CTADOH, 4271 m/z)  
and unhydroxylated CTAD (4255 m/z).  Initial rates were determined from 5-7 quenched 
timepoints.  The steady-state rate constants, kcat and kcat/KM, were obtained by nonlinear 
least-squares fitting of initial rate data (0 to ~15% fractional conversion) to the 
Michaelis-Menten equation.   
3.2.4 Viscosity Assays 
Steady-state assays were performed in 50 mM HEPES pH 7.00, using sucrose as 
the viscosogen to test for the rate limitation of diffusional steps.  Initial rates were 
measured as described above, using buffers containing 10% (ηrel=1.3), 18% (ηrel=1.8) and 
25% (ηrel=2.4) sucrose solutions (w/w).21  
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3.2.5 Solvent Isotope Assays 
Deuterium oxide (D, 99.9%) was purchased from Cambridge Isotope Laboratories 
(Andover, MA, USA) and used as received.  The pD was determined by pre-soaking the 
pH meter in D2O for ten minutes and then adding 0.4 to the meter reading of the D2O 
solution of interest (pD = pHread + 0.4).23 Steady-state assays were performed as 
described above.  All reagent stocks used in the steady-state assays in D2O, were 
prepared using D2O.  Working FIH stock solutions were made by diluting high 
concentration stocks from H2O into D2O containing 50mM HEPES pD 7.00. Assays were 
performed in 50 mM HEPES, pD 7.00, with a final D2O percentage of 97%.  SIEs were 
calculated from the ratio of rate constants observed in buffers containing H2O or D2O; 
e.g. D2Okcat = kcat(H2O)/kcat(D2O). 
3.2.6 Coupling Ratio 
The extent of coupling between FIH’s two half reactions in D2O was determined 
from monitoring the succinate and CTADOH concentrations throughout a reaction.  
Reactions containing αKG (500 µM), FeSO4 (50 µM), CTAD (200 µM) and FIH (5 µM) 
were performed in 50 mM Tris pD 7.00, and analyzed similarly to previously reported 
procedures.14,24 A Hamilton PRP-X300 anion exclusion column was used to separate the 
succinate produced from the quenched reactions.  UV detection at 210 nm was used to 
determine the succinate concentration.  Using aliquots from the same quenched assay, a 
Bruker Daltonics Omniflex MALDI-TOF-MS was used to determine the CTADOH 
concentration.  The coupling ratio (C) was determined by fitting [succinate] as a linear 
function of [CTADOH] for multiple quench points, where C = [succinate]/[CTADOH]. 
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3.3 Results 
3.3.1 Solvent isotope effects 
Solvent isotope effects (SIEs) were measured to test for aquo release from the 
Fe(II) as part of substrate triggering during turnover in FIH.  By varying the degree of 
saturation with respect to αKG and CTAD, the SIE on kinetic constants reporting on 
different microscopic steps were accessed.  SIEs arising from the pre-equilibirum release 
of 1, 2, and 3 aquo ligands were predicted from the consensus mechanism, depending on 
the assay conditions (3.1).  As the limiting SIEs are multiples of the proton fractionation 
factor (Φ) for the O-L bond (L = H or D)25, they are quite distinct for the number of aquo 
ligands released.   
The fractionation factor for L2O (where L = H or D) is inverse when water is 
bonded to another Lewis acid, leading to a tendency for D2O to accumulate in bulk 
solvent.  For example, ΦO-L = 0.69 for L3O+ 26-28 due to zero-point energy differences. 
The fractionation factor, ΦO-L, for aquo release from Co(II) in two carbonic anhydrase 
isozymes has been found to be between 0.72 and 0.90,25,29 agreeing closely with the 
fractionation factor for Co(H!O)!!! in solution, (ΦO-L = 0.73).30 As the fractionation 
factor for the Fe2+-OH2 in FIH is unknown, we estimate Φ = 0.70 as is commonly done 
for fractionation of water from other M-OH2  M + OH2 equilibria.30 As Φ is reported 
on a per-bond basis, and are multiplicative, D2OKeq for the release of aquo ligands are 
diagnostic for the numbers of H2O released from Fe: one (D2OKeq = Φ2 = 0.49), two 
(D2OKeq = Φ4 = 0.24) and three (D2OKeq = Φ6 = 0.12). 
The equilibrium fractionation factors will lead to inverse kinetic SIEs on different 
kinetic constants provided that the aquo release is in a pre-equilibrium prior to a 
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subsequent rate-limiting step.  As shown in the Appendix, kcat and kcat/KM(CTAD) can report 
on one aquo release – leading to the prediction that the limiting values for D2Okcat ~ 
D2O(kcat/KM(CTAD)) = 0.49.  In contrast, the limiting values for D2O(kcat/KM(αKG)) will report 
on the release of 2 or 3 aquo ligands depending on the degree to which FIH is saturated 
with CTAD.  It is important to note that our assays used ambient [O2] (220µM), which is 
approximately 2xKM(O2),31 making our kinetic constants apparent.   
The rate constants obtained under conditions of saturating αKG, ambient [O2] and 
varied [CTAD] are kcat and kcat/KM(CTAD).  Under these conditions, kcat reports on all steps 
after CTAD binding up through product release, and is predicted to involve the release of 
one aquo ligand (Scheme 3.1).  The initial rate assays in D2O exhibited increased rates 
when compared to similar assays in H2O, indicating an inverse SIE on both kcat and 
kcat/KM(CTAD).  We observed D2Okcat = 0.51 ± 0.07, in good agreement with the limiting 
SIE (0.49) for the pre-equilibrium release of one aquo ligand (Figure 3.1).  Similarly, we 
observed D2O(kcat/KM(CTAD)) =  0.40 ± 0.07, which is also in good agreement with one 
aquo release prior to a rate-limiting step.   
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Figure 3.1. Steady-state kinetics of FIH in H2O (●) and 97% D2O (■) buffers.  FIH (0.5 
µM), ascorbate (2 mM), αKG (500 µM), FeSO4 (50 µM) and CTAD (0-250 µM) were in 
50mM HEPES pL 7.00, 37°C. 
 
 
Due to the sequential ordered mechanism (see below), the apparent kcat/KM(αKG) 
encompasses distinct steps depending on the fixed concentration of CTAD.  Since 
kcat/KM(αKG) reports on steps from the encounter with αKG up through the first irreversible 
step, high or low fixed concentrations of CTAD were used to isolate different 
microscopic steps.  CTAD binding is kinetically irreversible at high CTAD 
concentrations, meaning that kcat/KM(αKG)High[CTAD] reports on only those steps between 
αKG encounter and CTAD binding, encompassing the release of two aquo ligands. The 
observed SIE of 0.32 ± 0.08 on kcat/KM(αKG)High[CTAD] was in reasonable agreement with 
the limiting value (0.24) expected for the release of two aquo ligands.  In contrast, CTAD 
binding is kinetically reversible at sub-saturating CTAD concentrations, making a 
subsequent step (thought to be O2 activation) the first irreversible step.  Thus, 
kcat/KM(αKG)Low[CTAD] reports on all steps between αKG binding and O2 activation, which 
encompasses the release of three aquo ligands in the consensus mechanism.  The 
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observed SIE of 0.11 ± 0.03 for kcat/KM(αKG)Low[CTAD] agreed closely with the limiting 
value (0.12) expected for the release of three aquo ligands prior to a rate-limiting step 
(Figure 3.2).  
 
Figure 3.2. Steady-state kinetics of FIH for αKG at 37mM CTAD and 306mM CTAD, in 
H2O (●,■) and D2O(○,□) at 37.0°C.  FIH (0.5µM), ascorbate (2 mM), αKG (0 - 210 µM), 
FeSO4 (50 µM) and CTAD (37 µM and 306 µM) were in 50 mM HEPES pL 7.00. 
 
 
3.3.2 Validation of Observed SIEs 
A series of control experiments were completed to ensure that the SIEs arose from 
aquo release.  Control assays showed the steady-state rate constants, kcat and kcat/KM(CTAD), 
were pH independent between pH 6.50 and pH 8.00 at fixed ionic strength (I = 120 mM).  
Furthermore, steady-state assays at pH 7.00 showed that kcat and kcat/KM(CTAD).were 
independent of ionic strength (Figure 3.5).  Viscosity experiments were completed as a 
control for the increased relative viscosity of D2O, as solvent viscosity can affect the rate 
of diffusional steps, or of conformational changes.  The binding order of αKG and CTAD 
was also investigated to define the chemical steps reported on by kcat/KM(CTAD) and 
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kcat/KM(αKG), as these rate constants proved different microscopic steps within the 
chemical mechanism reporting the release of up to three aquo ligands.   
FIH’s activity increased approximately two fold in D2O, prompting us to check 
the coupling between the oxidative and reductive half-reactions in D2O.  As the oxidative 
half reaction produces succinate, and the reductive half-reaction produces CTADOH, the 
[succinate] / [CTADOH] ratio is equal to the coupling between these half reactions 
(C=[succinate]/[CTADOH]).  Previously we showed tight coupling between succinate 
production and CTAD hydroxylation in H2O.14 Here we observed that FIH’s two half 
reactions remained tightly coupled in D2O, with C equal to unity within experimental 
uncertainty (C = 1.1 ± 0.1) (Table 3.1). 
 
Table 3.1 Coupling of [Succinate] and [CTADOH] for FIH.   50 mM Tris pL 7.00, at 
37.0°C. 
        Ca 
D2O        1.1 ± 0.1b 
H2O 0.98 ± 0.03c 
a. 𝐶 =   !"#$%  !"##$%&'(!"#$%  !"#$!"  
b. Reactions contained αKG (500 µM), FeSO4 (50 µM), CTAD (200 µM) and FIH 
(5 µM) in 50 mM Tris pD 7.00. 
c. Reference 14. 
 
 
3.3.3 Diffusional steps are not rate-limiting 
Steady-state rate constants were measured as a function of relative viscosity to 
test for diffusional steps that might contribute to the observed rate constants and SIEs, as 
the viscosity of D2O is greater than that of H2O.  Initial rate data were collected in 50 mM 
HEPES, pH 7.00, with sucrose as the viscosogen, and fitted to the Michaelis-Menten 
equation.  Analysis of kcat, kcat/KM(CTAD) and kcat/KM(αKG) as a function of relative viscosity 
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indicated that each of the steady-state rate constants were independent of solvent 
viscosity (Figure 3.6).   
The normalized regression plot showed that relative viscosity had no effect on any 
rate constant.  Thus, neither diffusional encounter, relevant for kcat/KM, nor product 
release, relevant for kcat, are rate-limiting.  If diffusional encounter were rate limiting, 
kcat/KM would decrease as the relative solvent viscosity increased.32,33 Furthermore, the 
lack of a viscosity effect indicates FIH does not undergo a viscosity-sensitive 
conformational change, which has been shown to obscure SIEs for some enzymes.34,35  
3.3.4 Sequential Order: αKG binds before CTAD 
The consensus mechanism for αKG oxygenases is a sequential ordered model 
that, when applied to FIH, predicts αKG binds prior to CTAD.  Although steady-state 
analyses of several other αKG-dependent oxygenases have been shown to follow this 
binding order,36-38 we tested this sequential binding model for FIH due to the interesting 
SIEs that we observed under varied [CTAD].  As the binding order of αKG and CTAD 
affects the microscopic steps defined by the steady-state kinetic parameters, this is critical 
to our interpretations of the SIEs. 
Four different fixed CTAD concentrations, ranging from ½KM(CTAD) to 4xKM(CTAD) 
were chosen for steady state kinetic assays where the αKG concentration was the varied 
substrate.  In close agreement with previously reported values,14,31 the KM(αKG) remained 
constant at 20 ± 2 µM for all CTAD concentrations. The regression plot of kcat/KM(αKG) as 
a function of [CTAD] passed through the origin, as expected for ordered sequential 
binding of αKG prior to CTAD (Figure 3.3).39  
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Figure 3.3. Regression plot showing kcat/KM(αKG) as a function of CTAD concentration.  
Inset: Steady-state kinetics of FIH with αKG as varied substrate, at different fixed CTAD 
concentrations at 37.0°C.  FIH (0.5 µM), ascorbate (2 mM), αKG (0-210 µM), FeSO4 (50 
µM) and CTAD (39 - 306 µM) were in 50mM HEPES pH 7.00. 
 
3.4 Discussion 
O2 sensing by FIH is critical to cellular growth and development making close 
consonance between [O2] and the FIH-catalyzed hydroxylation of CTAD central to O2-
homeostasis. An additional benefit is that controlled O2 activation by FIH would avoid 
ROS production21, preventing anomalous oxidations.  Although it has been shown that 
decarboxylation of αKG and hydroxylation of CTAD by FIH is tightly coupled,14 the 
mechanistic strategy used by FIH to ensure that O2 activation leads to CTAD 
hydroxylation with high fidelity remains unclear.  Our overall hypothesis is the hydrogen 
bonding from the second coordination sphere ensures that the Fe(II) in (Fe + αKG)FIH 
remains 6-coordinate, and that CTAD binding alters these hydrogen bonds leading to O2 
activation – the substrate triggering model.  CTAD binding could trigger FIH by affecting 
any one of the microscopic steps in the overall chemical mechanism, so long as the rate 
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of O2-activation were increased upon CTAD binding.  Our observation of inverse SIEs on 
kcat/KM(CTAD) and  kcat/KM(αKG) indicate that the rate-limiting step in the steady state 
follows aquo release, and is either coincident with or precedes decarboxylation (Scheme 
3.1).  This points towards a strategy for tightly coupling O2-activation with CTAD 
hydroxylation that relies on substrate triggering.  
3.4.1 O2-activation is rate-limiting in FIH 
Inverse kinetic SIEs (SIE < 1) are diagnostic for aquo release from metal ions, as 
the vast majority of SIEs are normal (SIE > 1).29 Two other causes of inverse kinetic 
SIEs, the involvement of a CysS- nucleophile in catalysis, and a conformational change, 
were ruled out for FIH.  In the former case, there are no active site CysSH residues; in the 
latter case, we verified that viscosity did not affect the rate of turnover.   
Inverse kinetic SIEs have been reported for several metalloenzymes, including a 
number of hydrolases, carbonic anhydrase, and a point mutant of SLO.29, 40-43 In each 
case, the inverse kinetic SIEs indicated that aquo release was a pre-equilibrium step prior 
to a subsequent rate limiting step.  Our observation of inverse kinetic SIEs corresponding 
to multiple aquo release steps is the first such report, to the best of our knowledge.  The 
inverse SIEs arise from an unfavorable equilibrium for aquo release, combined with a 
slow O2 activation step.  
 
 
Scheme 3.2. Proposed kinetic mechanism for FIH (S = CTAD). 
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The consensus mechanism predicts that both kcat and kcat/KM(CTAD) encompass one 
aquo release for a limiting predicted SIE = 0.49.  The experimentally observed kinetic 
SIEs correlate nicely with the theoretical value expected for the equilibrium release of 
one aquo ligand, as D2Okcat = 0.51 ± 0.07 and D2Okcat/KM(CTAD) = 0.40 ± 0.07 (Table 3.2).  
A kinetic model with separate microscopic steps for αKG, CTAD and O2 binding, as well 
as the final aquo release, was constructed from the consensus chemical mechanism and 
used to analyze the observed SIEs (Scheme 3.2). As kcat encompasses all steps with the 
exception of diffusional encounter with substrates, a separate, reversible microscopic step 
for aquo release was needed, as the D2Okcat < 1 indicated that aquo release must be 
separate from CTAD encounter.   
The similarity in the SIEs for kcat and kcat/KM(CTAD) strongly suggests that the 
overall rate-limiting step in FIH turnover is common to both rate constants.  As 
kcat/KM(CTAD) encompasses steps between CTAD encounter and the first irreversible step, 
the common step has to be the O2-activation step (Scheme 3.1).  This step is typically 
viewed as the initial attack on the 2-oxo group of αKG which leads to oxidative 
decarboxylation.  This is noteworthy as that this predicts that FIH will not accumulate the 
ferryl intermediate during turnover, in contrast to TauD.12 Slow O2-activation can 
account for the tight coupling between decarboxylation and hydroxylation seen for FIH14 
as hydroxylation must be very fast relative to the decarboxylation step.  Thus, we 
conclude that FIH likely adopts a strategy to ensure tight coupling between O2-binding 
and -activation in which O2-activation is rate-limiting.  
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Table 3.2.    Solvent Isotope Effects for FIH. 50 mM HEPES pL 7.00, at 37.0°C 
 
H2O D2O 
Experimental      
SIE 
Theoretical 
SIE 
# of Aquo 
Ligands 
kcat                             
(min-1)a 30 ± 2.5 59 ± 2.0 0.51 ± 0.07 0.49 1 
kcat/KMCTAD         
(µM-1 min-1)a 0.43 ± 0.10 1.09 ± 0.11 0.40 ± 0.07 0.49 1 
kcat/KMαKG(High[CTAD]) 
(µM-1 min-1)b 1.94 ± 0.13 6.05 ± 1.37 0.32 ± 0.08 0.24 2 
kcat/KMαKG(Low[CTAD]) 
(µM-1 min-1)c 0.29 ± 0.07 2.60 ± 0.34 0.11 ± 0.03 0.12 3 
a. CTAD as the varied substrate; FIH (0.5µM), ascorbate (2 mM), αKG (500 
µM), FeSO4 (50 µM), and CTAD (0 - 250 µM).  
b. αKG as the varied substrate; FIH (0.5µM), ascorbate (2 mM), αKG (5 - 200 
µM), FeSO4 (50 µM), and CTAD (306 µM).  
c. αKG as the varied substrate;FIH (0.5µM), ascorbate (2 mM), αKG (5 - 200 
µM), FeSO4 (50 µM), and CTAD (37 µM).  
 
We analyzed the observed kinetic SIEs using language predominately developed 
by Northrop and Cleland44,45, in which observed kinetic SIEs are a function of 
“commitments to catalysis” and the equilibrium and kinetic isotope effects ( 𝐾!"   !!! and 𝑘!  !!! ) on the aquo release step (𝑘!).  The commitments to catalysis, Cf and Cr, are ratios 
of microscopic rate constants that describe the tendency of an enzyme to go forward or 
backward through the isotopically sensitive step.  Full expressions are provided in the 
Appendix.  In the case of D2Okcat/KM(CTAD) , this expression takes the form below.  The 
primary virtue of such a presentation is that it permits us to focus on specific segments of 
the kinetic mechanism. As equilibrium isotope effects reflect fractionation factors, the 
equilibrium SIE on aquo release is predicted to be ~ 0.5 (D2OK5 = 0.49).   
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!!"#!! !"#$ = !!!!! !!!!!! !!!!!!!!!!!!!!!    Equation 3.1 
 
It is clear that the only way for 𝑘!"#/𝐾!(!"#$)!!! = D2OKeq is for the reverse 
commitment to be very large (Cr >> Cf ).  Reverse commitment (Cr) is the kinetic 
competition between H2O and O2 for the triggered form of enzyme – when Cr is large, it 
means that H2O is the preferred ligand (Appendix – Eqn. A10).  Furthermore, the Cf/Cr 
ratio is, to a first approximation, the equilibrium for aquo release – when Cf/Cr <<1, it 
means that K5 is much less than one and that the position of this equilibrium favors the 
aquo-on state.   Similar analysis of the commitment factors for D2Okcat further supports the 
conclusion that aquo release is disfavored thermodynamically, despite a slightly different 
SIE expression and forward commitment on kcat (Cvf) (Appendix).   
3.4.2 Substrate triggering is faster than O2-activation  
Steps involved in substrate triggering were accessed by measuring the kinetic SIE 
with sub-saturating [αKG].  As kcat/KM(αKG) includes steps between diffusional encounter 
of αKG with FIH, up through and including the subsequent irreversible step, CTAD 
binding and substrate triggering may be observable on this kinetic constant. Under 
conditions of high [CTAD], only the two aquo ligands released upon αKG binding may 
be observed, as saturating FIH with CTAD makes CTAD binding kinetically irreversible 
for kcat/KM(αKG)High[CTAD].  In contrast, sub-saturating [CTAD] makes it possible to access 
release of all three aquo ligands on kcat/KM(αKG)Low[CTAD], provided that a later step be rate-
limiting.  
The observed SIE for kcat/KM(αKG)High[CTAD] (SIE = 0.32 ±  0.08) correlates well 
with the pre-equilibrium release of two aquo ligands (Table 3.2), as expected for 
  
 
69 
kinetically irreversible CTAD binding.  The key observation supporting rapid substrate 
triggering was the SIE on kcat/KM(αKG)Low[CTAD]  (SIE = 0.11 ± 0.03), as this indicated the 
pre-equilibrium release of all three aquo ligands prior to a subsequent rate-limiting step.  
This establishes that steps associated with CTAD binding and substrate triggering are not 
slow under these conditions, and further points to O2-activation as the rate-limiting step.   
3.4.3 Hydrogen bonding from the second coordination sphere 
Turnover in FIH and other αKG oxygenases depends on substrate triggering – 
minimally the release of the aquo ligand from the (Fe + αKG + Substr) enzyme form – 
prior to O2 binding. What is striking about the kinetics of FIH are the inverse kinetic 
SIEs, implicating slow O2-activation in this enzyme.  In the case of FIH, substrate 
triggering leads to rate-limiting O2-activation, meaning that the intermediate which is 
expected to accumulate in the steady-state is a relatively innocuous Fe2+ center.  In 
contrast, TauD exhibits SIEs of unity46, and the partially rate-limiting steps include 
product release and H-atom transfer by the [FeIVO]2+ intermediate.11 For TauD, substrate 
triggering leads to rapid O2-activation, and the partial accumulation of a powerful 
oxidant, [FeIVO]2+.12 It is as if TauD were built for speed, but FIH built for fidelity.  As 
the ligands to the Fe(II) are identical in these two enzymes, the reasons for such disparate 
strategies for the oxidation reaction must lie beyond the primary coordination sphere.  
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Figure 3.4. FIH active site with the 2.8 Å Asp201-aquo hydrogen bond  
(PDBID: 3P3P)20. 
 
We attribute the difference in oxidation strategies between these enzymes to their 
second coordination spheres. The most striking difference between their second 
coordination spheres is in the hydrogen bonding between the facial triad Asp201 ligand 
and the axial aquo ligand.  In FIH, the remote O-atom of Asp201 forms a 2.8 Å hydrogen 
bond to the bound aquo ligand in (Fe + αKG)FIH (Figure 3.4) – once CTAD binds, two 
new hydrogen bonds form to the Asp201 which appear to serve to partially stimulate aquo 
release.16,17 The extensive hydrogen bonding to this aquo ligand likely serves to stabilize 
the Fe-OH2 bond, which would explain the large reverse commitments to catalysis (Cr) 
and the inverse SIEs.  Such high affinity for the aquo ligand could serve to throttle back 
the oxidation reaction such that O2-activation only occurs when CTAD is present.  We 
note a certain similarity to the hydrogen bonding network found in PHD2, which leads to 
an inverse D2Okcat 47 and the absence of any accumulating intermediates in pre-steady state 
experiments.24 
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TauD is a significant contrast to FIH, structurally and kinetically.  The facial triad Asp of 
TauD is rotated away from the aquo ligand, and cannot form a hydrogen bond to the 
bound aquo ligand.  This leads to a weak Fe2+-OH2 bond strength48, and TauD readily 
activates O2 in the absence of the substrate taurine.49,50 The second coordination sphere of 
TauD favors aquo-release, which can lead to rapid O2-activation – unfortunately, this 
leads to a reduction in fidelity.  
 
3.5 Conclusions 
 The inverse SIEs observed in the steady state for FIH arise from a strong Fe-OH2 
bond that throttles back the reaction with O2.  The stable Fe-OH2 bond plays an important 
part in FIH’s regulatory role over O2 homeostasis in humans, and points toward a strategy 
for tightly coupling O2-activation with CTAD hydroxylation that relies on substrate 
triggering.  This tight control over O2-activation strongly suggests that oxidized 
intermediates will not accumulate in FIH under normal turnover conditions, and may 
reflect the demands of a regulatory function in O2-sensing by tightly correlating O2-
activation with substrate hydroxylation.   
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3.6 Appendix 
 
As there are multiple isotope sensitive steps for the kinetic mechanism of FIH 
(Scheme 3.2), algebraic expressions for each kinetic parameter were derived using the net 
rate method of Tian.51 The expression for D2Okcat takes the form:  
 
  𝑘!"#!!! =    !!!!!"!!! !!!!! ! !!" !!!!"!!!   !!! !!!!"!!!    (A1) 
 
  𝐶!" =   𝑘! !!!!!!!!! !! + !!! + !!!! + !!!"     (A2) 
 
  𝐶! =   𝑘! !!! !! + !!!!!! !!      (A3) 
 
The parameters CVf and Cr are the forward and reverse commitments to catalysis.  D2Ok5 is 
the kinetic SIE for water release, D2OK5 is the equilibrium SIE on aquo release and D2Ok15 
the kinetic SIE on water re-binding.  The equations derived for the SIEs for kcat/KM(CTAD), 
kcat /KM(αKG)High[CTAD], kcat /KM(αKG)Low[CTAD] take similar form and are shown below.  
 
!!"#!! !"# [!"#!!"#$] = !!!!! !![!"#$]!! ! !!!!!!!!! !"#$!!!!!     (A4) 
 
!!"#!! !"# [!"#$%&'] = !!!!! !! !"#$ !!!!!! ! !!!!! !!!! ! !!!!! !!!!!! !! !! !!!!!!!!!!!!!!!!!!  (A5) 
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𝐶! =   𝑘! !!! + !!!!!!         (A6) 
 𝐶! =   𝑘! !!! !! + !!!!!! !!        (A7) 
 
!!"#!! !"#$ = !!!!! !!!!!! !!!!!!!!!!!!!!!       (A8) 
 𝐶! =    !!!!         (A9) 
 𝐶! =   𝑘! !!! !! + !!!!!! !!        (A10) 
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3.7 Supplemental Information 
 
 
 
Figure 3.5.  Effect of ionic strength on the kinetic parameters, kcat (●), kcat/KM(CTAD)(□) of 
FIH.  FIH (0.5 µM), ascorbate (2 mM), αKG (500 µM), FeSO4 (50 µM) and CTAD (0-
250 µM) were in 50mM HEPES pH 7.00.  Ionic strength was adjusted using NaCl. 
 
 
 
Figure 3.6.  Microviscosity (sucrose) activity profile of FIH.  CTAD was the varied 
substrate, kcat/KMCTAD(■) and αKG as the varied substrate, kcat/KM(αKG)(○). FIH (0.5 µM), 
ascorbate (2 mM), αKG (500 µM or 5-200 µM), FeSO4 (50 µM) and CTAD (90 µM or 0-
250 µM) were in 50mM HEPES pH 7.00.  Inset:  Effect of microsviscosity on kcat.  FIH 
(0.5 µM), ascorbate (2 mM), αKG (500 µM), FeSO4 (50 µM) and CTAD (0-250 µM) 
were in 50mM HEPES pH 7.00 
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CHAPTER 4 
 
RATE-LIMITING O2 ACTIVATION IN THE HUMAN HYPOXIA SENSOR FIH  
 
 
4.1 Introduction 
 
Mammalian cells respond to decreased cellular pO2 levels through the increased 
transcriptional activity of the hypoxia inducible factor-1α (HIF-1α or HIF).1 HIF 
mediates  the transcription of hundreds of genes in response to hypoxia2 with the 
functions of the gene products ranging from glucose and iron metabolism to cell 
proliferation and angiogenesis.3,4 The Factor Inhibiting HIF (FIH) is a nonheme-Fe(II)/ 
αKG oxygenases which regulates the transcriptional activity of HIF, leading to cellular 
O2 sensing in human cells.5,6  Under normoxic conditions, FIH hydroxylates the β-carbon 
of Asn803 found in the C-terminal activation domain (CTAD) of HIF (Scheme 4.1),7,8  
which turns off HIF-mediated gene expression.7,9 Central to the function of FIH is O2 
activation chemistry, as pO2 is sensed through the hydroxylation of CTAD-Asn803. 
Identifying the chemical steps involved in O2 activation is crucial to understand how pO2 
is tightly correlated with CTAD hydroxylation .   
FIH is proposed to follow the consensus mechanism for Fe(II)/αKG oxygenases 
of which the steps are supported by spectroscopic, computational and kinetic studies.10–15 
VTVH MCD methodologies have been used to spectroscopically identify the release of 
the aquo ligand upon substrate binding to FIH16 and other Fe(II)/αKG oxygenases 
including TauD and CAS17,18. The release of the aquo ligand opens a coordination site for 
O2.  O2 is thought to bind as a ferric superoxide, which then attacks the C-2 carbonyl of 
αKG to ultimately form succinate and a ferryl intermediate.  The molecular details 
following O2 activation, including isolation of the ferryl intermediate and observation of 
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HAT have been characterized in the Fe(II)/αKG oxygenases TauD15,19–24 and Prolyl-4-
Hydroxylase (P4H)25 and the related Fe(II)/αKG halogenases CytC326 and SyrB227. 
 
 
Scheme 4.1. Consensus chemical mechanism of αKG oxygenases, adapted for FIH 
 
In contrast to the steps following ferryl formation, those steps of O2 activation are 
poorly understood.  Computational studies suggest that nucleophilic attack on the C-2 
carbonyl of αKG is the rate-limiting step on kcat/KM(O2), with a cyclic peroxohemiketal 
proposed as the transition state.28–30  Although this reaction sequence is supported by pre-
steady state kinetics and an oxygen-18 kinetic isotope effect (18O KIE) study of TauD,31 
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insight into O2-activation is limited because HAT or product release is rate-limiting in 
TauD and other well-characterized αKG oxygenases.20,32,33  Consequently, O2 activation 
is too rapid to allow for the accumulation of any intermediate prior to the ferryl.  
Recent studies showed that the kinetic mechanism of FIH differs from other αKG 
oxygenases,16,34 suggesting that it may provide an excellent system to discern O2 
activation chemistry.  Upon FIH binding CTAD, there is partial retention of the aquo 
ligand16 suggesting that aquo release may be less facile in FIH than in other enzymes.  
The inverse SKIE on kcat 34 for FIH indicates that the aquo release reaches equilibrium 
prior to the overall rate-limiting step in FIH – in other words, the overall rate limiting 
step is either coincident with, or prior to formation of the ferryl. In this work, we probe 
kcat/KM(O2), which focuses on the limited subset of steps that are involved in binding and 
reacting with O2, to understand O2 activation by  FIH.  Steady-state kinetics under 
conditions of varied solvent viscosity indicated that diffusional encounter of O2 with FIH 
was not rate limiting on kcat/KM(O2). Furthermore, we determined the 18O KIE on 
kcat/KM(O2) (18kcat/KM(O2) = 1.0114(5)), identifying the rate-limiting step as formation of the 
peroxohemiketal.  This showed that the chemical steps of O2 activation on FIH followed 
the consensus mechanism, indicating that FIH only differs from other αKG oxygenases 
in that this O2-actviation step is the overall rate-limiting step during turnover.34 
4.2 Materials and Methods 
4.2.1 Materials 
All reagents were purchased from commercial sources and used as received 
unless noted. The sequences of the synthetic 19 and 39-mer CTAD peptides 
corresponded to the C-terminal activation domain (CTAD) of HIF-1α788-806 and HIF-
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1α788-826 respectively, with a Cys800 →Ala point mutation. Peptides were purchased from 
EZBiolab (Carmel, Indiana, USA) with free N and C-termini.   The CTAD788-806 peptide 
(purity >95%) was used without further purification, however CTAD788-826 was 
purchased as a desalted peptide and purified to >95% purity using RP-HPLC as 
previously described.34 
4.2.2 Protein Expression and Purification 
FIH was overexpressed in E. Coli and purified as previously reported.34,35 
Thrombin cleavage of the His6 tag led to three additional residues preceding the native 
sequence of FIH on the N-terminus (NH2-Gly-Ser-His-).  The purity of the protein 
(>95%) was assessed through SDS-PAGE.  
4.2.3 Steady-State Kinetic Assays Varying O2 
All assays were performed in a AtmosBag (Sigma-Aldrich) with the O2 
concentration of the reaction buffers equilibrated to the O2 partial pressue within the bag.  
The atmosphere of the bag was equilibrated for 30 minutes with a controllable mixture of 
N2 and O2. 50 mM HEPES pH 7.00 was gently stirred for five minutes in a 37.0 °C water 
bath to equilibrate the reaction buffer with the atmosphere, then the O2 concentration was 
measured using a Clarke electrode. 
Steady-state assays in which O2 was the varied substrate (0.020 mM – 1 mM) 
utilized a fixed CTAD788-826 concentration of either 80 µM (~KM(CTAD)) or 150 µM 
(~2xKM(CTAD))  and saturating concentrations of FeSO4 (25 µM), αKG (100 µM) and 
ascorbate (2 mM), prepared in 50 mM HEPES pH 7.00. Upon addition of all reagents 
except FIH, the reaction mixture (45 µL) was incubated at 37.0 °C for an additional two 
minutes.  The enzyme stock was equilibrated to the atmosphere by gently pipetting the 
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solution down the side of the microcentrifuge tube, before injecting an aliquot (5 µL) to 
initiate the assays.  Reaction aliquots were removed throughout a three minute time 
course, quenched in 75% acetonitrile/0.2% TFA (20 µL) saturated with 3,5-dimethoxy-4-
hydroxycinnamic acid and analyzed for the initial rate of formation of CTADOH using a 
Bruker microFlex MALDI-TOF-MS. Initial rates were determined as previously 
described34 and fit to the Michaelis-Menten equation resulting in the kinetic parameters 
kcat KM(O2), and kcat/KM(O2).  
4.2.4 Solvent Viscosity Effect 
Assays to test for rate-limiting diffusional encounter of O2 utilized a fixed 
CTAD788-826 concentration of 80 µM (~KM(CTAD)) and saturating concentrations of FeSO4 
(25 µM), αKG (100 µM) and ascorbate (2 mM), with the exception of the addition of 
sucrose (25% w/w) to the 50 mM HEPES pH 7.00 to give a relative visocisty of η/η0 = 
2.4.36  Reactions were performed as described above to determine initial rates with O2 as 
the varied substrate which were then fit to the Michaelis-Menten equation. 
4.2.5 Steady-State Kinetic Assays Using CTAD788-806 
Assays in which CTAD788-806 was varied (0.10 - 4.6 mM) were performed at 37.0 
°C in 50 mM HEPES pH 7.00 and contained ascorbic acid (2 mM), αKG (1 mM), FeSO4 
(50µM) and an ambient O2 concentration (217 µM).  Assays in which αKG was varied 
(0.005 - 1 mM) were also performed at 37.0 °C in 50 mM HEPES pH 7.00 and contained 
ascorbic acid (2 mM), FeSO4 (50µM), CTAD788-806 (750 µM), with an ambient O2 
concentration (217 µM).  Reagents were mixed and incubated at 37.0 °C for two minutes 
before initiating turnover with enzyme (5 µM – 20 µM).  At predetermined time points, 
aliquots were quenched in 75% acetonitrile/0.2% TFA (20 µL) saturated with α-cyano-4-
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hydroxycinnamic acid.  Initial rates were detemined as described above and fit to the 
Michaelis Menten equation resulting in the apparent kinetic parameters kcat, kcat/KM and 
KM. 
4.2.6 18O KIE Sample Preparation and Analysis 
Assays used to determine the 18O KIE contained αKG (1.0 mM), CTAD788-806 
(250 µM), FeSO4 (50 µM), O2 (280 µM) in 50 mM HEPES pH 7.00.  Buffer was 
equilibrated to ambient O2 concentration (280 µM) by gently stirring for two days at 21 
°C.  All reagents were prepared freshly using the equilibrated buffer and gently mixed to 
make a common reaction mixture.  This reaction mixture was injected into a 10 mL crimp 
vial sealed with a butyl rubber stopper (Geo-Microbial Technologies, Inc; Ochelata, OK), 
ensuring all air was removed.  After a three minute incubation of the vial at 37.0 °C, each 
reaction was initiated with an injection (20 µL) of a high concentration FIH stock that 
had been equilibrated to room temperature.  Reactions were quenched using 6 M HCl, 3.5 
M ZnCl2 (40 µL) after an extended reaction time such that the fractional conversion 
based on O2 was as high as 35%.  An aliquot (5 µL) was removed to determine the 
reaction progress by measuring CTADOH formation using a Bruker MALDI-TOF-MS.  
The quantity of CTADOH produced was used to determine the fractional conversion of O2 
for each quenched reaction. The sealed crimp vials containing the quenched reactions 
were stored inverted and submerged in water until analysis by isotope-ratio mass 
spectrometry (IRMS). 
The 18O KIE samples were carefully transferred into small volume Emerson 
bottles that had been thoroughly pre-evacuated with carbon dioxide.  The Emerson bottle 
was then equilibrated by gently shaking in a 25°C water bath overnight.  Before IRMS 
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analysis, solution was removed using aspiration, leaving ~1 mL of sample in the bottle.  
The Emerson bottles were then connected to the IRMS to determine the δ18O.37 All δ18O 
isotopic values were reported using standard delta notation relative to the Vienna 
Standard Mean Ocean Water (VSMOW).38 Equation 4.1 was used to convert the δ18O to 
an R value (18O/16O isotopic ratio), where Rstd is the standard isotopic value for O2 in air 
(0.0020531)39 and Rf is the 18O/16O  isotopic ratio at O2-fractional conversion f. 
 
𝑅! = ! !!"!""" + 1 ∗ 𝑅!"#  Equation 4.1 
 
To determine the 18O/16O isotopic ratio at t = 0 (R0), a sample was prepared from 
the common reaction stock containing αKG (1.0 mM), CTAD788-806 (250 µM), FeSO4 (50 
µM), O2 (280 µM) in 50 mM HEPES pH 7.00 and injected into a sealed crimp vial.  After 
incubation for 3 minutes at 37.0 °C,  an aliquot of 50 mM HEPES pH 7.00 (20 µL) was 
injected into the vial immediately followed by an injection (40 µL) of 6 M HCl, 3.5 M 
ZnCl2 to quench the reaction. 
The 18O KIE was determined by fitting Rf/Ro vs f to equation 4.2, where f is the 
fractional conversion of O2 in the reaction aliquot, Rf is the 18O/16O isotope ratio of the 
aliquot, and Ro is the 18O/16O isotope ratio of the blank. 
 
!!!! = (1− 𝑓) !!  !!" !"  !!    Equation 4.2   
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4.3 Results and Discussion 
The O2 activation mechanisms of Fe(II)/αKG oxygenases is of enormous interest 
due to the biomedical significance of these enzymes.12,40,41 FIH is one of the members of 
this family which binds a relatively large substrate for hypoxia sensing, but other 
members are also involved in processes such as DNA and RNA repair and histone 
demethylation.12,42,43 A crucial mechanistic feature of this family of enzymes is O2 
activation to form an active oxidant, identified in several enzymes as a ferryl 
species.19,25,26  Despite the importance of the chemical steps leading up to formation of 
the ferryl, these steps remain largely uncharacterized. As the overall rate-limiting step for 
FIH either precedes or coincides with O2-activation,34 FIH could be an excellent enzyme 
to interrogate steps involved in O2 activation that are common to other αKG oxygenases,  
provided that FIH follows the consensus mechanism.    
4.3.1 Steady-State Kinetics with varied O2 
To characterize the O2 activation steps of FIH, steady-state kinetic assays with O2 
as the varied substrate were performed using a fixed CTAD788-826 concentration.  As our 
assays used sub-saturating [CTAD] due to reagent expenses, these steady-state assays 
used two different CTAD788-826 concentrations to measure the second order rate constant, 
kcat/KM(O2).  
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Figure 4.1. Steady-state kinetics varying O2. Reactions contained FIH (0.25-0.5µM), 
ascorbate (2 mM), αKG (100 µM), FeSO4 (25 µM) and CTAD788-826  (80 µM, or 150 
µM,  ) in 50 mM HEPES pH 7.00, 37.0 °C.	  
 
The initial rate data using 80 µM CTAD788-826 was fit to Michaelis-Menten 
equation with kinetic parameters of kcatapp (33 ± 3 min-1) and kcat/KM(O2)app (0.17 ± 0.03 
µM-1min-1) (Figure 4.1).  The steady-state assays varying O2 using an increased [CTAD] 
(150µM) resulted in the kcat/KM(O2)app (0.21 ±0.04) statistically equivalent to the 
kcat/KM(O2)app at 80 µM CTAD788-826. These results indicated that kcat/KM(O2) was 
independent of [CTAD] as expected for the sequential consensus mechanism (Scheme 
4.1). The high value for the Michaelis constant (KM(O2)app > 200 µM) was in agreement 
with previous reported values (90 - 237 µM) obtained using oxygen consumption assays 
and 14CO2 capture assays,44,45 and is thought to be essential for a proportionate sensory 
response to increasing pO2. 
When converted into standard units, kcat/KM(O2)app = 3.5 x103 M-1 s-1, indicating 
that O2 activation in FIH was significantly slower than other nonheme iron oxygenases 
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including TauD (1.5 x 105 M-1 s-1)33,46, tyrosine hydroxylase (6.0 x 104 M-1 s-1)47 and 
lipoxygenase (~5.0 x 105 M-1 s-1)48,49.  The low magnitude of kcat/KM(O2)app is intriguing, 
raising the potential for FIH to use an unusual strategy for O2 activation and offers the 
question: why is O2 activation slow in FIH?  We speculated that it was likely due to a 
slow chemical step limiting kcat/KM(O2) and O2 activation, but felt that it was necessary to 
exclude diffusional encounter as a possibility.  
 
Table 4.1. Apparent kinetic parameters for FIH with varied [O2].a 
[CTAD788-826] 
(µM) 
kcatapp  
(min-1) 
kcat/KM(O2)app  
(µM-1 min-1) 
KM(O2)app  
(µM) 
80 33 ± 3.0 0.17 ± 0.03 200 ± 40 
150 54 ± 4.0 0.21 ± 0.04 270 ± 50 
a. Reactions contained ascorbate (2 mM), αKG (100 µM), FeSO4 (25 µM) and CTAD788-
826  in 50 mM HEPES pH 7.00, 37.0 °C. 
  
4.3.2 Solvent Viscosity Effect 
To test for diffusional encounter with O2 as a partially rate-limiting step on 
kcat/KM(O2), we performed steady-state assays at varied solvent viscosity. Although 
kcat/KM(O2) is orders of magnitude slower than expected for a diffusional process (ca. 
1x109 M-1 s-1), we could not dismiss the possibility that there was an unfavorable pre-
equilibrium leading to a very small fraction of FIH being competent for reaction upon 
collision.  For diffusion controlled processes, kcat/KM(O2) would decrease in the presence 
of added viscosogen due to a lower diffusion rate as observed for other enzymes such as 
superoxide dismutase50,51 and carbonic anhydrase.52,53   
Our assays were performed as described above in the presence and absence of the 
viscosgen sucrose, giving a final relative viscosity (η/ηo) of 1.0 and 2.4 respectively 
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(Figure 4.2).  At increased solvent viscosity, the resulting kinetic parameter kcat/KM(O2)app 
(0.18 ± 0.04 µM-1min-1) was indistinguishable from the kinetic parameter collected in the 
absence of viscosogen (Table 4.2).  The resulting insignificant solvent viscosity effect on 
kcat/KM(O2) indicated that the diffusional encounter with O2 did not a partially limit O2 
activation in FIH.   
 
 
Figure 4.2. Steady-state kinetics varying O2 with 0% sucrose (solid line, η/ηo=1) and 
25% sucrose (dashed line, η/ηo=2.4).  Assays contained ascorbate (2 mM), αKG (100 
µM), FeSO4 (25 µM), CTAD788-826 (80 µM) and sucrose (0, 25%) in 50 mM HEPES pH 
7.00, 37.0 °C. 
 
 
	  
Table 4.2.	  	  Solvent viscosity effect on kcat/KM(O2)a	  
η/ηo kcatapp 
(min-1) 
kcat /KM(O2)app 
(µM-1 min-1) 
KM(O2)app 
(µM) 
1.0 33 ± 3.0 0.17 ± 0.03 200 ± 40 
2.4 39 ± 3.0 0.18 ± 0.04 220 ± 43 
a.  Assays contained ascorbate (2 mM), αKG (100 µM), FeSO4 (25 µM), CTAD788-826 
(80µM) and sucrose (0 or 25% w/w) in 50 mM HEPES pH 7.00, 37.0 °C. 
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Diffusion limited rate constants are typically thought of as arising from enzymes 
that have achieved catalytic perfection, and are thought of as reflecting a physiological 
role that requires bulk turnover of a large quantity of substrate.   For example, diffusion 
limited rate constants fit well for SOD’s cellular function to scavenge superoxide to 
minimize oxidative damage.54 As an O2 sensor, one would imagine that FIH turnover 
could be limited by collisional encounter.  However, the absence of a viscosity effect on 
kcat/KM(O2) and kcat showed that FIH was not diffusionally limited under varied [O2].  This 
implicates a chemical step as rate-limiting under conditions of low [O2], consistent with 
prior results indicating that kcat was limited by a step which followed aquo release but 
preceded the HAT.34 
4.3.3 Competitive 18O kinetic isotope effect  
As kcat/KM(O2) encompasses all steps between diffusional collision of FIH with O2 
through the subsequent irreversible step, the O-18 heavy atom isotope effect on this rate 
constant is an ideal reporter of the rate-limiting step on this rate constant.  We employed 
competitive 18O/16O KIE measurements using O2 at natural isotopic abundance to identify 
the rate limiting step on kcat/KM(O2) in FIH.  The 18O/16O isotopic abundance of residual 
O2 was measured by IRMS from quenched reactions of FIH, which were fit to equation 2 
resulting in a 18kcat/KM(O2) = 1.0114(5) (Figure 4.3).  As the typical range of values for 
18kcat/KM(O2) is 1.00 – 1.03, this places O2 activation by FIH in a clear context with the 
mechanisms followed by other nonheme Fe enzymes.31   
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Figure 4.3.	  	  18O fractionation (Rf/Ro) versus the fractional conversion of O2 in quenched 
reactions of FIH.  Each reaction contained αKG (1.0 mM), CTAD788-806 (250 µM), FeSO4 
(50 µM), and O2 (280 µM) in 50 mM HEPES pH 7.00, 37.0. Data are fit to eq. 2., 
18kcat/KM(O2) = 1.0114(5). 
 
18kcat/KM(O2) reflects the changes in O-O bonding between molecular O2 and the 
transition state of the kinetically irreversible step on kcat/KM(O2).55,56 As the oxygen-18 
equilibrium isotope effect (18O EIE) provides an upper limit for the 18O KIE,57 previously 
calculated 18O EIEs for the equilibrium Fe2+ + O2 ó X provide an excellent barometer 
linking transition sate structure to measured value of 18kcat/KM(O2).31 For example, the 
calculated 18O EIE for X = Fe3+(O2-) is small (18O EIE =1.0080),31 meaning that rate-
limiting formation of the this intermediate would lead to a correspondingly small value 
for 18kcat/KM(O2).  A larger 18O EIE is calculated for X = ferric peroxo-carbonate (18O EIE 
=1.0129),31 a structure resembling the putative peroxohemiketal, which is in good 
agreement with the observed 18kcat/KM(O2) for FIH, suggesting that the rate-limiting step 
for FIH proceeds through a transition state that resembles this structure.  In contrast, the 
observed 18kcat/KM(O2) is inconsistent with the 18O EIE calculated for X = ferryl (18O EIE 
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= 1.0287),31 indicating that the ferryl intermediate is formed after the rate-limiting step on 
kcat/KM(O2) in FIH.    
18kcat/KM(O2) has been utilized to study the O2 activation pathways of other 
nonheme iron enzymes including soluble methane monooxygenase,58 ACCO,59 TauD,31 
HppE,31 and tyrosine hydroxylase60.  In each case, the magnitude of 18kcat/KM(O2) provided 
important insight into the chemical strategy followed for O2 activation.  For those 
enzymes in which O2 binds at Fe2+ intialy, the initial step is the reversible formation of a 
Fe3+(O2-) adduct, which subsequently requires electrons from cofactor or (co)substrate to 
activate the O-O bond for chemistry.  In the case of TauD, this activation takes the form 
of a nucleophilic attack of the Fe3+(O2-) on the C-2 keto position of αKG.  
The 18kcat/KM(O2) for FIH (1.0114(5)) is very similar to that observed for TauD 
(18kcat/KM(O2) = 1.0102),31 indicating a common transition state structure for αKG 
decarboxylation in these two enzymes.  The larger value for the 18kcat/KM(O2) for FIH than 
for TauD is likely due to the relative rate constants found in these enzymes.  In particular, 
the observed 18kcat/KM(O2) will approach the 18O EIE when the forward commitment, 
which is the ratio of the forward and reverse rate constants for disappearance of the 
species immediately preceding the rate-limiting step, is small as might be expected for 
slower chemistry in FIH.  
The chemical strategy for O2 activation to proceed through the nucleophilic attack 
on the αKG cofactor was predicted by DFT calculations,28,29  and is supported by the O-
18 KIE results.  The recent self consistent field (SCF) calculations predicted that 
decomposition of the initially formed cyclic peroxohemiketal intermediate is barrier-less, 
leading to concurrent decarboxylation with the formation of a Fe2+(peroxysuccinate) 
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intermediate which then rapidly forms the Fe4+(O)(succinate).  As the decarboxylation is 
chemically irreversibly, kcat/KM(O2) only reports on steps between the collision with O2 up 
through this decarboxylation step.  
Studies to date that address O2-activation chemistry in αKG oxygenases have 
relied on steady state mechanistic probes and point mutagenesis,22,44,61–64 and suggest that 
hydrogen bonding contacts to the αKG play an important role in facilitating 
decarboxylation. Further insight into oxidative decarboxylation has been hampered by the 
identity of the rate limiting steps in TauD and other αKG oxygenases.  In the cases of 
TauD,20 P4H,25 CytC3,32 and by analogy DAOCS 65 and the histone demethylase 
KDM4E,66 HAT by the ferryl and/or product release are rate-limiting on turnover at 
elevated [O2], preventing the accumulation of any species involved in O2-activation 
during the pre-steady state.  A crucial difference between these enzymes and FIH is that 
several lines of evidence indicate that decarboxylation is rate-limiting in FIH, suggesting 
that it may be possible to directly access this and other steps involved in O2-activation. 
 
4.4. Conclusions  
We have used multiple kinetic probes to characterize kcat/KM(O2) of FIH.  Unlike 
other previously characterized Fe(II)/αKG enzymes, FIH is fully limited by O2 
activation.  This kinetic feature contributes to FIH’s function as an O2 sensor − strong 
oxidants such as the ferryl and proceeding intermediates with radical character are short 
lived, preventing aberrant oxidations.  This allows for a tight coupling between O2 
activation and CTAD hydroxylation. It may be possible other biomedically important 
Fe(II)/αKG enzymes such as the JmjC and JmjD domain-containing hydroxylases, and 
PHD2 employ a similar mechanistic strategy to regulate their function.  If so, rate-limited 
  
 
95 
O2 activation may be a more common mechanistic feature among Fe(II)/αKG 
oxygenases. 
4.5. Supplemental Material 
4.5.1 Steady-state kinetics with CTAD788-806 
 
FIH was kinetically characterized through steady-state assays using CTAD788-806 
to ensure the CTAD788-806 peptide was a suitable substrate for mechanistic studies. These 
assays were performed as described in the Methods section.  
Steady-state assays with αKG as the varied substrate used a fix CTAD788-806 
concentration ~KM(CTAD788-806).  The fit of the initial rate to the Michaelis-Menten equation 
resulted in the apparent kinetic parameters kcat (8.5 ± 0.5 min-1), kcat/KM(CTAD788-806) (0.34 
± 0.07) and the Michaelis constant (25 ± 5 µM). 
 
 
Figure 4.4.  Steady-state kinetics varying αKG using CTAD788-806.  Assays contained 
ascorbate (2 mM), FeSO4 (50 µM) , CTAD788-806 (750 µM) and αKG (5 -1000 
µM) in 50 mM HEPES pH 7.00, 37.0°C. 
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When CTAD788-806 was the varied substrate, the initial rate data fit to the 
Michaelis-Menten equation resulted in the apparent kinetic parameters kcat (28 ± 2 min-1), 
kcat/KM(CTAD788-806) (0.020 ± 0.003) and the Michaelis constant (1400 ± 200 µM).  The 
shorter CTAD788-806 peptide had a dramatically increased KM compared to the CTAD788-
826 peptide (KM=70 µM), but kcat remained unchanged.  The dramatic decrease in kcat/KM 
and not kcat  suggest CTAD788-806  binding is less efficient compared to that of CTAD788-
806. 
 
 
Figure 4.5.  Steady-state kinetics varying CTAD788-806.  Assays contained ascorbate (2 
mM), αKG (1 mM), FeSO4 (50 µM), CTAD788-826 (0.1-4.6 mM) and FIH (10 µM) in 50 
mM HEPES pH 7.00, 37.0°C. 
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When ascorbic acid was omitted from the reaction, FIH was still able to 
hydroxylate both CTAD peptides.  As it is generally accepted ascorbate maintains an 
available pool of FeII, the decrease in initial rates in the absence of ascorbate is likely due 
to Fe oxidation. 
 
Figure 4.6. Steady-state kinetics varying CTAD788-806 in the absence of ascorbate (red, 
p) or presence of 2 mM ascorbate (black, ), αKG (1 mM), FeSO4 (50 µM), CTAD788-
806 (0-800 µM), and FIH (10 µM) in 50 mM HEPES pH 7.00, 37.0°C.	  
 
Figure 4.7. Steady-state kinetics varying CTAD788-826 in the absence of ascorbate (red, 
p) or presence of 2 mM ascorbate (black, ), αKG (1 mM), FeSO4 (50 µM), CTAD788-
826 (0-260 µM), and FIH (0.5 µM) in 50 mM HEPES pH 7.00, 37.0°C.	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CHAPTER 5 
SUBSTRATE POSITIONING BY GLN239 STIMULATES TURNOVER IN FIH, 
AN αKG-DEPENDENT HYDROXYLASE 
This chapter has been published as: 
Hangasky, J.A.; Ivison, G.T.; Knapp, M.J. (2014) Substrate Positioning by Gln239 
Stimulates Turnover in FIH, an αKG-Dependent Hydroxylase. Biochemistry 53, 5750-
5758l 
 
5.1 Introduction 
Nonheme Fe(II)/αKG dependent oxygenases are a large superfamily of enzymes 
catalyzing diverse reactions including demethylations, hydroxylations, ring expansions 
and epoxidations.1,2 Many of these enzymes have important function in human health due 
to their role in O2 sensing,3,4 DNA repair,5,6 histone demethylation,7  and RNA 
processing,8,9 making this superfamily a growing class of therapeutic targets.10,11  As the 
consensus chemical mechanism is ordered sequential, with O2 reacting at the Fe prior to 
oxidation of the primary substrate (Scheme 5.1),12,13 identifying features of the active site 
by which substrate binding stimulates O2-reactivity is crucial to understanding the 
chemistry of this superfamily.  An ideal enzyme for interrogating these connections is 
Factor Inhibiting HIF (FIH), a human enzyme that controls hypoxia sensing which 
inherently controls O2-reactivity.  It’s large substrate binding pocket would presumably 
allow for subtle changes within the active site to have a minimal effect on substrate 
binding, allowing for correlations to be made between substrate positioning and turnover. 
Human cells sense O2 through the Hypoxia Inducible Factor (HIF) pathway, 
which is controlled by a small number of αKG oxygenases including FIH.14,15 HIF is an 
αβ-dimeric transcription factor that regulates numerous genes involved in tissue 
development, controlling processes including glycolysis, erythropoiesis and 
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angiogenesis.1,16–18  In the presence of O2, FIH hydroxylates the β-carbon of HIF1α-
Asn803,19 which is found in the C-terminal activation domain (CTAD) of HIF1α.  CTAD-
Asn803 hydroxylation blocks recruitment of the cAMP response element-binding protein 
(CREBP), preventing HIF-dependent gene transcription.4,20 The connection between 
CTAD-Asn803 positioning and O2-reactivity is critical to understand how substrate 
stimulates O2 activation in this enzyme superfamily, as well as illuminating FIH’s role as 
an O2 sensor.  
 
Scheme  5.1. Proposed chemical mechanism for FIH 
 
The consensus chemical mechanism for FIH is based upon an array of kinetic and 
spectroscopic studies of FIH and other αKG oxygenases.  Kinetic studies of thymine 
hydroxylase, FIH, CAS, and TauD support the ordered, sequential binding of αKG and 
primary substrate followed by O2.21–24  Although αKG, O2, and an oxidizable compound 
are all substrates for these enzymes, we will refer to the oxidizable substrate as the 
  
 
107 
‘primary substrate’.  Spectroscopic studies of CAS,25–27 TfdA,28 FIH,29 and TauD30 
revealed that the Fe(II) released an aquo ligand after primary substrate bound, creating a 
site for O2 binding.  Binding and activation of O2 leads to the oxidative decarboxylation 
of αKG and the formation of a highly reactive ferryl intermediate (Scheme 5.1). Although 
the precise sequence of intermediates is not known, the ferryl intermediate has been 
observed in TauD31–33 and P4H34 demonstrating that H-atom abstraction by the ferryl 
intermediate occurs,35 with the next step likely to be ●OH rebound to hydroxylate the 
primary substrate.   
The most intriguing feature of the consensus mechanism is that binding primary 
substrate stimulates O2 reactivity.21,36,37 Loss of an aquo ligand when the primary 
substrate is bound opens a coordination site for O2 binding, as observed upon binding 
primary substrate in several αKG-dependent oxygenases including CytC3, TauD, CAS 
and FIH.25,29,30 Although aquo release is central to the widely accepted model for 
substrate-stimulated O2 activation,38 we note that simple ligand exchange is insufficient 
for O2 activation in these enzymes.  For example, substrate binding to FIH leads to only 
fractional release of the aquo ligand,29 and mutagenesis suggests that hydrogen bond 
donors to the αKG are necessary for full activity in this enzyme.39 Computational studies 
40–43 and mechanistic probes 44–46 further point to turnover being limited by steps after O2 
binds to the Fe(II).  These and related observations lead us to propose that substrate 
stimulated O2-reactivity arises from bonding changes throughout the active site, ranging 
from aquo release at the iron cofactor to altered contacts in the second coordination 
sphere.   
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A focus of is work is to identify those active site features that change upon 
substrate binding to stimulate O2 activation in αKG oxygenases.  Although the precise 
sequence of intermediates formed during turnover is not known, we define O2-activation 
as the steps between O2 binding and oxidative decarboxylation (Scheme 5.1) by virtue of 
the irreversible chemistry; this step is depicted as the nucleophilic attack of the putative 
ferric-superoxide on the α-keto position of αKG. Based on known crystal structures of 
FIH,47–49 we have used point mutagenesis to identify several essential second 
coordination sphere interactions in FIH, including those hydrogen bonding to Fe(II) 
ligands, as well as FIH-Gln239, an anchor residue which forms two hydrogen bonds with 
the target residue, CTAD-Asn803 (Figure 5.1).48 Intriguingly, disruption of this two-point 
hydrogen bond in the FIH-Gln239→Asn point mutant led to a decrease in kcat of 250-fold, 
but a negligible change in KM(CTAD).39 This was attributed to a combination of steric 
hindrance near the open coordination site on Fe(II) and incorrect CTAD positioning for 
the HAT step.  Subsequently, it was shown that an irreversible step associated with O2 
activation was rate limiting in WT-FIH,24 suggesting that the slower turnover for the 
Gln239→Asn variant could arise from slower O2 activation.  This suggests the intriguing 
possibility that target residue position may stimulate O2 activation, and that the overall 
structure of the active site is crucial for O2 activation. 
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Figure 5.1. CTAD-Asn803 (Blue) positioned by FIH-Gln239 (Grey) over the active site. 
Hydrogen bonding distances angstroms. PDBID: 1H2L.48 
 
The present study tests the role of substrate positioning on substrate hydroxylation 
in αKG oxygenases.  As FIH hydroxylates a specific target residue within a large peptide 
(CTAD-Asn803) our focus was directed on this target residue pocket, formed by the side 
chains of FIH residues Tyr102, His199, Arg238 and Gln239 (Figure 5.1).  Five FIH-
Gln239→X variants were prepared (X = Ala, Asn, Glu, His and Leu) to vary the bulk and 
hydrogen bonding potential within the target residue pocket.  Although these variants 
exhibited significantly reduced steady-state rate constants that decreased monotonically 
with increasing residue bulk, CTAD binding affinity was unaffected by mutation.  In 
contrast to WT-FIH, O2 activation was appreciably uncoupled from CTAD hydroxylation 
in the variants; uncoupled O2 activation was partially suppressed in D2O. This data 
establishes that proper orientation of CTAD-Asn803 by FIH-Gln239 is required for 
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substrate hydroxylation, most likely due to the need for the proper target residue 
positioning during steps after O2 activation. 
 
5.2 Experimental Procedures 
5.2.1 Materials 
All reagents were purchased from commercial vendors and were not further 
purified, with the exception of the 39-mer CTAD peptide.  The 39-mer CTAD peptide 
corresponding to the C-terminal activation domain of human HIF-1α, (HIF-1α788–826) 
contained a Cys800 → Ala substitution,  
DESGLPQLTSYDAEVNAPIQGSRNLLQGEELLRALDQVN.  This was purchased as a 
desalted peptide from EZBiolab (Carmel, IN, USA) with free N and C-termini.  The 
peptide was purified as previously described using RP-HPLC to obtain CTAD of >95% 
purity.24 The 19-mer CTAD peptides corresponding to HIF-1α788–806 also contained a 
Cys800→Ala point mutation. These were purchased with >95% purity from EZBiolab 
with free N and C-termini.  The CTAD-Asn803→Gln, peptide was the 19-mer sequence, 
but contained the Asn803→Gln substition, DESGLPQLTSYDAEVQAPI.       
5.2.2 FIH Mutations  
The Stratagene QuikChange mutagenesis kit was used to insert mutations in the 
pET28a-FIH construct.50 All mutations were sequenced (Genewiz, NJ, USA) to confirm 
the sequence contained only the desired point mutation.  Sequenced plasmids were 
transformed into BL21 (DE3) cells for protein expression. 
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5.2.3 Protein Expression and Purification 
WT-FIH and all mutants were overexpressed in E. coli with an N-terminal His6 
tag and purified as previously described.24 Three additional residues (NH2-GlySerHis-), 
from the fusion protein remained on the N-terminus following thrombin cleavage.  
Purified FIH was buffer exchanged into 50 mM HEPES pH 7.00.  The purity (>95%) of 
each mutant was assessed by SDS-PAGE. 
5.2.4 Steady-state kinetics assays 
All assays used saturating concentrations of FeSO4 (25 µM) and ascorbate (2 
mM), ambient O2 concentration (217 µM at 37.0°C), and were performed in 50 mM 
HEPES, pH 7.00 at 37.0°C unless specifically noted otherwise.  DTT (200 µM) was 
added to assays for FIH-Gln239→His and FIH-Gln239→Glu to obtain linear initial rates at 
high [CTAD] in D2O.   Assays in which CTAD was the varied substrate (15 µM - 300 
µM) utilized saturating αKG (500 µM).   Assays with αKG as the varied substrate (2.5 
µM - 100 µM) utilized a fixed CTAD concentration of 100 µM (~KM(CTAD)) in order to 
conserve on the use of the peptide. Assay reagents were mixed and incubated for two 
minutes at 37.0°C before the addition of enzyme ([E]T = 1.5 - 10µM).  Reaction aliquots 
(5 µL) were quenched with 75% acetonitrile/0.2% TFA (20 µL) saturated with 3,5-
dimethoxy-4-hydroxycinnamic acid and analyzed for peptide hydroxylation using a 
Bruker Daltonics Omniflex MALDI-TOF-MS. Initial rates were determined from 5-7 
quenched timepoints (0 to ~15% fractional conversion).  The nonlinear least-squares 
fitting of initial rate data to the Michaelis-Menten equation yielded the apparent steady-
state rate constants, kcat and kcat/KM.  All assays were replicated a minimum of three 
times. 
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5.2.5 Solvent Kinetic Isotope Effects (SKIEs) 
Steady-state assays for SKIEs were performed under the same conditions as 
reported above, with the exception that all reagents were prepared in D2O.  Deuterium 
oxide (D, 99.9%) was purchased from Cambridge Isotope Laboratories (Andover, MA, 
USA) and used as received.  Working FIH stock solutions were made by diluting high 
concentration stocks from H2O into D2O containing 50 mM HEPES pD 7.00. Assays 
were performed in 50 mM HEPES, pD 7.00, with a final D2O percentage estimated as 
96%.  SKIEs were calculated from the direct comparison of kinetic parameters observed 
in buffers containing H2O and D2O; e.g. D2Okcat = kcat(H2O)/kcat(D2O). 
5.2.6 Succinate Quantification 
The coupling between the two half reactions was determined from monitoring the 
production of succinate and CTADOH concentrations in several quench points from a 
common reaction.  Reactions containing αKG (500 µM), FeSO4 (25 µM), CTAD (350 
µM) and FIH (5-10 µM) were run at 37.0 °C and analyzed similarly to previously 
reported procedures.24,39,46 As HEPES interfered with the succinate analysis, Tris buffer 
was used for these assays to minimize background signal in the HPLC chromatograms 
that arose due to buffer components.  A Hamilton PRP-X300 anion exclusion column 
was used to separate the succinate produced from the quenched reactions and UV 
detection at 210 nm was used to determine the succinate concentration.  Using aliquots 
from the same quenched assay, a Bruker Daltonics Omniflex MALDI-TOF-MS was used 
to determine the CTADOH concentration.  The coupling ratio (C) was determined by 
taking the ratio of the rate of succinate formation and the rate of CTADOH formation from 
matched time points.   
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5.2.7 Fluorescence Spectroscopy 
The FIH/CTAD binding constants were measured through quenching of the 
intrinsic tryptophan fluorescence of (Co + αKG)FIH upon CTAD binding at room 
temperature (~20°C).  The fluorescence cuvette contained FIH (1.5µM), CoSO4 (25 µM), 
αKG (500 µM) and 50 mM HEPES (pH 7.05).  This solution was titrated with 50 mM 
HEPES (pH 7.05) containing CTAD (1mM), FIH (1.5µM), CoSO4 (25 µM) and αKG 
(500 µM).   After each addition of titrant, samples were gently mixed and allowed to 
equilibrate for five minutes before being excited at 295 nm.  The fluorescence intensities 
at 330 nm were plotted versus the total CTAD concentration, and fit using equation 5.1, 
where I is the measured fluorescence intensity, [E] is the protein concentration, [S] is the 
total CTAD concentration, n is the number of binding sites and KD is the binding affinity.  
The initial intensity (Io) and final intensity (If) were obtained from measured spectra. 
 
!!!!!!!!! = ( ! ! ! !!!)! ! ! ! !!! !! ! ! ! !! !  Equation 5.1   
 
5.3 Results 
Variants of FIH-Gln239 were used to test the effect of target residue positioning on 
substrate hydroxylation and O2 reactivity in FIH.  The variants were designed to alter 
hydrogen bonding potential (Gln239→Glu, Gln239→His) and cavity size (Gln239→Ala, 
Gln239→Asn, Gln239→Leu) in the target residue pocket of FIH.  The Gln239 variants were 
kinetically characterized in the steady-state with CTAD as the varied substrate giving the 
apparent rate constants kcat and kcat/KM(CTAD). The kinetic characterization revealed 
  
 
114 
significantly diminished rates for turnover, leading us to determine the binding affinity of 
CTAD as well as the coupling ratio of the two half reactions for each point mutant.  
5.3.1 Kinetic Characterization of Gln239→X mutants 
We hypothesized the positioning of CTAD-Asn803 by FIH-Gln239 was necessary 
to support turnover and therefore focused our studies towards steady-state 
characterization by monitoring CTADOH formation via MALDI-TOF mass spectrometry.  
Although O2 uptake was the first method that we considered, the slow turnover for FIH 
makes high precision kinetic determinations by this method challenging.  Assays using 
fixed concentrations of αKG and O2 and varied concentrations of CTAD were used to 
measure initial rates, which were then fit to the Michaelis-Menten equation to obtain the 
apparent steady-state rate constants, kcat and kcat/KM(CTAD). 
 
 
Figure 5.2. Steady-state kinetics of Q239A in H2O.  FIH (1.5µM), ascorbate (2 mM), 
αKG (500 µM), FeSO4 (25 µM) and CTAD (0-300 µM) were in 50mM HEPES pH 7.00.  
Inset:  Steady-state kinetics of Q239N (▲),Q239H (■) and Q239E (u) in H2O. FIH (1.5-
30 µM), ascorbate (2 mM), αKG (500 µM), FeSO4 (25 µM) and CTAD (0-300 µM) were 
in 50mM HEPES pH 7.00. 
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The Michaelis constant for αKG was determined for each variant (KM(αKG) = 4-7 
µM), which was slightly lower than that for WT-FIH (KM(αKG) = 16 µM).  Due to the O2 
concentration being subsaturating, the apparent kcat encompasses all steps after CTAD 
binding, including those involved in O2 binding and activation.  All of the Gln239→X 
variants exhibited a significant decrease in kcat (Figure 5.2).  The Gln239→Ala (kcat = 1.27 
± 0.10 min-1) variant was most active, as kcat decreased 20 fold relative to WT-FIH, 
whereas kcat for Gln239→Asn (0.14 ± 0.02 min-1) decreased 200 fold.  The kcat for variants 
capable of one-point hydrogen bonding decreased over 1200 fold: Gln239→His (0.023 ± 
0.003 min-1) and Gln239→Glu (0.024 ± 0.002 min-1).  We were unable to observe 
hydroxylation from the  Gln239→Leu variant (Table 5.1). 
Table 5.1. Kinetic Parameters for FIH and Mutants.a 
  kcat kcat/KM(CTAD)   KM(CTAD) KD KM(αKG) 
 (min-1)b (µM-1 min-1)b  (µM)b (µM)c (µM)d 
WT 30 ± 2.5e 0.43 ± 0.10e  70 ± 20
e 78 ± 7f 16 ± 3.0 
Q239A 1.27 ± 0.10 0.021 ± 0.002  61 ± 10 100 ± 16 5.0 ± 0.5 
Q239N 0.14 ± 0.02 2.0 x 10-3 ± 8.0 x 10-4  74 ± 30 98 ± 10 4.0 ± 0.4 
Q239H 0.023 ± 0.003 3.4 x 10-4 ± 1.0 x 10-4  68 ± 18 64 ± 14 7.0 ± 1.4 
Q239E 0.024 ± 0.002 3.4 x 10-4 ± 7.0 x 10-5  71 ± 10 75 ± 15 4.7 ± 2.0 
Q239L <0.005g < 8 x 10-5g  N.D.h 80 ± 8 N.D.h 
a. 50 mM HEPES pH 7.00, 37.0°C 
b. Assays in which CTAD was the varied substrate; ascorbate (2 mM), αKG (500    
µM), FeSO4 (25 µM), and CTAD (0 - 300 µM)  
c. Determined using intrinsic tryptophan fluorescence with Co substituted FIH  
d. Assays in which αKG was the varied substrate: Ascorbate (2 mM), αKG (2-200 
µM) FeSO4 (25 µM) and  CTAD (100 µM) 
e. Reference 24 
f. Reference 29 
g. No activity detected; estimated detection limits as reported 
h. N.D., Not determined 
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Steps from CTAD binding through the first irreversible step (decarboxylation) 
comprise kcat/KM(CTAD) (Scheme 5.1).  The effect of each point mutant on kcat/KM(CTAD) was 
nearly identical to their effects on kcat, indicating that the variants affected a step that was 
separate from CTAD binding. 
We tested the activity of FIH-Gln239→Asn using a 19-mer CTAD peptide 
containing the complementary CTAD-Asn803 →Gln substitution, which switched the 
residues at this target site.  This switch mutation was designed to restore the bulk and 
hydrogen bonds observed between WT-FIH and WT-CTAD.  However, even with this 
‘optimized’ substrate the activity level was below our detection limit (0.002 min-1), as 
hydroxylated CTAD-Asn803→Gln was not detected when incubated with FIH-
Gln239→Asn.  WT-FIH was similarly unreactive toward this mutant CTAD, as WT-FIH 
hydroxylated the 19-mer WT-CTAD with an appreciable rate, but did not hydroxylate the 
mutant CTAD (Table 5.2). 
 
Table 5.2. Initial Rates for 19-mer peptides: CTAD and CTAD-N803Qa 
 Initial Rate (min
-1) 
  WT CTAD 
N803Q 
CTAD 
WT 0.70 <0.005b 
Q239N <0.005 <0.005b 
a. Assays contained ascorbate (2 mM), αKG (500 µM), FeSO4 (25 µM) and 19-
mer CTAD (400 µM) in 50 mM HEPES pH 7.00, 37.0°C.  The CTAD peptide 
used contained 19 residues. 
b. No activity detected; estimated detection limit, if active 
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5.3.2 Binding affinity of CTAD to Gln239 →X mutants  
The binding affinity of each FIH mutant for CTAD was measured by titration 
using the intrinsic tryptophan fluorescence of FIH. The experimentally determined KD for 
each point mutant (Table 5.1) was similar to that of WT-FIH (78 ± 7 µM), indicating the 
thermodynamics of CTAD binding was not affected by point mutation.   
5.3.3 Uncoupled turnover in the Gln239 →X mutants 
The kinetic parameters of the Gln239→X variants led us to explore the coupling of 
O2-activation to substrate hydroxylation.  We hypothesized that if the conformational 
state of CTAD-Asn803 was incorrect for HAT, then the two half reactions would uncouple 
to produce more succinate than hydroxylated product (CTADOH).  
The coupling values for the Gln239→X (X = Ala, Asn, Glu, His) variants were 
obtained by taking the ratio of the rates of formation for succinate and CTADOH.   All 
variants produced 3 - 5 succinate per equivalent CTADOH; succinate formation was 
observed for the Gln239→Leu variant (kobs(suc)=0.08 min-1), indicating O2 activation 
occurred even though CTAD hydroxylation was not detected for this variant (Table 5.3).  
This uncoupling is similar to the values found previously for second coordination sphere 
variants of FIH.39   
The coupling of WT, Gln239→Ala and Gln239→Asn in deuterated buffer was used 
to determine if the coupling ratio changed between protonated and deuterated buffers.  
The coupling for WT FIH in H2O (C = 1.0 ± 0.1) and D2O (C = 1.0 ± 0.1) was in 
agreement with our previous work,24 showing WT to remain tightly coupled under all 
tested conditions.  However, the coupling ratio in D2O for Gln239→Ala (C = 1.4 ± 0.2) 
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and Gln239→Asn (C = 2.2 ± 0.2) approached unity, indicating that solvent deuteration led 
to more tightly coupled turnover for these variants.  
 
Table 5.3. Coupling of [Succinate] and [CTADOH] for FIH and variantsa 
 
kobs(H2O) [𝑠𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒]/𝑚𝑖𝑛𝐹𝐼𝐻  𝐶!!!!  𝐶!!!!  
WT 28 ± 2 1.0 ± 0.1 1.0 ± 0.1 
Q239A 5.5 ± 0.3 4 ± 1 1.4± 0.2 
Q239N 0.49 ± 0.08 3.3 ± 0.3 2.2 ± 0.2 
Q239H 0.06 ± 0.02 3 ± 1 N.D 
Q239E 0.07 ± 0.03 5 ± 1 N.D 
Q239L 0.08 ± 0.02 N.D. N.D 
a. Reactions contained FIH (5-10µM), αKG (500 µM), FeSO4 (25 µM), and 
CTAD (350 µM) in 50 mM Tris pL 7.00, 37 °C 
b. 𝐶 =   !"#$  !"##$%&'(/!"#!"#$  !"#$!"/!"#        
c. N.D., Not Determined 
 
 
5.3.4 Solvent Kinetic Isotope Effects (SKIEs) 
SKIEs on both kcat and kcat/KM(CTAD) were used to test the importance of solvent-
dependent steps during turnover. Initial rates from steady-state assays using saturating 
αKG concentrations, ambient O2 concentrations and varied concentrations of CTAD were 
fit to the Michaelis-Menten equation (Figure 5.3).  In all cases, turnover was faster in 
D2O, leading to an inverse SKIE on kcat and kcat/KM(CTAD) as seen for WT-FIH (Table 5.4).  
However, these SKIEs must be considered in the context of the solvent dependent 
uncoupling observed for the point mutants.51 
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Figure 5.3. Steady-state kinetics of Q239A in H2O (●) and 97% D2O (■) buffers.  FIH 
(1.5-30 µM), ascorbate (2 mM), αKG (500 µM), FeSO4 (25 µM) and CTAD (0-300 µM) 
were in 50mM HEPES pL 7.00, 37°C. 
 
 
Table 5.4. Kinetic parameters  in D2O and SKIEs for FIH and variants.a 
  kcat kcat/KM(CTAD) D2Okcatc D2Okcat/KM(CTAD)d   (min-1)b (µM-1 min-1)b 
WTe 59 ± 2 1.09 ± 0.11 0.51 ± 0.07 0.40 ± 0.07 
Q239A 2.55 ± 0.21 0.044 ± 0.011 0.50 ± 0.05 0.48 ± 0.15 
Q239N 0.27 ± 0.02 0.005 ± 0.001 0.50 ± 0.06 0.41 ± 0.18 
Q239H 0.050  ±  0.003 2.0 x 10-3 ± 8 x 10-4 0.46 ± 0.07 0.17 ± 0.06 
Q239E 0.046 ± 0.002 8.3 x 10-4 ± 3 x 10-4 0.52 ± 0.05 0.41  ± 0.16 
Q239L f f f f 
a. 50 mM HEPES pD 7.00, 37.0°C 
b. Determined from assays with CTAD as the varied substrate; ascorbate (2 mM),     
αKG (500 µM), FeSO4 (25 µM), and CTAD (0 - 250 µM),  χD2O = 0.96 
c.  D2Okcat= kcat (H2O)/ kcat(D2O) 
d.  D2Okcat/KM(CTAD) = kcat/KM(CTAD) in H2O / kcat/KM(CTAD) in D2O 
e.  Reference 24 
f.  Not determined 
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5.4 Discussion 
 The ordered sequential consensus mechanism for αKG oxygenases leads to 
coupled turnover when primary substrate binding stimulates reactivity toward O2, a 
phenomenon termed substrate-induced activity enhancement,52 priming,53 or triggering54 
by different workers.  As substrate does not directly bind to the Fe(II), altered local 
contacts within the active site likely stimulate O2 activation. Although the idea of 
stimulated O2-activation refers to the empirical observation of increased turnover rates 
induced by substrate binding, the dominant model used to explain this focuses on the 
aquo release, which creates an open coordination site for O2 binding.38 In our opinion, 
broader changes within the active site are correlated with this effect – such as the position 
of the primary substrate.   
FIH is notable in that enzyme/substrate contacts are quite extensive due to the 
substrate being a large peptide (CTAD), with the target residue positioned above the Fe 
by a two-point hydrogen bond to the side chain of an anchoring residue, FIH-Gln239.48,55 
The present study varied the sterics and H-bonding potential of this anchor residue to test 
its role in the positioning and hydroxylation of CTAD-Asn803.   
 5.4.1 CTAD hydroxylation is slowed by Gln239 mutation 
Each of the Gln239→X mutants (X=Ala, Asn, Glu, His or Leu) altered the 
hydrogen bond potential and/or bulk of the target residue pocket, disrupting the 
positioning of the target residue.  This incorrect positioning could have impacted any one 
of several steps within the kinetic mechanism, which may be distinguished through 
analysis of steady-state kinetic parameters and coupling ratios.  The significant reduction 
in kcat and kcat/KM(CTAD) relative to those of WT-FIH indicated that the anchor residue 
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played a prominent role in supporting turnover.  Combined with the observation that the 
binding affinity of CTAD was unchanged from that of WT-FIH (Table 5.1), we are led to 
conclude that the predominant role of FIH-Gln239 is to position substrate for a chemical 
step rather than to bind CTAD.   
Although it may seem surprising that the anchor residue FIH-Gln239 contributes 
very little to the CTAD binding affinity, this is consistent with prior studies CTAD-
derived peptides with non-native sequences.  As the length of the CTAD has been shown 
to have a significant affect the KM,56 it appears that the dominant factor in CTAD binding 
is the surface contact with FIH, with only minor contributions from the target residue 
pocket.  Alanine scanning of CTAD revealed that CTAD-Val802 was the most significant 
residue for CTAD binding, with a two-fold increase in the KM(CTAD) for the CTAD-
Val802→Ala mutant.57 Molecular dynamic studies suggested that this mutation led to 
reorientation of Asn803,57 perhaps due to disruption of the tight turn conformation in 
residues 801-803 of CTAD.  Further support for minimal impact from FIH-Gln239 is the 
observation that FIH hydroxylate substrates with target residues other than 
asparagine.58,59 The structural features of these substrates suggest the overall contact 
between FIH and the whole peptide is important in determining the substrate binding 
affinity to FIH.59,60   
5.4.2 Inverse SKIEs 
We recently reported inverse solvent kinetic isotope effects (SKIEs) for WT FIH, 
on both kcat and kcat/KM(CTAD).24 This was due to the isotopically sensitive metal-aquo 
fractionation prior to a rate-limiting step for WT-FIH.  Importantly, WT-FIH exhibited 
fully coupled turnover, such that O2 activation always led to substrate hydroxylation.  
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Consequently, it was deduced that the rate-limiting step for kcat and kcat/KM(CTAD) was an 
irreversible step immediately after aquo release.  This step is depicted as the oxidative 
decarboxylation of αKG in Scheme 5.1. 
For each of the Gln239→X variants, inverse SKIEs were measured on both kcat and 
kcat/KM(CTAD) when determined from the rate of  CTADOH formation (Table 5.4).  
Although the SKIE data resembled that reported for WT-FIH, turnover for these variants 
was significantly uncoupled which precluded the use of SKIEs to diagnose rate-limiting 
steps in the steady state.  Nevertheless, uncoupling in the variants depended on solvent 
isotopic composition (Table 5.3), suggesting that the ferryl intermediate could form even 
when CTAD was improperly positioned. The fact that C approached unity in D2O for 
these variants suggested that the main effect of the Gln239→X change was to perturb the 
hydroxylation step. 
5.4.3 Sterics and H-bonding impact substrate hydroxylation  
A simple model to explain how the target residue pocket impacts productive 
turnover is one in which multiple conformational states of the target residue are adopted, 
but only one conformation supports hydroxylation. X-ray crystal structures of 
(M+αKG)FIH bound to CTAD 48  or Notch-derived peptides 55 revealed that the target 
residue adopted a specific rotameric conformation,  with a side chain torsional angle(HN-
Cα-Cβ-Cγ) of -71°.  This is observed for both Notch target residues Notch-Asn210 and 
Notch-Asn1945 (PDB: 3P3P, 3P3N).55  As a good deal of flexibility near Gln239 was 
observed crystallographically for (Fe+αKG)FIH when CTAD was absent (PDB: 
1MZF),47 changing the hydrogen bonding potential and packing density of this anchor 
residue should alter the target residue position above the Fe(II).  The significant reduction 
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in catalytic efficiency for each point mutant strongly suggests that the major role of FIH-
Gln239 is to stabilize the proper rotamer of CTAD-Asn803 which can undergo 
hydroxylation during turnover.   
The kinetic data further suggest that packing near the target residue may also 
impact O2 activation in FIH.  The overall trend in the kinetic parameters measured by 
coupled turnover (Table 5.1) was dominated by bulk, as the kinetic parameters for the 
Gln239→X point variants decreased monotonically in a series: X = (Ala > Asn > Glu, His 
>> Leu).  As the kinetic parameters of the variants listed in Table 5.1 are functions of all 
steps leading to CTAD hydroxylation, it is not possible to separately identify the impact 
of the variants on O2-activation.  However, the coupling data directly measured succinate 
production (Table 5.3) which reports directly on O2 activation.   The rates of succinate 
production clearly showed that each variant produced succinate much more slowly that 
WT-FIH, suggesting that O2-activation was slowed in these variants.  As the packing 
about CTAD-Asn803 is quite tight in WT-FIH,48 it is possible that the Gln239àX variants 
excluded CTAD-Asn803 from the proper conformation, which could impede O2 access to 
the Fe(II) as well as hydroxylation by the putative ferryl intermediate (Scheme 5.2).   
  
 
124 
 
Scheme 5.2. Minimal chemical scheme for uncoupling. 
 
 
5.5 Conclusion 
This work establishes that proper positioning of the substrate is required to 
support coupled turnover by FIH.  We conclude that proper positioning of substrate is 
crucial for the hydroxylation of CTAD, as well as to stimulate O2 activation.  Mis-
positioned CTAD impedes O2 activation suggesting that the environment near to the 
Fe(II) cofactor plays a marked role in O2 activation. 
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5.6 Supplemental Material  
5.6.1 Differential Scanning Calorimetry  
The thermal stability of all the Gln239→X variants was determined using a 
MicroCal VP-DSC Microcalorimeter.  FIH (30 µM) was reconstituted with CoCl2 (30 
µM) and αKG (400 µM) in 50 mM HEPES pH 7.00.  Samples were heated in the 
calorimeter over a 10-70°C range with a scan rate of 30 °C/h.  Thermal unfolding of FIH 
was irreversible, and the apparent melting temperature (TM(app)) was taken as the peak in 
the heat capacity data.  To correct for baseline drift, a buffer scan was subtracted from 
each data set. 
 
Table 5.5.  Melting temperatures determined using DSC for Gln239→X variants 
 
TM(app) 
(°C) 
WT FIH39 54.5 
Q239A 54.3 
  Q239N39 56.2 
Q239H 53.2 
Q239E 51.9 
Q239L 53.3 
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5.6.2 Intrinsic Tryptophan Fluorescence  
 
 
 
Figure 5.4.  Intrinsic tryptophan fluorescence.  Normalized fluorescence intensity at 330 
nm versus total [CTAD].  FIH (1.5 mM), CoCl2 (25 mM) and αKG (500 mM) in 50 mM 
HEPES pH 7.05 was titrated with a CTAD stock (1.00 mM) containing FIH (1.5 mM), 
CoCl2 (25 mM) and αKG (500 mM) in 50 mM HEPES pH 7.05.  Inset: Fluorescence 
emission spectra collected after each addition of CTAD. 
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CHAPTER 6 
O2 ACTIVATION AND LIGAND SELECTIVITY IN THE FE(II)/αKG 
OXYGENASE FIH: CONTRIBUTIONS OF THE FACIAL TRIAD 
CARBOXYLATE 
 
 
6.1 Introduction 
 Physiological gases such as NO, CO and O2 have a vital role in cellular signaling 
pathways and cell homeostasis. Heme-based gas sensors such as sGC, H-NOX and 
CooA,1–5 as well as the nonheme Fe(II)/αKG oxygenases prolyl hydroxylase domain 
(PHD) and factor inhibiting HIF (FIH),6–8 rely on selectively binding and discriminating 
these diatomic molecules for gas specific signaling. A common theme emerges from 
previous studies of heme-based gas sensing: the steric and electrostatic environment of 
the gas pocket tunes gas selectivity.9–12 However, unlike heme counterparts, the ligand 
selectivity mechanisms in the nonheme Fe(II)/αKG oxygenases are unclear.   
 The nonheme Fe(II)/αKG dioxygenases are a subset of nonheme mononuclear 
Fe(II) enzymes, which catalyze a wide range of oxidations including hydroxylation of 
proteins, demethylation of RNA and DNA, and desaturation reactions.13,14 Enzymes in 
this superfamily coordinate of the nonheme iron by a 2His-1Carboxylate ligand set, αKG 
and an aquo ligand in the resting state.15,16 FIH, an αKG oxygenase responsible for O2 
sensing in humans, is one of the few enzymes that has been found to be active with only 
two protein derived ligands to the Fe.17,18 This affords an unique opportunity to 
understand how local contacts with the facial triad carboxylate, Asp201, affect O2 
activation and the binding of exogenous ligands.  
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 Although the active site of FIH is six coordinate in the resting form,19 crystal 
structures reveal it is exposed to solvent until the primary substrate, CTAD, is bound.20,21 
The resting form of FIH and other αKG oxygenases have been shown to slowly activate 
O2 in the absence of the primary substrate, suggesting exogenous ligands could access a 
diffusible site on the Fe.  The rate of O2 activation only increases upon the binding of 
prime substrate as a combination of steric interactions with the substrate, strong donor 
ligands and the H-bonds in the second coordination sphere promote aquo release opening 
a coordination site for O2 to bind.22  In structures where the aquo ligand is resolved, the 
facial triad carboxylate of FIH is well positioned to hydrogen bond to the Fe-
H2O,20,21,23,24 may be a key structural feature controlling O2 activation and preventing 
exogenous ligand binding (Figure 6.1). 
 
Figure 6.1 (Left) Active site of (Fe+αKG+CTAD)FIH.  αKG(yellow), CTAD (green),  
PDB: 1H2L.20 (Right) Active site of (Fe+αKG+Notch-1)FIH. αKG(yellow),  PDB: 
3P3P.23  Bond lengths shown in angstroms. 
 
In this work, three Asp201→X (X=Glu, Gly, Ala) variants were constructed to 
perturb the active site H-bonding to the Fe-H2O.  Steady-state kinetic characterization 
indicated the Asp201→Glu and Asp201→Gly variants exhibited diminished hydroxylation 
activity compared to WT FIH; Asp201→Ala was inactive under all tested assay 
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conditions. The kcat/KM(O2) for Asp201→Gly (0.18 µM-1min-1) was unchanged compared to 
WT, whereas there was a ten fold decrease in the  kcat/KM(O2) for Asp201→Glu (0.014 µM-
1min-1), suggesting Asp201 was crucial to O2 activation.   Moreover, activity based screens 
and UV-Vis spectroscopy identified exogenous ligands that could interact with the active 
site Fe of the Asp201→X variants, indicating the facial triad carboxylate may serve as a 
selectivity filter. 
 
6.2 Methods 
6.2.1 Steady-State Kinetics 
A three component buffer consisting of 20 mM MES, 20 mM PIPES, 20 mM 
HEPES with controlled ionic strength (I=100mM) adjusted using NaCl was used between 
the pH range 5.50 and 8.50; 20 mM TABS (I=100 mM) over the pH range 8.20-9.60; and 
20 mM CHES (I=100 mM) over the pH range 9.00-9.88.  The reaction buffer for assays 
where CTAD was the varied substrate contained ascorbic acid (2 mM), αKG (100 µM), 
FeSO4 (25 µM) and CTAD (15-275 µM).  Assays in which αKG was the varied substrate 
(0-200 µM) contained ascorbate (2 mM), FeSO4 (25 µM) and a fixed CTAD 
concentration (80 µM). Initial rate measurements were made as previously described 
using a Bruker MicroFlexII MALDI-TOF-MS and fit to the Michaelis-Menten equation 
resulting in the apparent kinetic parameters kcat and kcat/KM(CTAD) or kcat/KM(αKG). 
Regression plots were created from the steady-state assays where CTAD was the 
varied substrate, plotting kcat or kcat /KM(CTAD) as a function of pH.  Plots that displayed a 
bell shape curve were fit to equation 6.1 where kMax is the maximal rate of the enzyme, 
pKa1 is the pKa at low pH and  pKa2 is the pKa at high pH.  
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𝑦 = 𝑘!"# 1+ 10!"#!!!" + 10!"!!"#!  Equation 6.1 
 
Plots displaying a sigmoidal shape were fit to equation 6.2 where enzH is the rate 
of the fully protonated enzyme species and enz is the rate of the conjugate base. 
 
𝑦 = !"#$∗!" !! !!"#∗!"!!"#!" !! !!"!!"#  Equation 6.2 
 
6.2.2 Exogenous Ligand Screens 
Reactions were performed at 37°C with ambient [O2] (217 µM).  The reaction 
buffer consisted of 50 mM HEPES 100 mM NaCl pH 7.00, ascorbic acid (2 mM), CTAD 
(100µM) and saturating conditions of αKG (100µM) and FeSO4 (25 µM).  Small 
molecule assays contained either 2 mM of a sodium salt compound (acetate, azide, 
bicarbonate, cyanide, cyanate, thiocyanate, nitrate, nitrate), 1.33 mM DEANO (2 mM 
NO) or CO (750 µM).  The control assay for CO used an equivalent volume of anaerobic 
buffer instead of CO saturated buffer.  Compounds were added to the reaction buffer 
prior to initiating the reaction with enzyme (0.5 µM).  Hydroxylation activity was 
monitored by determining the mole fraction of CTADOH using MALDI-TOF-MS as 
previously described.  
6.2.3 Steady-State Kinetics varying O2 
Mixtures of N2 and O2 were used to vary the oxygen concentration inside an 
AtmosBag (Sigma-Aldrich).  Once the atmosphere of the bag was equilbrated, 50 mM 
HEPES pH 7.00 containing 100 mM NaCl was gently stirred for ten minutes at 37.0°C to 
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equilibrate the reaction buffer with the atmosphere.  The O2 concentration of the buffer 
was recorded using a Clarke electrode. 
Steady-state assays in which O2 was the varied substrate (0.020 mM – 1 mM) 
utilized a fixed CTAD788-826 concentration of 80 µM (~KM(CTAD)) and saturating 
concentrations of FeSO4 (25 µM), αKG (100 µM) and ascorbate (2 mM), prepared in 50 
mM HEPES pH 7.00 containg 100 mM NaCl. Upon addition of all reagents except FIH, 
the reaction mixture (45 µL) was incubated at 37.0 °C for two minutes.  The enzyme 
stock was equilibrated to the atmosphere by gently pipetting the solution down the side of 
the microcentrifuge tube.  Assays were initated with an injection of FIH (5 µL).  Reaction 
aliquots were removed throughout a two minute time course, quenched in 75% 
acetonitrile/0.2% TFA (20 µL) saturated with 3,5-dimethoxy-4-hydroxycinnamic acid 
and analyzed for the initial rate of formation of CTADOH using a Bruker microFlex 
MALDI-TOF-MS. Initial rates were determined as previously described25 and fit to the 
Michaelis-Menten equation resulting in the kinetic parameters kcat KM(O2), and kcat/KM(O2).  
The values reported for each kinetic parameter are an average of a minimum of three 
trials. 
6.2.4 Auto-hydroxylation Assays 
Autohydroxylation assays were performed as previously described.26  Briefly, all 
reagents except buffer were degassed individually by argon flush before being handled in 
a glove box.  The buffer (50 mM HEPES pH 7.00) was made anaerobic using multiple 
cycles of vacuum and N2 flush. Samples containing FIH (100µM), FeSO4 (100µM) and 
αKG (500µM) in 50 mM HEPES pH 7.00 were prepared in a masked cuvette and sealed.  
Removal of the cap exposed the anaerobic samples to air, allowing for slow oxidation of 
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the samples.  Experiments were performed at room temperature and all spectra were 
collected using an Agilent HP 8453 diode-array UV-Vis spectrometer. 
6.2.5 Circular Dichroism(CD) Spectroscopy 
Samples containing FIH (10 µM) FeSO4 (10 µM) and n-oxalylglycine (NOG) (10 
µM) in 5 mM MPH buffer (pH 6.85 or 8.50) at 20°C were gently mixed before being 
placed in a quartz cuvette with 0.1 cm path length.  CD spectra were monitored from 250 
nm to 200 nm, measured on a Jasco J-720 circular dichroism spectrometer.  All spectra 
were normalized using equation 6.3, where θmilli is the measured molar ellipticity, MRW 
is the mean molar ellipticity, L is the pathlength of the cell and C is the concentration of 
the sample. 
 𝜃!"# = !!"##"!"∗! !"#! !" !" Equation 6.3 
 
6.2.6 UV-Vis Absorption Spectroscopy  
FIH and αKG were made anaerobic by argon flush.  The buffer was made 
anaerobic by multiple cycles of N2 and vacuum flush. FeSO4 and all exogenous ligands 
were brought into the glovebox as solids and then dissolved in either anaerobic water or 
buffer.  Samples contained FIH(500 µM), FeSO4 (475 µM) and αKG (500 µM) in 50 
mM HEPES pH 7.00 containing 100 mM NaCl and were prepared anaerobically in a 
glove box.   Each ligand (L, L= acetate, azide, bicarbonate, cyanide, cyanate, nitrate, 
nitrite, thiocyanate, CO, NO) was titrated into an individual (Fe+αKG)FIH sample.  An 
Avantes UV-Vis spectrometer was used with an integration time (25 ms), averaging (25) 
  
 
139 
was used to record all spectra.  (Fe)FIH spectra were subtracted from (Fe+αKG)FIH or 
(Fe+αKG+L)FIH resulting in the observed spectral features. 
6.2.7 Dose Response curves 
Assays to determine the IC50 for NaN3 and NO were performed at 37°C in air 
saturated 50 mM HEPES pH 7.00 containing NaCl (100 mM), αKG (100 µM), FeSO4 
(25 µM), ascorbate (2 mM), CTAD (100 µM) and either NaN3 or NO (0-2 mM).   Initial 
rates were normalized to percent activity and fit to a single-site dose response curve.  The 
Hill coefficient was fixed at -1 for all fits. 
NO was generated from dissolving DEA NONOate in 0.01 M NaOH.  The 
concentration of DEA NONOate was determined from the A250 (6500 M-1cm-1).  DEANO 
generated 1.5 moles of NO per mol of donor molecule with a t1/2= 3 minutes at 23°C at 
pH 7.00.  After addition of NO, assays were aged for 1 min at 37°C before initiation.  NO 
concentrations were estimated based off of concentration of DEA NONOate added. 
 
6.3 Results and Discussion 
 Numerous crystal structures of αKG oxygeneases show the noncoordinating O to 
show the facial triad carboxylate to form contacts with the diffusible ligand site of the 
Fe.27–32 Previous studies by Somolon and coworkers have shown when the 
noncoordinating O is well positioned for H-bonding, the Fe-H2O is strongly 
coordinated,19,33–35 indicating the facial triad carboxylate may have a crucial role in H2O 
binding and its substrate-triggered release, as well as subsequent O2 activation.  As we 
have shown FIH to be an excellent enzyme to study O2 activation in the αKG 
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oxygenases, we characterized three facial triad variants of FIH to understand the 
contributions of the facial triad to O2 reactivity. 
6.3.1 Initial steady-state characterization 
 The Asp201→Glu, Asp201→Ala and Asp201→Gly variants of FIH were 
constructed, purified and kinetically characterized in vitro (Supplementary Data). Our 
initial steady-state characterization of these variants varying CTAD at pH 7.00 revealed 
WT-like activity for Asp201→Gly (kcat=23 ± 2 min-1) and diminished activity for 
Asp201→Glu (kcat=1.6 ± 0.2 min-1) (Supplementary Data). Hydroxylation activity was not 
detected for Asp201→Ala.  As the Asp201→X variants may have altered the optimal pH 
for turnover, pH profiles were constructed for WT FIH and each Asp201→X variant 
(Figure 6.2).  
 
 
Figure 6.2. (Left) Regression plot of kcat as a function of pH. (Right)  Enlarged 
regression plot of kcat as a function of pH for Asp201→Glu.  Assays contained ascorbic 
acid (2 mM), αKG (100µM), FeSO4 (25 µM) and CTAD (15-275 µM) in 60 mM MPH, 
I=100 mM (pH 5.50-8.50), 37°C. 
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6.3.2 WT FIH kcat is pH independent 
At saturating concentrations of CTAD and αKG, kcat was independent of pH 
between pH 6.50 and pH 9.88, with a value of 30 ± 2.5 min-1 (Figure 6.2).  As the pH 
dependence of kcat reflects enzyme forms found after CTAD binding, suggesting that 
there is no titratable acid or base present in those enzyme forms.  
Saturating FIH with CTAD was difficult at basic pH values as reflected in the 
decreased kcat/KM(CTAD) values. kcat/KM(CTAD) decreased from a maximum of 0.43 ± 0.1 
µM-1min-1  at pH 6.50 to a minimum of 0.08 ± 0.01 µM-1min-1 at pH 9.88.  This pH 
profile was fit to equation 6.2, calculating a pKa of 8.9 ± 0.2 (Figure 6.3).  As 
kcat/KM(CTAD) is the rate constant for binding CTAD and going through the first 
irreversible step, binding of CTAD to FIH was likely responsible for the decreased 
kcat/KM(CTAD) at elevated pH.   
To further investigate the decreased kcat/KM(CTAD), intrinsic tryptophan 
fluorescence spectroscopy was used to determine CTAD’s binding affinity at pH 7.00 
and pH 9.88.  Under conditions where CTAD binding limits KM(CTAD), it is expected for 
the binding step that KM ~ KD.  The dissociation constant for CTAD/(Co+αKG)FIH was 
determined at pH 7.05 (KD = 92 ± 4 µM) and pH 9.88 (KD = 302 ± 17 µM).  The increase 
in KD at pH 9.88 very closely mirrored the three fold decrease in kcat / KM(CTAD), indicating 
that decreased CTAD binding affinity was responsible for the pH dependence of kcat / 
KM(CTAD).  
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Figure 6.3. (Left) Regression plot of kcat/KM(CTAD) as a function of pH. (Right)  Enlarged 
regression plot of kcat/KM(CTAD) as a function of pH for Asp201→Glu.  Assays contained 
ascorbic acid (2 mM), αKG (100µM), FeSO4 (25 µM) and CTAD (15-275 µM) in 60 
mM MPH, I=100 mM (pH 5.50-8.50), 37°C. 
 
6.3.3 Asp201→X activity is pH dependent 
Regression plot analysis of the kinetic parameters kcat and kcat/KM(CTAD) revealed 
that the activity of the Asp201→Gly and Asp201→Glu variants was pH dependent.  At pH 
6.85, WT-like activity was observed for Asp201→Gly (kcat = 25 ± 1 min-1), whereas 
Asp201→Glu had maximal activity between pH 6.85 and pH 7.35 (kcat = 1.5 ± 0.2 min-1).  
Asp201→Ala was inactive under all tested conditions. 
Multiple kinetic pKa values were observed on both kcat and kcat/KM(CTAD) for the 
Asp201→Gly variant at high pH.   The kinetic pKa on kcat/KM(CTAD) (7.4 ± 0.1) was 
identical to the kinetic pKa observed on kcat indicating a deprotonation on the ES complex 
led to the diminished activity at high pH (Figure 6.2 and 6.3). The Asp201→Gly variant 
also displayed a distinct kinetic pKa on kcat low pH, which was not kcat/KM(CTAD). This 
indicates an enzyme form after αKG decarboxylation is being protonated. The observed 
kinetic pKa at high pH for Asp201→Gly could be a result of an increased K(MαKG).  Steady-
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state assays varying αKG at pH 8.00 resulted in  K(MαKG)  values that were equivalent to 
the K(MαKG) at pH 7.00 (Supplemental Data).   
Kinetic pKas were observed on both kcat and kcat/KM(CTAD) for the Asp201→Glu 
variant. The kinetic pKa kcat/KM(CTAD) for Asp201→Glu (8.8 ± 0.3) closely mirror the 
kinetic pKa observed on kcat.  As both kcat and kcat/KM(CTAD) have similar pKa, it is likely 
the deprotonation affects a common kinetic step.  
6.3.4 Secondary Structure of Asp201 Variants 
The kinetic pKas on kcat at high pH could be a result of protein instability.  Far-UV 
CD spectroscopy was used to probe the possibility of the attenuated activity of the Asp201 
was a result of the unfolding of FIH’s secondary structure.  The CD spectra of WT FIH 
and the Asp201 variants at pH 6.85 were nearly superimposable, suggesting the attenuated 
activity was not a result of significant changes in secondary structure.  The CD spectra 
collected for the Asp201 variants at pH 6.85 and pH 8.50 were also nearly superimposable 
(Supplemental Data).  This suggests the variants are stabile between pH 6.85 and 8.50 
and the kinetic pKas observed are not a result of protein denaturation.  
6.3.5 Steady-State Kinetics Varying O2 
The most meaningful correlations for O2 activation are reported on the second 
order rate constant kcat/KM(O2). In WT FIH, O2 activation is quite slow (kcat/KM(O2)=0.21 
µM-1 min-1), which may be in part due to a strong H-bond between Asp201 and the Fe-
H2O.  To probe for changes in the rate of O2 activation for the Asp201 variants, steady-
state kinetics with O2 as the varied substrate were performed (Figure 6.4). 
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Figure 6.4 Steady-state kinetics varying O2.  (Left) WT () and D201G () (Right) D201E.  
Assays contained ascorbic acid (2mM), αKG (100 µM), FeSO4 (25 µM) and CTAD (80 
µM) in 50 mM HEPES pH 7.00 containing 100 mM NaCl. 
 
The Asp201→Gly and the Asp201→Glu variants displayed Michaelis-Menten-like 
kinetics, whereas the Asp201→Ala did not hydroxylate CTAD at neither high nor low O2 
concentrations.  The kcat/KM(O2) for Asp201→Gly (0.20 µM-1 min-1) mirror the kcat/KM(O2) 
for WT.  However, a ten fold decrease in kcat/KM(O2) was measured for Asp201→Glu 
(0.020 µM-1 min-1).  The KM(O2) for both Asp201→Gly (115 µM) and Asp201→Glu (70 
µM) decreased compared to that of WT FIH (210 µM) (Table 6.1). 
Table 6.1 Kinetic parameters of FIH and Asp201→X variants, 50 mM HEPES pH 7.00. 
 kcatapp 
(min-1) 
kcat/KM(O2)app 
(µM-1 min-1) 
KM(O2)app 
(µM) 
WT FIHa 33 ± 3 0.17 ± 0.03 200 
Asp201→Glu 1.0 ± 0.2  0.014 ± 0.002 70 
Asp201→Gly 21 ± 2 0.18 ± 0.02 115 
Asp201→Ala b b b 
 
a. Data collected in Chapter 4.  
b. No hydroxylaion activity detected. 
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6.3.6 UV-Vis Absorption Spectroscopy 
The altered hydroxylation activity of the variants led us to probe if the electronic 
environment of the Fe active site was perturbed due to the mutation to Fe coordinating 
residue.  A metal -to-ligand charge transfer (MLCT) attributed to transitions between the 
Fe t2g(π) and the αKG π* orbitals are typically  centered ~500 nm for the αKG 
dioxygenases.  The MLCT for (Fe+αKG)WT is centered at 500 nm and the MLCT 
observed for (Fe+αKG)Asp201→Glu is centered at 505 nm.  However, the MLCTs for 
both (Fe+αKG)Asp201→Gly and (Fe+αKG)Asp201→Ala are centered at 485 nm (Figure 
6.5). The observed MLCT indicated all three variants can bind FeSO4.  The altered Fe(II) 
electronic environment does not account for Asp201→Ala’s lack of hydroxylation 
activity, suggesting other structural factors influence hydroxylation chemistry. 
 
 
Figure 6.5 Anaerobic UV-Vis spectra of WT FIH and the Asp201 variants showing the 
MLCTs for (Fe+αKG)WT (λMax=500nm), (Fe+αKG)Asp201→Glu (λMax=505nm), 
(Fe+αKG)Asp201→Ala (λMax=485nm) and (Fe+αKG)Asp201→Gly (λMax=485nm) after 
subtraction of (Fe)FIH.  50mM HEPES pH 7.00. FIH (400 µM), FeSO4, (375 µM), αKG 
(400 µM). Spectra offset for clarity. 
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6.3.7 Auto-hydroxylation of FIH and variants 
EPR data collected by Cornelius Taabazuing (data not shown) suggests these 
variants are constitutively triggered, which would allow for increased O2 activation even 
in the absence of CTAD. To test this, we performed auto-hydroxylation assays to 
measure the rate of O2 activation in the Asp201→X variants. Samples containing apo-FIH 
or Asp201→X, FeSO4 and αKG were prepared anaerobically and then exposed to air 
allowing for the slow oxidation of the sample.  UV-Vis spectroscopy was used to monitor 
the changes in the (Fe+αKG)FIH absorption spectra as a function of time. 
The slow oxidation of anaerobic (Fe+αKG)WT exhibits the formation of a new 
chromophore (λMax = 583 nm) at a rate of 0.35 µM min-1. This chromophore has 
previously attributed to the auto-hydroxylation of protein forming Fe(III)-O-Trp296 26,36   
and can be thought of as the basal rate for O2 activation. (Fe+αKG)Asp201→Glu forms 
the same chromophore (λMax = 583 nm) as WT FIH, but at significantly faster initial rate 
(2.2 µM s-1) (Figure 6.6). This suggests this mutation perturbs the active site increasing 
the basal rate O2 activation. 
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Figure 6.6  (Left)Time course following the formation of purple FIH.  Samples were 
preared anaerobically before being exposed to air.   FIH (100 µM), FeSO4 (100 µM) and 
αKG (500 µM) in 50 mM HEPES pH 7.00 containing 100 mM NaCl. Inset:  Time course 
for Asp201→Glu. (Right)  UV-Vis spectra following the formation of the Fe(III)-O-
Trp296. 
 
When (Fe+αKG)Asp201→Gly and (Fe+αKG)Asp201→Ala were exposed to air, a 
pink chromophore formed with λMax =515 nm (ε515=2500 M-1 cm-1)  and λMax =510 nm 
(ε510= 2000 M-1 cm-1) respectively (Figure 6.7). The formation of these chromophores 
were O2-dependent, as they only formed after the sample was exposed to oxygen.  The 
rate of formation was significantly higher (1.4-2.2 µM min-1) when compared to that of 
WT FIH.  The 583 nm chromophore associated with Trp296 autohydroxylated was not 
observed. 
The new chromophores observed for Asp201→Ala and Asp201→Gly indicate an 
altered electronic environment of the Fe(II) active site.  This new chromophore could 
arise as a result of numerous new interactions, including a stabile Fe-O2 complex, an 
autohydroxylated residue, or the binding of succinate or another reaction intermediate.   
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Figure 6.7 (Left) Timecourse following the formation of 510nm chromophore observed 
upon exposure of (Fe+αKG)Asp201→Ala to air. Inset: UV-Vis spectra of 510nm 
chromophore (Right) Timecourse following the formation of 515nm chromophore 
observed upon exposure of (Fe+αKG)Asp201→Gly to air.  Inset: UV-Vis spectra of 515 
nm chromophore.  All samples were prepared anaerobically containing FIH (100 µM), 
FeSO4 (100 µM) and αKG (500 µM) in 50 mM HEPES pH 7.00 containing 100 mM 
NaCl before being exposed to air. 
 
To probe if these new chromophores were a result of succinate binding, we 
monitored the MLCT of anaerobic (Fe+αKG)Asp201→Ala and (Fe+αKG)Asp201→Gly in 
the presence and absence of succinate.  The MLCTs for (Fe+αKG)Asp201→Ala and 
(Fe+αKG)Asp201→Gly were centered at 485 nm. Upon addition of succinate to these 
complexes, the (Fe+ αKG+succinate)Asp201→Gly/Ala MLCT remained centered at 485 
nm.  This suggests the new chromophores observed when exposed to O2 are not due to 
succinate rebinding to the active site and points towards the new chromophores forming 
as a result of either a stabile Fe-O2 complex or an autohydroxylated residue.   
Once the ferryl forms, it can either interact with solvent, as observed with the 
Gln239 variants or undergo HAT with a nearby residue of appropriate electron density, 
leading to autohydroxylation.   Autohydroxylation of Tyr93, Tyr102, or Tyr145 could result 
in the new observed chromophore observed in the Asp201→Gly/Ala variants.  Tyrosine 
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has been found to be autohydroxylated in the related αKG oxygenase TauD with a 
chromophore centered at 550 nm.37 Studies using QSTAR-TOF-MS are currently being 
employed to determine if a new residue is being autohydroxylated in the 
Asp201→Gly/Ala variants. 
6.3.8 Exogenous ligands access the active site 
A series of ligands were selected as probes for the accessibility of the Fe.  Ligands 
which bound to the Fe would block O2 activation, inhibiting FIH.  Ligands were 
categorized as either an O2 mimic (NO, CO, NaCN), a CO2 mimic (NaN3, 
NaHCO3,NaNO2) or complex ions (NaNO3, NaOCN, NaSCN, NaC2H3O2).  Of the ten 
ligands screened only the O2 mimic, NO, had a significant inhibitory effect on WT 
(Figure 6.8).  NaCN modestly inhibited activity, but UV-Vis spectroscopy indicated the 
inhibition was likely due to iron sequestration (Supplementary Data).  The reduced rate 
observed in the presence of CO was due to O2 depletion rather than inhibition of FIH.  
None of the compounds classified as either CO2 mimics or complex ions resulted in 
inhibition.  Additionally, UV-Vis spectroscopy revealed no change in the metal-ligand 
charge transfer in the presence of each exogenous ligand.  Combined, this data suggests 
WT FIH has developed mechanisms for ligand selectivity. 
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Figure 6.8 Activity screen for WT FIH.  Control assays were performed at 37°C in 50 
mM HEPES pH 7.00 containing100 mM NaCl, ascorbate (2 mM), αKG (100 µM), 
FeSO4 (25 µM), CTAD (100 µM).  Screen assays used identical buffer containing 
exogenous ligand (2 mM), with the exception of CO (750 µM).   
   
The activity of the Asp201→Glu and Asp201→Gly variants were screened in the 
presence of the same ten ligands as WT FIH, to probe the role of the facial triad 
carboxylate as a selectivity filter.  Selectivity was evident from the differential inhibition 
observed from the screen.  Hydroxylation activity of both the Asp201→Glu and 
Asp201→Gly variants was inhibited by the O2 mimic ligands, NO and NaCN, as well as 
by the CO2 mimic, NaN3 (Figure 6.9).  
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Figure 6.9 Activity screen for Asp201→Glu and Asp201→Gly.  Control assays were 
performed at 37°C in 50 mM HEPES pH 7.00 100 mM NaCl containing ascorbate (2 
mM), αKG (100 µM), FeSO4 (25 µM), CTAD (100 µM).  Screen assays used identical 
buffer containing exogenous ligand (2 mM), with the exception of CO (750 µM).  
Reactions were initiated with either Asp201→Glu (5 µM) or Asp201→Gly (2 µM). 
 
As with WT FIH, UV-Vis absorption spectroscopy indicated Fe sequestration in 
the presence of NaCN, making it unclear whether or not CN- was bound to the active site 
(Supplementary Data).  In the presence of NaN3, shifts in the MLCTs were observed, 
whereas in the presence of NO a LMCT dominated the observed spectra (Figure 6.10).  
These new spectra features were a result of each compound interacting with the diffusible 
ligand site suggesting this was the mode of inhibition.  Previously reported methods using 
UV-Vis absorption spectroscopy have allowed for the binding affinity of anionic ligands 
be determined through the formation of these new spectral features.38 Although a clear 
shift in the MLCT was apparent, we were unable to obtained accurate binding affinities 
due to low signal-to-noise ratios in the difference spectra. 
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Figure 6.10 MLCTs for (Fe+αKG)Asp201→Glu and (Fe+αKG)Asp201→Gly. 50mM 
HEPES pH 7.00. FIH (400 µM), FeSO4, (375 µM), αKG (400 µM), (___) NaOCN or (…) 
NaN3 (2 mM). 
 
The ligand screen also identified NaOCN as an activator of Asp201→Gly.  Under 
the same conditions, Asp201→Ala hydroxylation activity (v/[E] = 11 min-1) was also 
rescued with NaOCN; none of the other exogenous ligands rescued Asp201→Ala 
hydroxylation activity.  The selective activation of variants where the carboxylate is 
absent suggests OCN- is interacting with the coordination site of the missing carboxylate, 
rather than with the axial ligand diffusible site.  Additional experiments are needed to 
further investigate the mechanism of activation. 
Asp201→Glu and Asp201→Gly displayed a simple dose-response to NaN3 and NO 
indicating inhibition occurred at a single site and that these two ligands were effective 
inhibitors of the variants.(Figure 6.11) The IC50’s for both Asp201→Glu and Asp201→Gly 
were at significantly lower concentrations than that of WT (Table 6.2), suggesting that 
Asp201 played a marked role in ligand selectivity. NO showed the highest level of 
inhibition for both Asp201→Glu (4 ± 0.4 µM) and Asp201→Gly (22 ± 2.0 µM), closely 
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mirroring the trend observed for the change in the K(MO2).  NaN3 inhibited both 
Asp201→Glu  (280 ± 20 µM) and Asp201→Gly (130 ± 15 µM) in an opposite trend 
observed for the NO inhibition.   
 
  
Figure 6.11 (Left) Dose response curves for NaN3 (Right) Dose response curves for NO. 
Asp201→Glu(n), Asp201→Gly(q), WT (l).  Assays were performed at 37°C in 50 mM 
HEPES pH 7.00 containing 100 mM NaCl, ascorbic acid (2 mM), αKG (100 µ), FeSO4 
(25 µM), and CTAD (100 µM) and either NaN3 (0-5 mM) or NO (0-0.8 mM). 
 
Table 6.2 IC50 values for FIH, Asp201→Glu and Asp201→Gly 
 NaN3 NO 
WT FIH > 2000 80 ± 10 
Asp201→Glu 280 ±20 4.0 ± 0.4 
Asp201→Gly 130 ± 15 22 ± 2.0 
Asp201→Ala b b 
a. Assays were performed in 50 mM HEPES pH 7.00 containing 100 mM NaCl 
ascorbate (2 mM), αKG (100 µ), FeSO4 (25 µM), and CTAD (100 µM), 37.0C 
b. Not determined 
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6.4 Conclusion 
In summary, Asp201 is critical to controlling O2 activation, as well as important for 
O2 selectivity in the hypoxia sensing enzyme FIH.  Disruption of the H-bond between 
Asp201 and the Fe-H2O leads to rapid autohydroxylation. It also allows new small 
molecules to access and interact with the diffusible site on the Fe.  The steric and 
electrostatic interactions of the active site still limit the binding of all exogenous ligands 
suggesting there are additional residues that contribute to ligand selectivity.  As the facial 
triad carboxylate is conserved among this family of enzymes, it possibly serves as a 
selectivity filter among other Fe(II)/αKG dioxygenases.  
 
6.5 Supplemental Information  
6.5.1 Steady-State Characterization of WT FIH, Asp201→Glu and Asp201→Gly 
Steady-state assays were performed in 50 mM HEPES pH 7.00 100 mM NaCl at 
37°C with saturating conditions of ascorbic acid (2 mM), αKG (100 µM), FeSO4 (25 
µM) and an ambient [O2] (217 µM). Reactions were initiated with an aliquot (5 µL) of 
enzyme (0.5-5 µM).  Over a predefined time course (1.25 minutes), reaction aliquots 
were quenched with 75% acetonitrile/0.2% TFA saturated with 3,5-dimethoxy-4-
hydroxycinnamic acid.  Samples were analyzed using a Bruker microFlexII as previously 
reported to determine initial rates.25 Initial rates were fit to the Michaelis-Menten 
equation to obtain the steady-state kinetic parameters kcat and kcat/KM. 
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 Figure 6.12 (Left) Steady-state kinetics varying CTAD for WT FIH and Asp201→Gly 
(Right) Steady-state kinetics varying CTAD Asp201→Glu.  Assays were performed at 
37°C in 50 mM HEPES pH 7.00 100 mM NaCl containing ascorbate (2 mM), αKG (100 
µM) and FeSO4 (25 µM). 
 
 
Table 6.2 Steady-state kinetic parameters of WT FIH, Asp201→Gly 
and Asp201→Glua 
 
a. Reactions contained ascorbate (2 mM), αKG (100 µM), FeSO4 (25 µM) and CTAD (0-
260 µM) in 50 mM HEPES pH 7.00, 37.0 °C. 
 
 
 
 
 kcat (min-1) 
kcat/KM(CTAD) 
(µM-1min-1) 
 
WT 33 ± 2 0.42 ± 0.08  
Asp201→Gly 1.6 ± 0.2 0.022 ± 0.002  
Asp201→Glu 23 ± 1 0.34 ± 0.05  
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6.5.2 Circular Dichroism 
 
 
Figure 6.13 Circular dichroism spectra WT FIH and the Asp201 variants at pH 6.85 
(solid) and pH 8.50(dashed).  Samples were prepared in 5 mM MPH buffer pH 6.85 
contain FeSO4 (10 µM), NOG(10 µM)  and enzyme (10 µM). 
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6.5.3 UV-Vis Spectroscopy 
Upon addition of NaCN, the MLCTs for WT, Asp201→Gly, and Asp201→Glu all 
significantly decreased over time, with a new absorption feature appearing at 420 nm.  
For WT FIH, this feature became prominent within 20 minutes, whereas for both variants 
it was present within approximately one minute.  We interpret these spectra as indicating 
CN- chelating the Fe from FIH’s active site forming [Fe(CN6)]3-1 [Fe(CN6)]4- + e-.  Thus, 
the inhibition observed in the initial screen is likely due to iron sequestration and not 
(Fe+αKG+CN-)FIH inhibition.   
6.5.4 Steady-State Kinetics varying αKG 
 
Figure 6.14 Steady-state kinetics varying αKG (5-200µM).  Reactions contained 
ascorbic acid (2 mM), FeSO4 (25 µM), CTAD (60 µM) and Asp201→Gly (1 µM) in 60 
mM MPH buffer (I=100 mM) pH 5.50 (red, p) or pH 8.00 (black, l ). 
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CHAPTER 7 
STERIC CONTRIBUTIONS OF FACIAL TRIAD CARBOXYLATE 
 
 
7.1 Introduction 
 
Two closely related subsets of nonheme Fe(II) enzymes are the Fe(II)/αKG 
halogenases and Fe(II)/αKG hydroxylases. The active site features of the hydroxylases 
and halogenases are remarkably similar.1  The hydroxylases coordinate the Fe through a 
2His-1Carboxylate ligand set, whereas the halogenases contain a non-coordinating Ala in 
place of the carboxylate and coordinate an equatorial halide (Figure 7.1).  As both of 
these enzymes families are able to activate O2, the facial triad carboxylate is not an 
absolute requirement to activate O2. 
 
 
Figure 7.1 Crystal structures of (Left) (Fe+αKG)FIH (PDB 1MZF)2 and (Right) 
(Fe+αKG+Cl-)SyrB2 (PDB 2FCT)3; Cl- is green and H2O is red. αKG is yellow in both 
structures. An unresolved axial ligand is noted for FIH.2 
 
The chemical mechanisms for these enzymes are nearly identical, diverging after 
the formation of the ferryl and HAT.  Both the Fe(II)/αKG hydroxylases and halogenases 
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bind the primary substrate and position it above the Fe(II). The binding of substrate 
triggers the loss of the axial aquo ligand, opening a coordination site for O2.4,5  The 
oxidative decarboxylation of αKG forms succinate, CO2 and a ferryl intermediate.6–9  The 
ferryl abstracts a hydrogen atom from the prime substrate forming a substrate 
radical/Fe(III)-OH complex.10,11  Following HAT, the mechanism diverges, catalyzing 
either hydroxylation or halogenation based on the rebound of either •OH or Cl•. (Scheme 
7.1) 
 
 
Scheme 7.1  Mechanism of Fe(II)/ αKG hydroxylases and Fe(II)/ αKG  halogenases. 
R=primary substrate; for hydroxylases X=Carboxylate; for halogenases X=halide. 
 
 
The positioning of substrate has been found to partition hydroxylation chemistry 
and halogenation in SyrB2,12 indicating the carboxylate is not a requirement for 
hydroxylation chemistry. However, previous attempts to convert hydroxylases to 
halogenases via a carboxylate to Ala substitution have been unsuccessful.13,14  Likewise, 
Ala to carboxylate substitutions have been unsuccessful in converting halogenases to 
hydroxylases.3 We hypothesized the steric contributions of the facial triad carboxylate 
were key for hydroxylation chemistry for the Fe(II)/αKG hydroxylases. 
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Factor Inhibiting HIF (FIH) is an Fe(II)/αKG hydroxylase responsible for cellular 
O2 sensing in mammalian cells, regulating the transcriptional activity of factor hypoxia 
inducible factor (HIF).15 Under normoxic conditions, FIH hydroxylates HIF-Asn803 found 
in the C-terminal transactivation domain (CTAD) HIF leading to HIF inactivation.16,17 
FIH has been well characterized with spectroscopic18, computational19 and kinetic 
studies20–22 and is an ideal enzyme to probe the steric contributions of the facial triad 
carboxylate to hydroxylation activity.  
Three variants of FIH’s facial triad carboxylate have previously been reported:  
Asp201→Glu, Asp201→Ala and Asp201→Gly In the presence of chloride (50 mM), all 
three of the variants activated O2, but only Asp201→Gly hydroxylated CTAD.13  Crystal 
structures show the positioning of CTAD is unaffected in Asp201→Gly but only residues 
HIF-794-799 were resolved in the Asp201→Ala.13,23 The resulting diminished 
hydroxylation activity for Asp201→Ala may be attributed to the mis-positioning of 
substrate. We hypothesize the sterics of the active site carboxylate were key for 
hydroxylation chemistry. 
We screened the Asp201 variant’s hydroxylation activity in the presence of various 
sodium halide salts to probe the steric contribution of the facial triad carboxylate.  
Hydroxylation activity of the Asp201→Ala and Asp201→Gly variants were dependent on 
the sodium halide salt and Asp201→Glu exhibited no dependence; halogenase activity 
was not detected for any of the variants.     UV-Vis spectroscopy suggests the sodium 
halide salt had no affect the Fe(II) electronic environment.  Our data points towards the 
steric environment of FIH’s active site being key for CTAD hydroxylation. 
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7.2 Methods 
7.2.1 Activity assays with sodium halide salts 
The buffer used was 50 mM HEPES pH 7.00 and contained 100 mM of either 
NaF, NaCl, NaBr or NaI.  Each assay also contained ascorbic acid (2 mM), CTAD 
(100µM) and saturating conditions of αKG (100µM) and FeSO4 (25 µM).  Reactions 
were performed at 37°C with an ambient [O2] (217 µM).  Reactions mixtures were 
incubated at 37°C for two minutes before the addition of enzyme.  Initial rates were 
determined by quantifying the formation of CTADOH as previously described using a 
Bruker MicroFlexII MALDI-TOF-MS. 
7.2.2 UV-Vis Spectroscopy 
All reagents were prepared anaerobically by argon flush or multiple cycles of 
evacuation and N2 flush. Samples consisting of FIH (400 µM), FeSO4 (375 µM) and 
αKG (400 µM) were prepared in 50 mM HEPES pH 7.00 at 23°C containing 100 mM of 
either NaF, NaCl, NaBr or NaI and were prepared in an anaerobic glove box.  UV-Vis 
spectra of each sample were recorded anaerobically using an Avantes UV-Vis 
spectrometer with an integration time of 25 ms and averaging of 25 spectra.  (Fe)FIH 
spectra were subtracted from (Fe+αKG)FIH/Halide resulting in the observed MLCT. 
 
7.3 Results 
7.3.1 Halide Screen 
We hypothesize the steric contributions of the facial triad carboxylate, Asp201, 
were key to hydroxylation activity.  Two Asp201→X variants  (X=Ala, Gly) were 
constructed, forming an active site pocket in which exogenous ligand could potentially 
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access to coordinate the Fe.  Halides with an ionic radius capable of accessing the Fe and 
providing the proper steric environment would support hydroxylation activity. Thus, 
activity assays were used to screen the effect of sodium salt halides on the activity of WT 
FIH and the Asp201→X variants  (X=Ala, Gly, Glu).  
Both WT FIH and Asp201→Glu had a coordinating facial triad carboxylate and 
were not expected to exhibit halide-dependent activity.  WT FIH’s hydroxylation activity 
was unaffected by NaF, NaCl and NaBr.  However, in the presence of NaI, WT FIH 
activity was reduced two fold.  Under all assays conditions, hydroxylation activity of the 
Asp201→Glu variant was reduced 15 fold compared to that of WT FIH, indicating no 
halide dependence (Figure 7.2).  
Both Asp201→Gly and Asp201→Ala activity was dependent on the sodium salt 
halide.  Under our normal assay conditions containing no salt, Asp201→Gly activity was 
greatly diminished compared to WT and the Asp201→Ala variant was inactive.  However, 
both Asp201→Gly and Asp201→Ala hydroxylation activity was rescued upon addition of 
specific sodium salt halides to the reaction buffer. When NaCl was added to the reaction 
mixture, Asp201→Gly activity increased ten fold. Similarly, Asp201→Ala hydroxylation 
activity was rescued when the assays were performed in the presence of NaF (Figure 7.2). 
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Figure 7.2 WT FIH, Asp201→Glu, Asp201→Gly and Asp201→Ala Activity screen in the 
presence of sodium salt halides (100mM). 50 mM HEPES pH 7.00, 37°C. 
 
The Asp201→Gly and Asp201→Ala variants provided a new active site pocket, 
which could potentially accommodate a halide ligand. Upon formation of the substrate 
radical/Fe(III)-OH, if halide rebound was more favorable than •OH, halogenation 
chemistry would occur.  However, halogenated CTAD was not detected from assays with 
WT or any of the Asp201→X variants. 
7.3.2 UV-Vis spectroscopy 
The halide-dependent activity observed with Asp201→Ala and  Asp201→Gly lead 
us to explore if the increased activity was due the halide altering the electronic 
environment of the active site Fe.  Halides that interacted with the Fe would alter the Fe 
electronic environment, shifting the MLCT.  
The MLCTs for WT and Asp201→Glu have been previously recorded in the 
absence of salt and are centered at 500 and 505 nm respectively.  Regardless of the added 
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halide, the MLCTs for WT and Asp201→Glu remained unchanged, suggesting the halide 
did not affect the electronic environment of Fe active site.  
The MLCT for Asp201→Ala and Asp201Gly have also been previously recorded in 
the absence of added salt, with the MLCTs centered at 485 nm.  The Asp201→Gly MLCT 
remained centered at 485 nm in the presence of each added sodium halide salt (Figure 
7.3).  This suggests the halides do not interact in the active site.   
The Asp201→Ala MLCT also remained centered at 485 nm in the presence of 
NaCl, NaBr and NaI.  The MLCT for (Fe+αKG)Asp201Ala/NaF  was red shifted 15 nm 
and was centered at 500 nm (Figure 7.4). The shift in the MLCT suggests the F- ion 
interacts with the Fe(II) and helps to stabilize the active site. 
 
  
Figure 7.3  UV-Vis spectra of (Left )(Fe+αKG)WT; (Right) (Fe+αKG)Asp201→Glu; 
Samples consisted of FIH (400 µM), αKG (400 µM) and FeSO4 (375 µM) in 50 mM 
HEPEs pH 7.00 with 100 mM NaF, NaCl, NaBr or NaI. 
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Figure 7.4 UV-Vis spectra of (Left) (Fe+αKG)Asp201→Ala;(Right) 
(Fe+αKG)Asp201→Gly.  Samples consisted of FIH (400 µM), αKG (400 µM) and FeSO4 
(375 µM) in 50 mM HEPES pH 7.00 with 100 mM NaF, NaCl, NaBr or NaI. 
 
7.4 Discussion 
7.4.1 Hydroxylation vs. Halogenation 
Even though there are remarkable similarities between the active sites of 
Fe(II)/αKG hydroxylases and Fe(II)/αKG halogenases, efforts to interconvert the 
enzymes reactivity have largely been unsuccessful.  Attempts to convert the Fe(II)/αKG 
hydroxylases P4H and FIH to halogenases by mutation of the facial carboxylate to Ala 
(and Gly) have been unsuccessful, suggesting simple coordination of halides to the Fe(II) 
is not the only prerequisite for halogenase active.13,14 The Fe(II)/αKG halogenase SyrB2 
is capable of both hydroxylation and halogenation.  Numerous studies have been 
undertaken to understand the molecular basis between halogenation and hydroxylation 
chemistry.  Experimental and computational studies point toward the positioning of 
substrate as a key factor separating hydroxylation and halogenation chemistry,12,24,25 with 
substrates that are closer to active site favoring halogenation over hydroxylation. 
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The positioning of substrate is the prominent reoccurring theme between 
hydroxylation chemistry and halogenase or azidation or nitration chemistry. The FIH-
Asp201→Ala/Gly variants activity is halide specific, with the halide presumably at the 
active site.  However, FIH positions HIF-Asn803 directly over the active site such that 
•OH rebound is favored over Cl•.  
7.4.2 Sterics control hydroxylation 
Mutation of the facial triad carboxylate has proven deleterious to hydroxylation 
activity in numerous Fe(II)/αKG dioxygenases.  Mutation of this residue to Ala or Gly 
creates a pocket in the active site, leading to multiple reasons for the diminished 
hydroxylation activity.  Three prominent explanations include the variant cannot bind 
iron, the electronic environment of the Fe(II) has been altered making O2 reactivity less 
favorable and the steric contributions from the carboxylate are need to position substrate 
and/or direct the ferryl intermediate. Increased concentrations of iron did not rescue 
PAHX activity26 and the FIH-Asp201 variants have previously been shown to produce 
succinate13 making it is unlikely iron binding and/or O2 activation has been affected. The 
chemical rescue of the Asp201→Ala and Asp201→Gly variants with different sodium 
halide salts point to the steric contributions of Asp201 key to hydroxylation activity.  
Chemical rescue of similar mutations in Chlamydomonas reinhardtii P4H with 
halides have been unsuccessful.14 The crystal structures P4H show the noncoordinating O 
atom of the carboxylation does not make a hydrogen bond to the Fe-H2O27, whereas FIH-
Asp201 is well positioned to H-bond.2  The chemical rescue with halides point towards the 
steric contributions of the carboxylate O atom in FIH having a more significant role in 
directing hydroxylation chemistry than in P4H. 
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The Asp201→Gly and Asp201→Ala vary to the distance between the Fe(II) and the 
sidechain, altering the size of the pocket formed. Based on the distance between the Cα 
of Asp201 and the Fe(II), the upper limit for the diameter of this pocket is 5.40 Å.  Based 
strictly on bond lengths, the sidechains of Asp201→Gly and Asp201→Ala would 
effectively make this diameter smaller by ~1.1 Å and ~2.6 Å, respectively. Crystal 
structures of (Fe+αKG+CTAD)Asp201→Ala and (Zn+αKG+CTAD)Asp201→Gly indicate 
the size of the pocket is altered due to the Ala side chain.  The size of the pocket could 
dictate which halides access this new active site pocket. The ionic radius of halides 
increases with increasing atomic weight, with F- (1.33 Å) and Cl- (1.81 Å) having the 
smallest ionic radius and Br- (1.96 Å) and I- (2.2 Å) having the largest radius.28 The 
pockets of Asp201→Gly and Asp201→Ala variant pocket is likely large enough to 
accommodate either F- and Cl- whereas the Asp201→Ala variant pocket is significantly 
smaller, only capable of accommodating F-.  In agreement with this, Asp201→Ala was 
only activated in the presence of NaF.  However, Asp201→Gly was activated only in the 
presence of NaCl and not NaF, suggesting the correct steric environment is necessary for 
hydroxylation activity. 
7.5 Conclusions 
The Asp201→Ala and Asp201→Gly variants were rescued using NaF and NaCl 
respectively.  As these variant’s activity were only rescued with specific halides, the 
steric contributions of the facial triad carboxylate are key for hydroxylation chemistry.  
Additional experiments are necessary to fully resolve the steric contributions to O2 
reactivity and CTAD positioning, as well as the mechanism of rescue observed in the 
presence of NaCl. 
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CHAPTER 8 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
8.1  Conclusions and Future Directions 
 
 FIH is a robust enzyme which controls it’s overall activity through rate-limiting 
O2 activation.  This is a unique mechanistic feature among enzymes in the Fe(II)/αKG 
superfamily.   Previously characterized Fe(II)/αKG oxygenases have been found to be 
rate-limited by kinetic steps after O2 activation, with transient studies showing the ferryl 
intermediate to accumulate.  As FIHs function is key to O2 sensing, controlling O2 
activation ensures the ferryl does not accumulate.  This prevents aberrant oxidations of 
either FIH or substrate, and ensures efficient O2 sensing.  FIH is a model enzyme to 
elucidate molecular details surrounding O2 activation, directing biochemical studies 
towards kinetic steps of kcat/KM(O2) and not later steps in the mechanism.   
 Other enzymes in the Fe(II)/ αKG superfamily, including JmjC and JmjD domain 
containing proteins, also catalyze reactions with biomedical importance 1–3 .  As the 
mechanism of this family of enzymes is conserved, the chemical steps of O2 activation 
are a key feature for catalysis.  Do these enzymes also rate-limit activity through 
controlled O2 activation? Solvent isotope effects have been shown to be an effective 
mechanistic probe to Fe(II)/αKG oxygenases for rate-limiting O2 activation and can be 
used to initially probe these enzymes mechanism.   
 The structural basis for controlling O2 activation was probed through mutagenesis 
of two residues, Gln239 and Asp201. Mutation of Gln239 indicated the positioning of 
CTAD-Asn803 was key to increase O2 activation. The Gln239Ala had the highest level of 
activity of all the variants suggest the two hydrogen bonds are not an absolute 
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requirement for hydroxylation.  FIH has previously been shown to hydroxylate a variety 
of substrates containing ankyrin repeat domains, including IkB4 and Notch family 
proteins5.  It would be of interest to see how positioning by Gln239 affects O2 activation 
and hydroxylation these substrates.  Additionally, it may be possible for Gln239 Ala to 
accommodate alternative target residues, resulting in new hydroxylated products. 
 Mutation of Asp201 probed many different aspects of the facial triad carboxylate, 
indicating it served a key role in O2 selectivity and reactivity. Asp201 not only serves as a 
selectivity filter preventing exogenous ligands from accessing the active site, but also 
helps to control O2 reactivity for hydroxylation chemistry.   The position of the facial 
triad carboxylate O atom appears to have an impact in catalysis and additional studies are 
need to probe its contributions to O2 reactivity.  It is likely the KM(O2) of the Asp201 
variants have been altered and the characterization kcat/KM(O2) would elucidate the 
molecular details surrounding O2 activation.   
  Enzymes such as TauD with smaller substrates are better suited for initial studies 
to engineering proteins for alternative functions.  However, as the fundamental 
biochemical aspects surrounding the partitioning of hydroxylation and halogenase 
chemistry is better known, FIH may indeed be an ideal enzyme to engineer to catalyze 
nonnative chemistry. The identification residues of FIH that are key to substrate 
positioning and controlling O2 reactivity in this document are key to engineering FIH to 
accommodate and hydroxylate new substrates and/or perform alternative chemistry.  The 
application of this knowledge, combined with FIH inherent promiscuity, may allow for 
FIH to be engineered for alternative chemistry. 
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